{"SLR NAME":"Venous thromboembolism in COVID-19: a systematic review and meta-analysis","References":[{"title1":"Beneficial Effect of Statins in COVID-19–Related Outcomes—Brief Report","References":[{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: Summary of a report of 72314 cases from the chinese center for disease control and prevention.","References":[]},{"title2":"Coronavirus disease (COVID-2019) situation reports.","References":[]},{"title2":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications.","References":[]},{"title2":"Mental health care for medical staff in china during the COVID-19 outbreak.","References":[{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"By 24:00 on 9 February, the latest situation of new coronavirus pneumonia"},{"title3":"The psychological impact of the SARS epidemic on hospital employees in China: exposure, risk perception, and altruistic acceptance of risk"},{"title3":"The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus"},{"title3":"Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed"}]},{"title2":"The replication of a mouse adapted SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression of proinflammatory cytokines.","References":[{"title3":"Construction of a SARS-CoV infectious cDNA clone and a replicon to study coronavirus RNA synthesis"},{"title3":"Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome"},{"title3":"Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Persistent infection of SARS coronavirus in colonic cells in vitro"},{"title3":"Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus"},{"title3":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo"},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques"},{"title3":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo"},{"title3":"Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis"},{"title3":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"SARS coronavirus and innate immunity"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Coronavirus spike proteins in viral entry and pathogenesis"},{"title3":"RNA replication of mouse hepatitis virus takes place at double-membrane vesicles"},{"title3":"Susceptibility of different eukaryotic cell lines to SARS-coronavirus"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Brain tumors induced with Rous sarcoma virus, Schmidt-Ruppin strain. I. Induction of brain tumors in adult mice with Rous chicken sarcoma cells"},{"title3":"A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for de SARS coronavirus"},{"title3":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus"},{"title3":"Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Proliferative growth of SARS coronavirus in Vero E6 cells"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome"},{"title3":"Apoptosis induced by the SARS-associated coronavirus in Vero cells is replication-dependent and involves caspase"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Animal models and vaccines for SARS-CoV infection"},{"title3":"Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus"},{"title3":"Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium"},{"title3":"Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Molecular diversity of coronaviruses in bats"},{"title3":"SARS coronavirus induces apoptosis in Vero E6 cells"},{"title3":"Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection"},{"title3":"Detection of cell apoptosis in the pathological tissues of patients with SARS and its significance"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"},{"title3":"Virus-encoded proteinases and proteolytic processing in the Nidovirales"}]},{"title2":"Immune modulatory effects of statins.","References":[]},{"title2":"Treating influenza with statins and other immunomodulatory agents.","References":[]},{"title2":"Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis.","References":[]},{"title2":"Statins and the COVID-19 main protease: in silico evidence on direct interaction.","References":[{"title3":"Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV"},{"title3":"Going global - Travel and the 2019 novel coronavirus"},{"title3":"Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic"},{"title3":"Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2"},{"title3":"Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review"},{"title3":"Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019"},{"title3":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)"},{"title3":"Understanding the potential role of statins in pneumonia and sepsis"},{"title3":"Severe sepsis and septic shock"},{"title3":"Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms"},{"title3":"Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial"},{"title3":"Statin therapy reduces plasma endothelin-1 concentrations: a meta-analysis of 15 randomized controlled trials"},{"title3":"Association between statin use and plasma D-dimer levels: a systematic review and meta-analysis of randomised controlled trials"},{"title3":"New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect?"},{"title3":"Rationale of statin therapy in septic patients"},{"title3":"Statins suppress Ebola virus infectivity by interfering with glycoprotein processing"},{"title3":"Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study"},{"title3":"The crytal structure of 2019-NCoV main protease in complex with an inhibitor N3"},{"title3":"Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation"},{"title3":"Structure of Mpro from COVID-19 virus and discovery of its inhibitors"},{"title3":"Familial hypercholesterolemia and COVID-19: triggering of increased sustained cardiovascular risk"},{"title3":"Management of patients with familial hypercholesterolaemia"},{"title3":"Effect of statin therapy on arterial wall inflammation based on 18F-FDG PET/CT: a systematic review and meta-analysis of interventional studies"},{"title3":"Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies"},{"title3":"COVID-19 treatment by repurposing drugs until the vaccine is in sight"},{"title3":"A practical treatment for patients with Ebola virus disease"}]},{"title2":"Hiding in plain sight: an approach to treating patients with severe COVID-19 infection.","References":[{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19):China, 2020"},{"title3":"A practical treatment for patients with Ebola virus disease"},{"title3":"Simvastatin decreases lipopoly-saccharide-induced pulmonary inflammation in healthy volunteers"},{"title3":"Role of claudin-5 in the attenuation of murine acute lung injury by simvastatin"},{"title3":"Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases"},{"title3":"Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-kappaB pathways"},{"title3":"Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola"},{"title3":"Treating the host response to Ebola virus disease with generic statins and angiotensin receptor blockers"},{"title3":"Treating Ebola patients: a 'bottom up' approach using generic statins and angiotensin receptor blockers"},{"title3":"A randomized, controlled trial of Ebola virus disease therapeutics"},{"title3":"Treating Ebola in eastern DRC"},{"title3":"Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist"},{"title3":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications"},{"title3":"Imbalance between pulmonary angiotensin-converting enzyme and angiotensin-converting enzyme 2 activity in acute respiratory distress syndrome"},{"title3":"Do viral infections mimic bacterial sepsis? The role of microvascular permeability: a review of mechanisms and methods"},{"title3":"The Damage-Response Framework as a tool for the physician-scientist to understand the pathogenesis of infectious diseases"},{"title3":"Clinician-initiated research on treating the host response to pandemic influenza"}]},{"title2":"Massachusetts general hospital (mgh) COVID-19 treatment guidance.","References":[]},{"title2":"Out-of-hospital cohort treatment of coronavirus disease 2019 patients with mild symptoms in Korea: an experience from a single community treatment center.","References":[{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications"},{"title3":"Korean Society of Pediatric Infectious Diseases; Korean Society of Epidemiology; Korean Society for Antimicrobial Therapy; Korean Society for Healthcare-associated Infection Control and Prevention; Korea Centers for Disease Control and Prevention. Report on the epidemiological features of coronavirus disease 2019 (COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"}]},{"title2":"Virus isolation from the first patient with SARS-CoV-2 in Korea.","References":[{"title3":"Cultivation of a novel type of common-cold virus in organ cultures"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Isolation of Middle East respiratory syndrome coronavirus from a patient of the 2015 Korean outbreak"},{"title3":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures"},{"title3":"Processing tissue and cells for transmission electron microscopy in diagnostic pathology and research"},{"title3":"Simultaneous and complete genome sequencing of influenza A and B with high coverage by Illumina MiSeq Platform"},{"title3":"Viral subpopulation diversity in influenza virus isolates compared to clinical specimens"},{"title3":"Retrospective use of next-generation sequencing reveals the presence of Enteroviruses in acute influenza-like illness respiratory samples collected in South/South-East Asia during 2010-2013"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data"},{"title3":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability"},{"title3":"MEGA X: molecular evolutionary genetics analysis across computing platforms"}]},{"title2":"Detection of 2019 novel coronavirus (2019-ncov) by real-time RT-PCR.","References":[{"title3":"World Health Organization (WHO). Coronavirus. Geneva: WHO; 2020 [Accessed 21 Jan 2020]. Available from: https://www.who.int/health-topics/coronavirus "},{"title3":"Zhang Y-Z. Novel 2019 coronavirus genome. Virological. [Accessed 21 Jan 2020]. Available from: http://virological.org/t/novel-2019-coronavirus-genome/319 "},{"title3":"de Groot RJ, Baker SC, Baric R, Enjuanes L, Gorbalenya AE, Holmes KV, et al. Family Coronaviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy: classification and nomenclature of viruses: ninth report of the International Committee on Taxonomy of Viruses. London; Waltham: Academic Press; 2012. p. 806-20."},{"title3":"The severe acute respiratory syndrome."},{"title3":"World Health Organization. (WHO. Novel Coronavirus (2019-nCoV). Situation report - 1. Geneva: WHO; 21 Jan 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf "},{"title3":"SARS testing: First past the post."},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A(H7N9) strain associated with human spillover infections in China."},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction."},{"title3":"Coordinated implementation of chikungunya virus reverse transcription-PCR."},{"title3":"Assay optimization for molecular detection of Zika virus."},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences."},{"title3":"Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission."},{"title3":"Hosts and sources of endemic human coronaviruses."},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS."},{"title3":"Origin and evolution of pathogenic coronaviruses."},{"title3":"The European Virus Archive goes global: A growing resource for research."},{"title3":"Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data."},{"title3":"Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018."},{"title3":"First international external quality assessment of molecular diagnostics for Mers-CoV."},{"title3":"Advancing preparedness for clinical research during infectious disease epidemics."}]},{"title2":"Data resource profile: the National health information database of the National Health Insurance Service in South Korea.","References":[]},{"title2":"The association of cardioprotective medications with pneumonia-related outcomes.","References":[{"title3":"Xu J, Kochanek KD, Murphy SL, Tejada-Vera B (2010) Deaths: Final Data for 2007. National Vital Statistics Reports 58."},{"title3":"National Hospital Discharge Survey: 2007 summary"},{"title3":"Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002"},{"title3":"The association between pneumococcal pneumonia and acute cardiac events"},{"title3":"Incidence of cardiovascular events after hospital admission for pneumonia"},{"title3":"Acute myocardial infarction in hospitalized patients with community-acquired pneumonia"},{"title3":"Vascular complications are associated with poor outcome in community-acquired pneumonia"},{"title3":"Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia"},{"title3":"The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia"},{"title3":"The Potential Role of Statins in Pneumonia"},{"title3":"VistA-U.S. Department of Veterans Affairs national-scale HIS"},{"title3":"Quality of care, process, and outcomes in elderly patients with pneumonia"},{"title3":"Validation of a combined comorbidity index"},{"title3":"Role of acute infection in triggering acute coronary syndromes"},{"title3":"Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes"},{"title3":"The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study"},{"title3":"Patterns of cytokine expression in community-acquired pneumonia"},{"title3":"Circulating interleukin 6 and interleukin 10 in community acquired pneumonia"},{"title3":"Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease"},{"title3":"Infection of myocytes with chlamydiae"},{"title3":"An atypical complication of atypical pneumonia"},{"title3":"Myocarditis: a rare complication during Legionella infection"},{"title3":"Pathology of human influenza revisited"},{"title3":"Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology"},{"title3":"Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis"},{"title3":"Protective effects of angiotensin II interruption: evidence for antiinflammatory actions"},{"title3":"Potential therapeutic role for statins in respiratory disease"},{"title3":"Angiotensin II type 1 receptor blocker inhibits pulmonary injury"},{"title3":"Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome"},{"title3":"Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome"},{"title3":"Use of outpatient care in VA and Medicare among disability-eligible and age-eligible veteran patients"},{"title3":"The autopsy as a measure of accuracy of the death certificate"},{"title3":"Accuracy of death certificates for coding coronary heart disease as the cause of death"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Meta-analysis of effect of statins in patients with COVID-19.","References":[{"title3":"Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection"},{"title3":"Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4/MYD88 pathway"},{"title3":"Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection"},{"title3":"Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats"},{"title3":"Statin drug therapy may increase COVID-19 infection"},{"title3":"Requirements for CEACAMs and cholesterol during murine coronavirus cell entry"},{"title3":"Are certain drugs associated with enhanced mortality in COVID-19?"},{"title3":"Association of elevated plasma interleukin-18 level with increased mortality in a clinical trial of statin treatment for acute respiratory distress syndrome"},{"title3":"Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China. Preprint"},{"title3":"In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19"},{"title3":"Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study"},{"title3":"Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy"},{"title3":"Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed July 27, 2020)"}]},{"title2":"Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study.","References":[{"title3":"Coronavirus disease 2019 treatment: a review of early and emerging options"},{"title3":"Castiglione V, Chiriaco M, Emdin M, Taddei S, Vergaro G. Statin therapy in COVID19 infection. Eur Heart J Cardiovasc Pharmacother. 2020. [Epub ahead of print]."},{"title3":"Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins"},{"title3":"Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study"},{"title3":"Sensitivity analysis in observational research: introducing the E-value"},{"title3":"Website and R package for computing E-values"}]},{"title2":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia.","References":[]},{"title2":"Cardiovascular disease, drug therapy, and mortality in COVID-19.","References":[]},{"title2":"Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis.","References":[]},{"title2":"Prescription fill patterns for commonly used drugs during the COVID-19 pandemic in the United States.","References":[]},{"title2":"Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019.","References":[{"title3":"The COVID-19 epidemic"},{"title3":"Defining the epidemiology of Covid-19:studies needed"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"2019 Novel coronavirus (COVID-19) pneumonia: serial computed tomography findings."},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases [published online ahead of print February 26, 2020]"},{"title3":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)"},{"title3":"Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)"},{"title3":"Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models"},{"title3":"Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway"},{"title3":"Therapeutic strategies to target the Ebola virus life cycle"},{"title3":"Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus"},{"title3":"Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by Remdesivir"},{"title3":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease"},{"title3":"CHMP assessment report"},{"title3":"First 12 patients with coronavirus disease 2019 (COVID-19) in the United States"},{"title3":"ClinicalTrials.gov [Internet]"},{"title3":"ClinicalTrials.gov [Internet]"},{"title3":"ClinicalTrials.gov [Internet]"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides"},{"title3":"Ebola virus infection: review of the pharmacokinetic and pharmacodynamic properties of drugs considered for testing in human efficacy trials"},{"title3":"A randomized, controlled trial of Ebola virus disease therapeutics"},{"title3":"ClinicalTrials.gov [Internet]"},{"title3":"Deliberations on design options for randomized controlled clinical trials to assess the safety and efficacy of investigational therapeutics for the treatment of patients with Ebola virus disease Appendix 4. Summaries of evidence from selected experimental therapeutics"},{"title3":"Effects of chloroquine on viral infections: an old drug against today's diseases?"},{"title3":"The anti-HIV-1 activity of chloroquine"},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread"},{"title3":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine"},{"title3":"Vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"ClinicalTrials.gov [Internet]"},{"title3":"Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia"},{"title3":"Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone"},{"title3":"Lopinavir/Ritonavir"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Old drugs for a new bug: influenza, HIV drugs enlisted to fight SARS"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"ClinicalTrials.gov"},{"title3":"ClinicalTrials.gov"},{"title3":"Chengdu (Sichuan): Ministry of Health (China).2020 Jan 23. Identifier ChiCTR2000029308, A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with 2019-nCoV infection"},{"title3":"Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission. Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States"},{"title3":"Administration of antiretroviral medication via enteral tubes"},{"title3":"Ribavirin's antiviral mechanism of action: lethal mutagenesis?"},{"title3":"Managing SARS amidst uncertainty"},{"title3":"Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto Area"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Ribavirin in the treatment of SARS: a new trick for an old drug?"},{"title3":"Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada"},{"title3":"Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C"},{"title3":"Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial"},{"title3":"Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora"},{"title3":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent"},{"title3":"Efficacy and safety of nitazoxanide in addition to standard of care for the treatment of severe acute respiratory illness"},{"title3":"Syntheses and antibacterial activities of tizoxanide, an N-(nitrothiazolyl)salicylamide, and its O-aryl glucuronide"},{"title3":"Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level"},{"title3":"The anti-infective nitazoxanide shows strong immunomodulating effects (155.21)"},{"title3":"A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs"},{"title3":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial"},{"title3":"Effects of nitazoxanide on pharmacokinetics and pharmacodynamics of a single dose of warfarin"},{"title3":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents"},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus"},{"title3":"Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation [published online ahead of print January 28, 2020]. bioRxiv"},{"title3":"Nelfinavir in expanded postexposure prophylaxis causing acute hepatitis with cholestatic features: two case reports"},{"title3":"Nelfinavir LiverTox: Clinical and Research Information on Drug-Induced Liver Injury"},{"title3":"Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease"},{"title3":"The interferons: a brief introduction"},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds"},{"title3":"Ribavirin and interferon for critically ill patients with Middle East respiratory coronavirus (MERS-CoV) infection"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Clinicaltrials.gov [Internet]"},{"title3":"ClinicalTrials.gov [Internet]"},{"title3":"Side effects of therapy for chronic hepatitis C"},{"title3":"Interferon-alpha in chronic hepatitis C infection in dialysis patients"},{"title3":"Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C"},{"title3":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"COVID-19: combining antiviral and anti-inflammatory treatments"},{"title3":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Effective treatment of severe COVID-19 patients with Tocilizumab"},{"title3":"ClinicalTrials.gov [Internet]"},{"title3":"ClinicalTrials.gov [Internet]"},{"title3":"ClinicalTrials.gov [Internet]"},{"title3":"Beijing: National Health Commission of the People's Republic of China and National Health Commission of the People's Republic of China"},{"title3":"Implications of COVID-19 for patients with pre-existing digestive diseases"},{"title3":"Convalescent plasma as a potential therapy for COVID-19"},{"title3":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"Convalescent plasma: a valid option in the treatment of COVID-19?"},{"title3":"ClinicalTrials.gov [Internet]"},{"title3":"Middle east respiratory syndrome"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"ClinicalTrials.gov [Internet]"},{"title3":"Arbidol as a broad-spectrum antiviral: an update"},{"title3":"Nucleosides for the treatment of respiratory RNA virus infections"},{"title3":"Thalidomide Combined with Low-dose Glucocorticoid in the Treatment of COVID-19"}]},{"title2":"Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission.","References":[]},{"title2":"Healthy user and related biases in observational studies of preventive interventions: a primer for physicians.","References":[]},{"title2":"Compliance of antihypertensive medication and risk of coronavirus disease 2019: a cohort study using big data from the korean national health insurance service.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Covid-19: WHO declares pandemic because of &quot;alarming levels&quot; of spread, severity, and inaction"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"Angiotensin converting enzyme 2: a double-edged sword"},{"title3":"Analysis on 54 mortality cases of coronavirus disease 2019 in the Republic of Korea from January 19 to March 10, 2020"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy"},{"title3":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers"},{"title3":"Clustering of unhealthy lifestyle behaviors is associated with a low adherence to recommended preventive practices among COPD patients in Spain"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020"},{"title3":"Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review"},{"title3":"Analysis of SARS-CoV-2 screening clinic (including drive-through system) data at a single university hospital in South Korea from 27 January 2020 to 31 March 2020 during the COVID-19 outbreak"}]}]},{"title1":"Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients","References":[{"title2":"FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy","References":[{"title3":"Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers"},{"title3":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease"},{"title3":"Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development"},{"title3":"Drugs acting on renin angiotensin system and use in ill patients with COVID-19"},{"title3":"Anon 2020 https://www.thecardiologyadvisor.com/home/topics/practice-management/fda-studies-underway-to-evaluate-chloroquine-for-covid-19/."},{"title3":"Anon 2020 https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html."},{"title3":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome"},{"title3":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial"},{"title3":"Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19?"},{"title3":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?"},{"title3":"Remdesivir for the treatment of Covid-19 - preliminary report"},{"title3":"Characteristics, treatment outcomes and role of hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: an epidemio-clinical study"},{"title3":"Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial"},{"title3":"Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities"},{"title3":"Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine"},{"title3":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase"},{"title3":"Experimental treatment with Favipiravir for COVID-19: an open-label control study"},{"title3":"The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro"},{"title3":"A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19"},{"title3":"Treatment with Lopinavir/Ritonavir or Interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial"},{"title3":"A study on clinical effect of Arbidol combined with adjuvant therapy on COVID-19"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria"},{"title3":"British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015"},{"title3":"Chloroquine: mode of action"},{"title3":"Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and middle east respiratory syndrome coronavirus fusion"},{"title3":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19"},{"title3":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade"},{"title3":"Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum"},{"title3":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection"},{"title3":"Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019:a retrospective cohort study"},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics"},{"title3":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)"},{"title3":"Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV"},{"title3":"Results of the cooperative north scandinavian enalapril survival study (CONSENSUS)"},{"title3":"Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality"},{"title3":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"},{"title3":"Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins"},{"title3":"Rationale and design of the PRAETORIAN-COVID trial: a double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses - a statement of the Coronavirus Study Group"},{"title3":"Compassionate use of remdesivir for patients with severe Covid-19"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis"},{"title3":"The role of adjuvant immunomodulatory agents for treatment of severe influenza"},{"title3":"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial"},{"title3":"Pharmacokinetics of Favipiravir in critically ill patients with COVID-19"},{"title3":"Nucleosides for the treatment of respiratory RNA virus infections"},{"title3":"Telbivudine"},{"title3":"Reversal of the progression of fatal coronavirus infection in cats by a broad-spectrum coronavirus protease inhibitor"},{"title3":"Arguments in favour of remdesivir for treating SARS-CoV-2 infections"},{"title3":"COVID-19: what do we need to know about ICU delirium during the SARS-CoV-2 pandemic?"},{"title3":"COVID-19: ICU delirium management during SARS-CoV-2 pandemic"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL(Pro) inhibitors"},{"title3":"WHO launches global megatrial of the four most promising coronavirus treatments"},{"title3":"COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"[Potential antiviral therapeutics for 2019 Novel Coronavirus]"},{"title3":"Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study"},{"title3":"Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression"},{"title3":"Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis"},{"title3":"Ongoing clinical trials for the management of the COVID-19 pandemic"},{"title3":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)"},{"title3":"The urgent need for integrated science to fight COVID-19 pandemic and beyond"},{"title3":"Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study"},{"title3":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV"},{"title3":"SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review"},{"title3":"Chloroquine affects biosynthesis of Ia molecules by inhibiting dissociation of invariant (gamma) chains from alpha-beta dimers in B cells"},{"title3":"Lopinavir-ritonavir in the treatment of COVID-19: a dynamic systematic benefit-risk assessment"},{"title3":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV"},{"title3":"A review of the safety of favipiravir-a potential treatment in the COVID-19 pandemic?"},{"title3":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Zidovudine (Retrovir) update"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Type 1 interferons as a potential treatment against COVID-19"},{"title3":"High- versus low-dose angiotensin converting enzyme inhibitor therapy in the treatment of heart failure: an economic analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Autophagy and SARS-CoV-2 infection: apossible smart targeting of the autophagy pathway"},{"title3":"Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes"},{"title3":"Risks of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence"},{"title3":"[Inhibitors of RAS might Be a good choice for the therapy of COVID-19 pneumonia]"},{"title3":"Kwak Sung-sun Physicians work out treatment guidelines for coronavirus. [cited 2020 27.03]; http://www.koreabiomed.com/news/articleView.html?idxno=7428."},{"title3":"Endoplasmic reticulum as a potential therapeutic target for covid-19 infection management?"},{"title3":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial"},{"title3":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy"},{"title3":"Lopinavir-Ritonavir in Covid-19"},{"title3":"SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets"},{"title3":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial"},{"title3":"SARS-CoV-2 invades host cells via a novel route: CD147-spike protein"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"COVID-19: knowns, unknowns, and questions"},{"title3":"Covid-19: remdesivir is recommended for authorisation by European Medicines Agency"},{"title3":"Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients"},{"title3":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike"},{"title3":"Combination antiviral therapy with lopinavir/ritonavir"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Arbidol/IFN-alpha2b therapy for patients with corona virus disease 2019: a retrospective multicenter cohort study"},{"title3":"Effective treatment of severe COVID-19 patients with tocilizumab"},{"title3":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"Asthma and influenza virus infection:focusing on cell death and stress pathways in influenza virus replication"},{"title3":"Suppression of influenza A virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1"},{"title3":"Autophagy activation is required for influenza A virus-induced apoptosis and replication"},{"title3":"SARS-CoV-2 and COVID-19: the most important research questions"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19"},{"title3":"Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance"},{"title3":"Lysosomes as mediators of drug resistance in cancer"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19"},{"title3":"Coronaviruses - drug discovery and therapeutic options"}]},{"title2":"Endoplasmic reticulum as a potential therapeutic target for covid-19 infection management?","References":[{"title3":"Endoplasmic reticulum stress signalling-from basic mechanisms to clinical applications"},{"title3":"Unfolded protein response (UPR) integrated signaling networks determine cell fate during hypoxia"},{"title3":"Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression"},{"title3":"Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein"},{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Metal ionophores-an emerging class of anticancer drugs"},{"title3":"Coronavirus-induced ER stress response and its involvement in regulation of coronavirus-host interactions"},{"title3":"Regulation of stress responses and translational control by coronavirus"},{"title3":"Coronavirus infection, ER stress, apoptosis and innate immunity"},{"title3":"The ER stress sensor IRE1 and MAP kinase ERK modulate autophagy induction in cells infected with coronavirus infectious bronchitis virus"},{"title3":"Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins"},{"title3":"Autophagy and the unfolded protein response promote profibrotic effects of TGF-beta1 in human lung fibroblasts"},{"title3":"Glioblastoma and chemoresistance to alkylating agents: involvement of apoptosis, autophagy, and unfolded protein response"},{"title3":"Apoptosis, autophagy and unfolded protein response pathways in Arbovirus replication and pathogenesis"},{"title3":"Integrity of the early secretory pathway promotes, but is not required for, severe acute respiratory syndrome coronavirus RNA synthesis and virus-induced remodeling of endoplasmic reticulum membranes"},{"title3":"XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response"},{"title3":"Population pharmacokinetics and pharmacodynamics of disulfiram on inducing latent HIV-1 transcription in a phase IIb trial"},{"title3":"Upregulation of CHOP/GADD153 during coronavirus infectious bronchitis virus infection modulates apoptosis by restricting activation of the extracellular signal-regulated kinase pathway"},{"title3":"Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy"},{"title3":"Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus"},{"title3":"The coronavirus transmissible gastroenteritis virus evades the type I interferon response through IRE1alpha-mediated manipulation of the microRNA miR-30a-5p/SOCS1/3 axis"},{"title3":"The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections"},{"title3":"The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor"},{"title3":"Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers"},{"title3":"Hydroxyquinolines inhibit ribonucleic acid-dependent deoxyribonucleic acid polymerase and inactivate Rous sarcoma virus and herpes simplex virus"},{"title3":"Structure and mechanism of action of the hydroxy-aryl-aldehyde class of IRE1 endoribonuclease inhibitors"},{"title3":"SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes"},{"title3":"Identification and characterization of pancreatic eukaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control"},{"title3":"Mediators of endoplasmic reticulum stress-induced apoptosis"},{"title3":"Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress"},{"title3":"Inhibition of IRE1alpha RNase activity reduces NLRP3 inflammasome assembly and processing of pro-IL1beta"},{"title3":"Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture"},{"title3":"The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations"},{"title3":"Triggering unfolded protein response by 2-deoxy-d-glucose inhibits porcine epidemic diarrhea virus propagation"},{"title3":"Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response"},{"title3":"Hepatitis B and C virus-induced hepatitis: apoptosis, autophagy, and unfolded protein response"},{"title3":"Asthma and influenza virus infection: focusing on cell death and stress pathways in influenza virus replication"},{"title3":"Transcriptional profiling of Vero E6 cells over-expressing SARS-CoV S2 subunit: insights on viral regulation of apoptosis and proliferation"},{"title3":"Porcine epidemic diarrhea virus ORF3 protein causes endoplasmic reticulum stress to facilitate autophagy"}]},{"title2":"Autophagy and SARS-CoV-2 infection: a possible smart targeting of the autophagy pathway","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers","References":[{"title3":"Testing for respiratory viruses in adults with severe lower respiratory infections"},{"title3":"Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults"},{"title3":"Severe 2009 A/H1N1v influenza in pregnant women in Spain"},{"title3":"Coronaviruses and immunosuppressed patients. The facts during the third epidemic"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Coagulopathy and antiphospholipid antibodies in patients with covid-19"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease in patients with coagulopathy"},{"title3":"Endemic human coronaviruses in hospitalized adults with community-acquired pneumonia: results from the Louisville Pneumonia Study"},{"title3":"Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases"},{"title3":"Coronavirus disease 2019 (COVID-19): a critical care perspective beyond China"},{"title3":"Utility of point-of-care lung ultrasound for initial assessment of acute respiratory distress syndrome patients in the emergency department"},{"title3":"COVID-19 pneumonia different respiratory treatment for different phenotypes?"},{"title3":"COVID-19 does not lead to a &quot;typical&quot; acute respiratory distress syndrome"},{"title3":"SARS-CoV-2 in Spanish intensive care: early experience with 15-day survival in Vitoria"}]},{"title2":"Endothelial cell infection and endotheliitis in COVID-19","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Offline: COVID-19:bewilderment and candour"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2"},{"title3":"The assessment of endothelial function: from research into clinical practice"},{"title3":"Endothelial dysfunction - a marker of atherosclerotic risk"},{"title3":"The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion"},{"title3":"Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients"},{"title3":"Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis"},{"title3":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis"},{"title3":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed"}]},{"title2":"Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily","References":[]},{"title2":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","References":[{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Frequency of thrombocytopenia and heparin-induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared with cardiopulmonary bypass and the limited sensitivity of pretest probability score"},{"title3":"Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure"}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Potential role of statins in COVID-19","References":[{"title3":"PRINCE Investigators. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study"},{"title3":"Unraveling pleiotropic effects of statins: bit by bit, a slow case with perspective"},{"title3":"Statin treatment and the risk of recurrent pulmonary embolism"},{"title3":"Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway"},{"title3":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19"},{"title3":"Treating influenza with statins and other immunomodulatory agents"},{"title3":"Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola"},{"title3":"What treating Ebola means for pandemic influenza"},{"title3":"Treating Ebola patients: a 'bottom up' approach using generic statins and angiotensin receptor blockers"},{"title3":"Hiding in plain sight: an approach to treating patients with severe COVID-19 infection"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Effects of renin-angiotensin system blockade on renin angiotensin-(1-7) forming enzymes and receptors"},{"title3":"COVID-19 coagulopathy in Caucasian patients"},{"title3":"Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily"},{"title3":"A randomized trial of rosuvastatin in the prevention of venous thromboembolism: the JUPITER trial"},{"title3":"Failure of statins in ARDS: the quest for the Holy Grail continues"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"},{"title3":"A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Statin treatment and mortality: Propensity score-matched analyses of 2007-2008 and 2009-2010 laboratory-confirmed influenza hospitalizations"},{"title3":"Characteristics and mechanism of liver injury in 2019 coronavirus disease"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"Cardiovascular disease, drug therapy, and mortality in Covid-19"},{"title3":"COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis"},{"title3":"Clinical phenotypes of SARS-CoV-2: Implications for clinicians and researchers"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Angiotensin-converting enzyme (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"}]},{"title2":"Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)","References":[{"title3":"Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)"},{"title3":"Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cyto-Chrome P450 inhibitors"},{"title3":"Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients"},{"title3":"Rhabdomyolysis caused by comedication with simvastatin and clarithromycin"},{"title3":"Simvastatin-amiodarone interaction resulting in thabdornyolysis, azotemia, and possible hepatotoxicity"}]},{"title2":"Pharmaco-Immunomodulatory therapy in COVID-19","References":[{"title3":"Pharmaco-immunomodulatory therapy in COVID-19"},{"title3":"Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?"},{"title3":"Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis"},{"title3":"Colchicine may not be effective in COVID-19 infection; it may even be harmful?"},{"title3":"Parra-Medina R, Sarmiento-Monroy JC, Rojas-Villarraga A, Garavito E, Montealegre-Gomez G, Gomez-Lopez A. Colchicine as a possible therapeutic option in COVID-19 infection. Clin. Rheumatol. 2020. 2487-8."},{"title3":"Kobak S. Comment on &quot;Colchicine may not be effective in COVID-19 infection; it may even be harmful?&quot;. Clin. Rheumatol. 2020. 2487-8."},{"title3":"The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al"},{"title3":"Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: the GRECCO-19 randomized clinical trial"}]},{"title2":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19","References":[{"title3":"Critical care management of adults with community-acquired severe respiratory viral infection"},{"title3":"Statin therapy in COVID-19 infection: much more than a single pathway"},{"title3":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial"},{"title3":"Statin therapy in COVID-19 infection"},{"title3":"A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study)"},{"title3":"Considerations for statin therapy in patients with COVID-19"},{"title3":"The effects of ARBs, ACEIs and statins on clinical outcomes of COVID-19 infection among nursing home residents"},{"title3":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals"},{"title3":"Position statement of the ESC council on hypertension on ACE-inhibitors and angiotensin receptor blockers"},{"title3":"Acute respiratory distress syndrome: advances in diagnosis and treatment"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Treating influenza with statins and other immunomodulatory agents"},{"title3":"Treating the host response to Ebola virus disease with generic statins and angiotensin receptor blockers"},{"title3":"Hiding in plain sight: an approach to treating patients with severe COVID-19 infection"},{"title3":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis"},{"title3":"Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide"},{"title3":"Survivor treatment selection bias in observational studies: examples from the AIDS literature"},{"title3":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies"},{"title3":"Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Chinese expert consensus on the use of statins in elderly with dyslipidemia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A statement from the International Society of Hypertension on COVID-19"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis"},{"title3":"Longitudinal association between markers of liver injury and mortality in COVID-19 in China"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study"},{"title3":"Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind"},{"title3":"Web site and R Package for computing E-values"},{"title3":"Simvastatin in the acute respiratory distress syndrome"},{"title3":"Neutrophils and immunity: challenges and opportunities"},{"title3":"The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial"},{"title3":"Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial"},{"title3":"Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - a systematic review and meta-analysis"},{"title3":"The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011"},{"title3":"The treatment of unrelated disorders in patients with chronic medical diseases"},{"title3":"Statins and the COVID-19 main protease: in silico evidence on direct interaction"},{"title3":"Pulmonary infections in the elderly lead to impaired neutrophil targeting, which is improved by simvastatin"},{"title3":"Simvastatin improves neutrophil function and clinical outcomes in pneumonia. A pilot randomized controlled clinical trial"},{"title3":"NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin"},{"title3":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation"},{"title3":"The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts"},{"title3":"Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study"},{"title3":"COVID-19, ACE2, and the cardiovascular consequences"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications"},{"title3":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome"},{"title3":"Sensitivity analysis in observational research: introducing the E-value"},{"title3":"C-reactive protein as a biomarker of severe H1N1 influenza"},{"title3":"Comparison of imputation methods for missing laboratory data in medicine"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases interim guidance"},{"title3":"Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation"},{"title3":"2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America"},{"title3":"Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4/MYD88 pathway"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"}]},{"title2":"Safety and efficacy of statin therapy","References":[]},{"title2":"Simvastatin induces unfolded protein response and enhances temozolomide-induced cell death in glioblastoma cells","References":[{"title3":"Whole brain apparent diffusion coefficient measurements correlate with survival in glioblastoma patients"},{"title3":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014"},{"title3":"Investigating Programmed Cell Death and Tumor Invasion in a Three-Dimensional (3D) Microfluidic Model of Glioblastoma"},{"title3":"Neuropathological and genomic characterization of glioblastoma-induced rat model: How similar is it to humans for targeted therapy?"},{"title3":"HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM)"},{"title3":"The epidemiology of glioma in adults: A &quot;state of the science&quot; review"},{"title3":"Systematic review of protein biomarkers of invasive behavior in glioblastoma"},{"title3":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma"},{"title3":"Autophagy modulates temozolomide-induced cell death in alveolar Rhabdomyosarcoma cells"},{"title3":"Could drugs inhibiting the mevalonate pathway also target cancer stem cells?"},{"title3":"Pleiotropic effects of statins: A focus on cancer"},{"title3":"HMG-CoA reductase inhibitors activate the unfolded protein response and induce cytoprotective GRP78 expression"},{"title3":"Statin use and survival following glioblastoma multiforme"},{"title3":"Statin use and reduced cancer-related mortality"},{"title3":"Statin use and cancer risk: A comprehensive review"},{"title3":"Statins are potential anticancerous agents (review)"},{"title3":"Statins: A new approach to combat temozolomide chemoresistance in glioblastoma"},{"title3":"The unfolded protein response and cell fate control"},{"title3":"To be or not to be? How selective autophagy and cell death govern cell fate"},{"title3":"UPR, autophagy, and mitochondria crosstalk underlies the ER stress response"},{"title3":"ER stress and UPR activation in glioblastoma: Identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation"},{"title3":"Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response"},{"title3":"Endoplasmic reticulum stress and the hallmarks of cancer"},{"title3":"Autophagy in breast cancer metastatic dormancy: Tumor suppressing or tumor promoting functions?"},{"title3":"The dynamic nature of autophagy in cancer"},{"title3":"Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: A dual role for p53"},{"title3":"Autophagy and SARS-CoV-2 infection: Apossible smart targeting of the autophagy pathway"},{"title3":"Simultaneous Detection of Autophagy and Epithelial to Mesenchymal Transition in the Non-small Cell Lung Cancer Cells"},{"title3":"Unfolded protein response (UPR) in survival, dormancy, immunosuppression, metastasis, and treatments of cancer cells"},{"title3":"Endoplasmic reticulum as a potential therapeutic target for covid-19 infection management?"},{"title3":"The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections"},{"title3":"Unfolded protein response to autophagy as a promising druggable target for anticancer therapy"},{"title3":"Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy"},{"title3":"Autophagy and the unfolded protein response promote profibrotic effects of TGF-beta1 in human lung fibroblasts"},{"title3":"Hepatitis B and C virus-induced hepatitis: Apoptosis, autophagy, and unfolded protein response"},{"title3":"Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts"},{"title3":"Airway mesenchymal cell death by mevalonate cascade inhibition: Integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins"},{"title3":"Endoplasmic reticulum stress induces epithelial-mesenchymal transition through autophagy via activation of c-Src kinase"},{"title3":"Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma"},{"title3":"08 Inhibition of autophagy by mevalonate pathway inhibitors, a new therapeutic approach to sensitize glioblastoma cells to temozolomide induced apoptosis"},{"title3":"Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes"},{"title3":"Mechanisms Targeting the Unfolded Protein Response in Asthma"},{"title3":"Simvastatin induces apoptosis in medulloblastoma brain tumor cells via mevalonate cascade prenylation substrates"},{"title3":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)"},{"title3":"Comparison of MTT assay, flow cytometry, and RT-PCR in the evaluation of cytotoxicity of five prosthodontic materials"},{"title3":"Limitations of the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays"},{"title3":"Mechanisms of simvastatin myotoxicity: The role of autophagy flux inhibition"},{"title3":"The role of the unfolded protein response in cancer progression: From oncogenesis to chemoresistance"},{"title3":"Stressed to death:Mechanisms of ER stress-induced cell death"},{"title3":"NOXA contributes to the sensitivity of PERK-deficient cells to ER stress"},{"title3":"The regulatory activity of autophagy in conjunctival fibroblasts and its possible role in vernal keratoconjunctivitis"},{"title3":"Pharmacologic Inhibition of Vacuolar H(+)ATPase Attenuates Features of Severe Asthma in Mice"},{"title3":"Autophagy Activation in Asthma Airways Remodeling"},{"title3":"Emerging mechanisms in initiating and terminating autophagy"},{"title3":"Autoimmune Hepatitis and Stellate Cells; an Insight into the Role of Autophagy"},{"title3":"ER stress and cancer"},{"title3":"Unfolded protein response in cancer: The physician's perspective"},{"title3":"Induction of autophagy: Role of endoplasmic reticulum stress and unfolded protein response"},{"title3":"Targeting the endoplasmic reticulum-stress response as an anticancer strategy"},{"title3":"Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress"},{"title3":"Atorvastatin mediates increases in intralesional BAX and BAK expression in human end-stage abdominal aortic aneurysms"},{"title3":"Lovastatin enhances cytotoxicity of temozolomide via impairing autophagic flux in glioblastoma cells"},{"title3":"Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy"},{"title3":"Coxsackievirus B3 Infection Triggers Autophagy through 3 Pathways of Endoplasmic Reticulum Stress"},{"title3":"Kaempferol induces autophagic cell death via IRE1-JNK-CHOP pathway and inhibition of G9a in gastric cancer cells"},{"title3":"Autophagy mediated by endoplasmic reticulum stress enhances the caffeine-induced apoptosis of hepatic stellate cells"},{"title3":"A close connection between the PERK and IRE arms of the UPR and the transcriptional regulation of autophagy"},{"title3":"Connecting endoplasmic reticulum stress to autophagy through IRE1/JNK/beclin-1 in breast cancer cells"},{"title3":"IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux"},{"title3":"The active nuclear form of SREBP1 amplifies ER stress and autophagy via regulation of PERK"},{"title3":"Seneca valley virus activates autophagy through the PERK and ATF6 UPR pathways"},{"title3":"ATG5 and ATG7 induced autophagy interplays with UPR via PERK signaling"},{"title3":"Downregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status"},{"title3":"The Antitumor Effect of the Atypical Retinoid ST1926 in Human Glioblastoma"},{"title3":"Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O 6-methylguanine"},{"title3":"Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma"},{"title3":"Temozolomide resistance in glioblastoma multiforme"},{"title3":"Geranylgeranyl transferase 1 modulates autophagy and apoptosis in human airway smooth muscle"},{"title3":"A dual role of p53 in the control of autophagy"},{"title3":"Loss of p53 enhances the function of the endoplasmic reticulum through activation of the IRE1alpha/XBP1 pathway"},{"title3":"Alternative Mechanisms of p53 Action During the Unfolded Protein Response"},{"title3":"Autophagy modulates transforming growth factor beta 1 induced epithelial to mesenchymal transition in non-small cell lung cancer cells"},{"title3":"Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cells"},{"title3":"Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway"},{"title3":"Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c"},{"title3":"Inhibition of autophagy inhibits the conversion of cardiac fibroblasts to cardiac myofibroblasts"},{"title3":"Role of BNIP3 in TNF-induced cell death--TNF upregulates BNIP3 expression"}]},{"title2":"Structural mechanism for statin inhibition of HMG-CoA reductase","References":[]},{"title2":"Potentially important considerations in choosing specific statin treatments to reduce overall morbidity and mortality","References":[]},{"title2":"Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels","References":[]},{"title2":"Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels","References":[]},{"title2":"Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus","References":[]},{"title2":"Low-dose statin therapy improves endothelial function in type 2 diabetic patients with normal serum total cholesterol: a randomized placebo-controlled study","References":[]},{"title2":"Statin ameliorates endothelial dysfunction and insulin resistance in Tibet women with polycystic ovary syndrome","References":[]},{"title2":"Improvement of endothelial dysfunction is mediated through reduction of remnant lipoprotein after statin therapy in patients with coronary artery disease","References":[]},{"title2":"Statin protects endothelial cell against ischemia reperfusion injury through HMGB1/TLR4 pathway","References":[]},{"title2":"Inhibition of aberrant MicroRNA-133a expression in endothelial cells by statin prevents endothelial dysfunction by targeting GTP Cyclohydrolase 1 in vivo","References":[{"title3":"Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension."},{"title3":"Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure."},{"title3":"In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I."},{"title3":"Prediction of plant microRNA targets."},{"title3":"Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs."},{"title3":"MicroRNAs expression profiles in cardiovascular diseases."},{"title3":"Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia."},{"title3":"Oxidative stress and microRNAs in vascular diseases."},{"title3":"Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of West of Scotland Coronary Prevention Study."},{"title3":"Statins for prevention of cardiovascular events in a low-risk population with low ankle brachial index."},{"title3":"MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention."},{"title3":"MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression."},{"title3":"Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase."},{"title3":"Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study."},{"title3":"Effect of statins on skeletal muscle function."},{"title3":"The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation."},{"title3":"Identification of tissue-specific microRNAs from mouse."},{"title3":"Rosiglitazone via PPARgamma-dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone."},{"title3":"Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice."},{"title3":"Analysis of reduced forms of biopterin in biological tissues and fluids."},{"title3":"MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16."},{"title3":"MicroRNA-133 controls cardiac hypertrophy."},{"title3":"MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo."},{"title3":"Silencing of microRNAs in vivo with 'antagomirs'."},{"title3":"4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation."},{"title3":"Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain."},{"title3":"AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes."},{"title3":"microRNA-133: expression, function and therapeutic potential in muscle diseases and cancer."},{"title3":"MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures."},{"title3":"Muscle-specific microRNA miR-206 promotes muscle differentiation."},{"title3":"Zebrafish miR-1 and miR-133 shape muscle gene expression and regulate sarcomeric actin organization."},{"title3":"MyomiR-133 regulates brown fat differentiation through Prdm16."},{"title3":"MicroRNA-133a regulates neurotensin-associated colonic inflammation in colonic epithelial cells and experimental colitis."},{"title3":"Peroxynitrite-dependent zinc release and inactivation of guanosine 5'-triphosphate cyclohydrolase 1 instigate its ubiquitination in diabetes."},{"title3":"GTP cyclohydrolase I phosphorylation and interaction with GTP cyclohydrolase feedback regulatory protein provide novel regulation of endothelial tetrahydrobiopterin and nitric oxide."},{"title3":"MicroRNA-133 modulates the beta1-adrenergic receptor transduction cascade."},{"title3":"Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5."},{"title3":"Role of microRNAs in vascular remodeling."},{"title3":"Lipid pharmacotherapy for treatment of atherosclerosis."},{"title3":"Activation of AMP-activated protein kinase alpha2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo."},{"title3":"Inhibition of the AMP-activated protein kinase-alpha2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice."},{"title3":"Statins activate AMP-activated protein kinase in vitro and in vivo."},{"title3":"Effect of statins on the proteasomal activity in mammalian endothelial and vascular smooth muscle cells."}]},{"title2":"Role of microRNAs 221/222 on statin induced nitric oxide release in human endothelial cells","References":[{"title3":"Inflammation and atherosclerosis"},{"title3":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace"},{"title3":"Nitric oxide, a protective molecule in the cardiovascular system"},{"title3":"Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression"},{"title3":"Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium"},{"title3":"Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells"},{"title3":"Clinical implications of pharmacogenomics of statin treatment"},{"title3":"Ezetimibe: cholesterol lowering and beyond"},{"title3":"The pleiotropic effects of the hydroxymethyl- glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review"},{"title3":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes"},{"title3":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method"},{"title3":"Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells"},{"title3":"Acute simvastatin increases endothelial nitric oxide synthase phosphorylation via AMP-activated protein kinase and reduces contractility of isolated rat mesenteric resistance arteries"},{"title3":"Regulation of endothelium-derived nitric oxide production by the protein kinase Akt"},{"title3":"The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin"},{"title3":"A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid"},{"title3":"Atorvastatin delays murine platelet activation in vivo even in the absence of endothelial NO synthase"},{"title3":"MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases"},{"title3":"A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia"},{"title3":"Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease"},{"title3":"MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation"},{"title3":"Ezetimibe inhibits PMAinduced monocyte/macrophage differentiation by altering microRNA expression: a novel anti-atherosclerotic mechanism"}]},{"title2":"Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1","References":[]},{"title2":"The association between saphenous vein endothelial function, systemic inflammation, and statin therapy in patients undergoing coronary artery bypass surgery","References":[]},{"title2":"Pleiotropic effects of statins: a focus on cancer","References":[]},{"title2":"Atorvastatin ameliorates LPS-induced inflammatory response by autophagy via AKT/mTOR signaling pathway","References":[]},{"title2":"Atorvastatin inhibits inflammatory response, attenuates lipid deposition, and improves the stability of vulnerable atherosclerotic plaques by modulating autophagy","References":[{"title3":"Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials."},{"title3":"Acute coronary syndromes: the way forward from mechanisms to precision treatment."},{"title3":"Autophagy in vascular disease."},{"title3":"Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice."},{"title3":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals."},{"title3":"Atorvastatin activates autophagy and promotes neurological function recovery after spinal cord injury."},{"title3":"Senescent vascular smooth muscle cells drive inflammation through an interleukin-1alpha-dependent senescence-associated secretory phenotype."},{"title3":"Treating hypercholesterolemia: looking forward."},{"title3":"Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis."},{"title3":"Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis."},{"title3":"Atorvastatin ameliorates LPS-induced inflammatory response by autophagy via AKT/mTOR signaling pathway."},{"title3":"Endogenous renovascular hypertension combined with low shear stress induces plaque rupture in apolipoprotein E-deficient mice."},{"title3":"The walking dead: macrophage inflammation and death in atherosclerosis."},{"title3":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice."},{"title3":"Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening."},{"title3":"Ursolic acid enhances macrophage autophagy and attenuates atherogenesis."},{"title3":"Autophagy in immunity and inflammation."},{"title3":"Perivascular adipose tissue-derived adiponectin inhibits collar-induced carotid atherosclerosis by promoting macrophage autophagy."},{"title3":"Activation of Nlrp3 inflammasomes enhances macrophage lipid-deposition and migration: implication of a novel role of inflammasome in atherogenesis."},{"title3":"Atorvastatin attenuates plaque vulnerability by downregulation of EMMPRIN expression via COX-2/PGE2 pathway."},{"title3":"Macrophage autophagy plays a protective role in advanced atherosclerosis."},{"title3":"Atorvastatin protects vascular smooth muscle cells from TGF-beta1-stimulated calcification by inducing autophagy via suppression of the beta-catenin pathway."},{"title3":"Moderate autophagy inhibits vascular smooth muscle cell senescence to stabilize progressed atherosclerotic plaque via the mTORC1/ULK1/ATG13 signal pathway."},{"title3":"ATG16L1 expression in carotid atherosclerotic plaques is associated with plaque vulnerability."},{"title3":"Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex."},{"title3":"Cryopyrin activates the inflammasome in response to toxins and ATP."},{"title3":"Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis."},{"title3":"Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors."},{"title3":"Statin-induced autophagy by inhibition of geranylgeranyl biosynthesis in prostate cancer PC3 cells."},{"title3":"P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation."},{"title3":"The use of electron microscopy for the detection of autophagy in human atherosclerosis."},{"title3":"Globular adiponectin causes tolerance to LPS-induced TNF-alpha expression via autophagy induction in RAW 264.7 macrophages: involvement of SIRT1/FoxO3A axis."},{"title3":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation."},{"title3":"Antiinflammatory therapy with canakinumab for atherosclerotic disease."},{"title3":"Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse."},{"title3":"Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production."},{"title3":"Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis."},{"title3":"Autophagy in atherosclerosis: a potential drug target for plaque stabilization."},{"title3":"Inclusion bodies enriched for p62 and polyubiquitinated proteins in macrophages protect against atherosclerosis."},{"title3":"Self-eating in the plaque: what macrophage autophagy reveals about atherosclerosis."},{"title3":"Atorvastatin suppresses inflammatory response induced by oxLDL through inhibition of ERK phosphorylation, IkappaBalpha degradation, and COX-2 expression in murine macrophages."},{"title3":"Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction."},{"title3":"Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells."},{"title3":"Flow-dependent remodeling in the carotid artery of fibroblast growth factor-2 knockout mice."},{"title3":"The PI3K/Akt/mTOR pathway regulates the replicative senescence of human VSMCs."},{"title3":"Atorvastatin induces autophagy in prostate cancer PC3 cells through activation of LC3 transcription."},{"title3":"Vascular smooth muscle cell senescence promotes atherosclerosis and features of plaque vulnerability."},{"title3":"Augmentation of autophagy by atorvastatin via Akt/mTOR pathway in spontaneously hypertensive rats."},{"title3":"Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence."},{"title3":"Atorvastatin attenuates TNF-alpha production via heme oxygenase-1 pathway in LPS-stimulated RAW264.7 macrophages."},{"title3":"Monocytes in atherosclerosis: subsets and functions."},{"title3":"Atorvastatin decreases Toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells."},{"title3":"Selective inhibition of PI3K/Akt/mTOR signaling pathway regulates autophagy of macrophage and vulnerability of atherosclerotic plaque."},{"title3":"Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice."}]},{"title2":"Simvastatin alleviates airway inflammation and remodelling through up-regulation of autophagy in mouse models of asthma","References":[]},{"title2":"Radiological Society of North America Expert Consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA","References":[{"title3":"CT imaging features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"Chest CT findings in Coronavirus Disease-19 (COVID-19): relationship to duration of infection"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 Novel Coronavirus (COVID-19) Pneumonia"},{"title3":"Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT"},{"title3":"Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients"},{"title3":"Imaging of pulmonary viral pneumonia"},{"title3":"Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use-associated lung Injury (EVALI): evolving knowledge and remaining questions"},{"title3":"Drug-induced lung disease: high-resolution CT findings"},{"title3":"Imaging of cancer immunotherapy: current approaches and future directions"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Acute pulmonary injury: high-resolution CT and histopathological spectrum"},{"title3":"Imaging profile of the COVID-19 infection: radiologic findings and literature review"},{"title3":"Temporal Changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study"},{"title3":"Emerging 2019 Novel Coronavirus (2019-nCoV) pneumonia"},{"title3":"Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review"},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Chest CT findings in cases from the cruise ship &quot;Diamond Princess&quot; with coronavirus disease 2019 (COVID-19)"},{"title3":"Sensitivity of chest CT for COVID-19: Comparison to RT-PCR"},{"title3":"Laboratory diagnosis of emerging human coronavirus infections - The State of the Art"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Fleischner society: glossary of terms for thoracic imaging"}]},{"title2":"The central role of the propensity score in observational studies for causal effects","References":[]},{"title2":"Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection","References":[]},{"title2":"Yang D, et al. COVID-19 &amp; chronic renal disease: clinical characteristics &amp; prognosis. QJM. 2020. 10.1093/qjmed/hcaa258.","References":[]},{"title2":"Saeed O, et al. Statin use and in-hospital mortality in diabetics with COVID-19. J Am Heart Assoc. 2020:e018475.","References":[]},{"title2":"Statin use is associated with lower disease severity in COVID-19 infection","References":[{"title3":"Situation Reports [Internet]. Situation Reports. 2020 [cited 2020May12]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200511-covid-19-sitrep-112.pdf?sfvrsn=813f2669_2."},{"title3":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients"},{"title3":"Preventing cytokine storm syndrome in COVID-19 using alpha-1 adrenergic receptor antagonists"},{"title3":"Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease"},{"title3":"Hyperinflammatory shock in children during COVID-19 pandemic"},{"title3":"COVID-19 and cardiovascular disease"},{"title3":"Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors"},{"title3":"Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?"},{"title3":"Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on coronary endothelial function"},{"title3":"Statins, like aspirin, should be given as early as possible in patients with acute coronary syndrome"},{"title3":"The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial"},{"title3":"The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia"},{"title3":"Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of covid-19"},{"title3":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019:United States, February 12-March 28, 2020"},{"title3":"Evaluation of the effectiveness of surveillance and containment measures for the first 100 patients with COVID-19 in Singapore:January 2-February 29, 2020"},{"title3":"The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study"},{"title3":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19"},{"title3":"Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study"},{"title3":"The effects of ARBs, ACEis, and statins on clinical outcomes of COVID-19 infection among nursing home residents"},{"title3":"Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2"},{"title3":"Cholesterol and COVID19 lethality in elderly"},{"title3":"The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity"},{"title3":"Purrello F (2020) May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?"},{"title3":"Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia"},{"title3":"Statins in coronavirus outbreak: It's time for experimental and clinical studies"},{"title3":"Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators"},{"title3":"Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomised placebo-controlled trial"},{"title3":"PRINCE Investigators. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study"},{"title3":"Statins directly suppress cytokine production in murine intraepithelial lymphocytes"},{"title3":"Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells"},{"title3":"A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammation"},{"title3":"Effect of atorvastatin on plasma NT-proBNP and inflammatory cytokine expression in patients with heart failure"},{"title3":"Immune modulatory effects of statins"},{"title3":"A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients"},{"title3":"The effect of statins on mortality in patients with bacteremia"},{"title3":"Systematic review and meta-analysis on the association between outpatient statins use and infectious disease-related mortality"},{"title3":"The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Statins: could an old friend help in the fight against COVID-19?"},{"title3":"Statin therapy in COVID-19 infection"},{"title3":"Considerations for statin therapy in patients with COVID-19"},{"title3":"Endothelial dysfunction in COVID-19: a position paper of the ESC working group for atherosclerosis and vascular biology, and the ESC council of basic cardiovascular science"},{"title3":"Pulmonary vascular endothelialitis, thrombosis and angiogenesis in COVID-19"},{"title3":"Cardiovascular disease during the COVID-19 pandemic: think ahead, protect hearts, reduce mortality"},{"title3":"Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19"},{"title3":"Coronary thrombosis in a young male with COVID-19"},{"title3":"Statin therapy improves endothelial dysfunction"},{"title3":"Influenza virus and atherosclerosis"},{"title3":"Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk"}]},{"title2":"Statin use is associated with decreased risk of invasive mechanical ventilation in COVID-19 patients: a preliminary study","References":[{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China"},{"title3":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Association of Cardiac Injury With Mortality in Hospitalized Patients with COVID-19 in Wuhan, China"},{"title3":"Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study"},{"title3":"Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms"},{"title3":"Statins for Prevention of Cardiovascular Disease in Adults"},{"title3":"Lipid-lowering effects of statins: A comparative review"},{"title3":"Statins in Acute Ischemic Stroke: A Systematic Review"},{"title3":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19"},{"title3":"Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19"},{"title3":"Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19"},{"title3":"Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"Statins in community acquired pneumonia: Evidence from experimental and clinical studies"},{"title3":"Influenza Morbidity and Mortality in Elderly Patients Receiving Statins: A Cohort Study"},{"title3":"Association Between Use of Statins and Mortality Among Patients Hospitalized With Laboratory-Confirmed Influenza Virus Infections: A Multistate Study"},{"title3":"Risk of pneumonia in patients taking statins: Population-based nested case-control study"},{"title3":"Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012"},{"title3":"Pre-Admission Statin Use and In-Hospital Severity of 2009 Pandemic Influenza A(H1N1) Disease"},{"title3":"Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: Open-label, randomized study"},{"title3":"Population-Based Study of Statins, Angiotensin II Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors on Pneumonia-Related Outcomes"},{"title3":"The impact of statin use on pneumonia risk and outcome: A combined population-based case-control and cohort study"},{"title3":"Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome"},{"title3":"Effect of Statin Therapy on Mortality in Patients With Ventilator-Associated Pneumonia"},{"title3":"An Assessment of H1N1 Influenza-Associated Acute Respiratory Distress Syndrome Severity after Adjustment for Treatment Characteristics"},{"title3":"Association of Elevated Plasma Interleukin-18 Level With Increased Mortality in a Clinical Trial of Statin Treatment for Acute Respiratory Distress Syndrome"},{"title3":"Understanding the potential role of statins in pneumonia and sepsis"},{"title3":"Statin therapy in COVID-19 infection"},{"title3":"Considerations for Statin Therapy in Patients with COVID-19"},{"title3":"Hiding in Plain Sight: An Approach to Treating Patients with Severe COVID-19 Infection"},{"title3":"Are certain drugs associated with enhanced mortality in COVID-19?"},{"title3":"Statins and the COVID-19 main protease: In silico evidence on direct interaction"},{"title3":"Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes"},{"title3":"Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms"},{"title3":"Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome"},{"title3":"Potential role of statins in COVID-19"},{"title3":"Statins as early therapy to mitigate COVID-19 (SARS-CoV-2)-associated ARDS and cytokine storm syndrome:Time is of the essence"},{"title3":"Statins: Could an old friend help in the fight against COVID-19?"},{"title3":"Treating influenza with statins and other immunomodulatory agents"},{"title3":"Treating the host response to emerging virus diseases: Lessons learned from sepsis, pneumonia, influenza and Ebola"},{"title3":"In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19"},{"title3":"Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: A retrospective cohort study"},{"title3":"The effects of ARBs, ACEIs and statins on clinical outcomes of COVID-19 infection among nursing home residents"},{"title3":"Mount Auburn Hospital. Atorvastatin as Adjunctive Therapy in COVID-19"},{"title3":"Coronavirus Response:Active Support for Hospitalised Covid-19 Patients"},{"title3":"Intermediate-Dose vs. Standard Prophylactic Anticoagulation and Statin vs. Placebo in ICU Patients with COVID-19"},{"title3":"Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019"},{"title3":"Comorbidity and its Impact on Patients with COVID-19"},{"title3":"A Modification of the Elixhauser Comorbidity Measures into a Point System for Hospital Death Using Administrative Data"}]},{"title2":"Associations of medications with lower odds of typical COVID-19 symptoms: cross-sectional symptom surveillance study","References":[{"title3":"WHO Coronavirus Disease (COVID-19) Dashboard"},{"title3":"Erfassung der SARS-CoV-2-Testzahlen in Deutschland (Update vom 15.4.2020)"},{"title3":"Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Could BCG vaccination induce protective trained immunity for SARS-CoV-2?"},{"title3":"BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?"},{"title3":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19"},{"title3":"The effects of ARBs, ACEis, and statins on clinical outcomes of COVID-19 infection among nursing home residents"},{"title3":"Statin use is associated with lower disease severity in COVID-19 infection"},{"title3":"Real-time tracking of self-reported symptoms to predict potential COVID-19"},{"title3":"COVIDApp as an innovative strategy for the management and follow-up of COVID-19 cases in long-term care facilities in Catalonia: implementation study"},{"title3":"Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease"},{"title3":"App-based tracking of self-reported COVID-19 symptoms: analysis of questionnaire data"},{"title3":"Sex differential in COVID-19 mortality varies markedly by age"},{"title3":"Statins and the COVID-19 main protease: evidence on direct interaction"},{"title3":"Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial"},{"title3":"Treating influenza with statins and other immunomodulatory agents"},{"title3":"Clinician-initiated research on treating the host response to pandemic influenza"},{"title3":"Simvastatin improves neutrophil function and clinical outcomes in pneumonia. A pilot randomized controlled clinical trial"},{"title3":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia"},{"title3":"Potential role of statins in COVID-19"},{"title3":"A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis"},{"title3":"Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis"},{"title3":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome"}]},{"title2":"Mitacchione G, et al. Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy. J Clin Lipidol. 2020. 10.1016/j.jacl.2020.12.008.","References":[]},{"title2":"Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study","References":[{"title3":"WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. WHO Dir. Gen. speeches. 2020;:4"},{"title3":"In-Hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19"},{"title3":"Identification of atovaquone, ouabain and mebendazole as FDA approved drugs Tar-geting SARS-CoV-2 (version 4)"},{"title3":"The effects of Arbs, ACEis, and statins on clinical outcomes of COVID-19 infection among nursing home residents"},{"title3":"Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection"},{"title3":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy"},{"title3":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)"},{"title3":"Predictors of early and late stroke following cardiac surgery"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis"},{"title3":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention"},{"title3":"Pleiotropic effects of statins on the cardiovascular system"},{"title3":"Immune modulatory effects of statins"},{"title3":"Statins: a viable candidate for host-directed therapy against infectious diseases"},{"title3":"[Pleiotropic effects of statins]"},{"title3":"Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins"},{"title3":"Effect of statin treatment on short term mortality after pneumonia episode: cohort study"},{"title3":"Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study"},{"title3":"Influenza morbidity and mortality in elderly patients receiving statins: a cohort study"},{"title3":"An assessment of the effect of statin use on the incidence of acute respiratory infections in England during Winters 1998-1999 to 2005-2006"},{"title3":"Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: open-label, randomized study"},{"title3":"Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial"},{"title3":"Statins may decrease the fatality rate of middle East respiratory syndrome infection"},{"title3":"Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease"},{"title3":"Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis"},{"title3":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications"},{"title3":"Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats"},{"title3":"The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Angiotensin-Converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Physiology of local renin-angiotensin systems"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"The Danish national patient register"},{"title3":"The Danish national prescription registry"},{"title3":"The Danish civil registration system"},{"title3":"Danish education registers"},{"title3":"Danish registers on personal income and transfer payments"},{"title3":"Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people"},{"title3":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study"},{"title3":"Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction"},{"title3":"Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction"},{"title3":"On the estimation of average treatment effects with right-censored time to event outcome and competing risks"},{"title3":"R core team 2014 R: a language and environment for statistical computing. R foundation for statistical computing"},{"title3":"Study of ruxolitinib plus simvastatin in the prevention and treatment of respiratory failure of COVID-19"},{"title3":"Coronavirus Response - Active Support for Hospitalised Covid-19 Patients"},{"title3":"Preventing cardiac complication of COVID-19 disease with early acute coronary syndrome therapy: a randomised controlled trial"},{"title3":"Atorvastatin in COVID-19 (STATCO19)"},{"title3":"Liver injury during highly pathogenic human coronavirus infections"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of COVID-19-Related liver functional abnormality"},{"title3":"Statins and its hepatic effects: newer data, implications, and changing recommendations"},{"title3":"ESC guidance for the diagnosis and management of cv disease during the COVID-19 pandemic"},{"title3":"Large-Vessel stroke as a presenting feature of covid-19 in the young"},{"title3":"SARS-CoV-2 and stroke in a new York healthcare system"},{"title3":"COVID-19 update: Covid-19-associated coagulopathy"}]},{"title2":"Statin treatment and reduced risk of pneumonia in patients with diabetes","References":[]},{"title2":"Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans","References":[]},{"title2":"Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury","References":[]},{"title2":"Reduction in blood pressure with statins: results from the UCSD statin study, a randomized trial","References":[]},{"title2":"Natural statins and stroke risk","References":[]},{"title2":"The role of statins in respiratory diseases","References":[]},{"title2":"Pleiotropic effects of statins","References":[]},{"title2":"Statins, bugs and prophylaxis: intriguing possibilities","References":[{"title3":"Beyond lipid lowering: the role of statins in vascular protection"},{"title3":"HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?"},{"title3":"Statins inhibit HIV-1 infection by down-regulating Rho activity"},{"title3":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site"},{"title3":"Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells"},{"title3":"New insights into the pharmacodynamic and pharmacokinetic properties of statins"},{"title3":"Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation"},{"title3":"Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro"},{"title3":"Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation"},{"title3":"In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans"},{"title3":"Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans"},{"title3":"Re-emergence of fatal human influenza A subtype H5N1 disease"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"Influenza and the challenge for immunology"},{"title3":"Statins, inflammation, and sepsis: hypothesis"},{"title3":"Do statins have a role in preventing or treating sepsis?"},{"title3":"Statins: panacea for sepsis?"},{"title3":"Statins as a newly recognized type of immunomodulator"},{"title3":"The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells"},{"title3":"Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection"},{"title3":"Vaccine development for an imminent pandemic: why we should worry, what we must do"},{"title3":"Systemic inflammatory response and progression to severe sepsis in critically ill infected patients"}]},{"title2":"Statins and sepsis: multiple modifications at multiple levels","References":[]},{"title2":"Evaluation of antiviral effect of atorvastatin on H1N1 infection in MDCK cells","References":[]},{"title2":"Simvastatin modulates cellular components in influenza a virus-infected cells","References":[{"title3":"The prostanoid 15-deoxy-Delta12,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection"},{"title3":"Confronting an influenza pandemic with inexpensive generic agents: can it be done?"},{"title3":"Dual prenylation is required for Rab protein localization and function"},{"title3":"Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States"},{"title3":"Antiviral resistance in influenza viruses-implications for management and pandemic response"},{"title3":"Infections with oseltamivir-resistant influenza A (H1N1) virus in the United States"},{"title3":"Pandemic influenza: a potential role for statins in treatment and prophylaxis"},{"title3":"Inhibition of MLC phosphorylation restricts replication of influenza virus-A mechanism of action for anti-influenza agents"},{"title3":"Intracellular trafficking of influenza virus: clinical implications for molecular medicine"},{"title3":"Complications of seasonal and pandemic influenza"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"Recognition of viruses by cytoplasmic sensors"},{"title3":"Influenza A virus abrogates IFN-gamma response in respiratory epithelial cells by disruption of the Jak/Stat pathway"},{"title3":"Preparing for the next pandemic"},{"title3":"Immunomodulatory therapy for severe influenza"},{"title3":"Pleiotropic effects of statin therapy: molecular mechanisms and clinical results"},{"title3":"A role for hydroxy-methylglutaryl coenzyme A reductase in pulmonary inflammation and host defense"},{"title3":"Role for influenza virus envelope cholesterol in virus entry and infection"},{"title3":"Cholesterol depletion induces autophagy"},{"title3":"Statins and sepsis: multiple modifications at multiple levels"},{"title3":"Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts"},{"title3":"Statin use reduces decline in lung function: VA Normative Aging Study"},{"title3":"Involvement of actin filaments in budding of measles virus: studies on cytoskeletons of infected cells"},{"title3":"Microtubules and actin filaments are not critically involved in the biogenesis of epithelial cell surface polarity"},{"title3":"Stabilization of actin filaments at early times after adenovirus infection and in heat-shocked cells"},{"title3":"Actin regulation in endocytosis"},{"title3":"Actin-binding proteins"},{"title3":"The effects of the small GTPase RhoA on the muscarinic contraction of airway smooth muscle result from its role in regulating actin polymerization"},{"title3":"Innate immune response of human alveolar macrophages during influenza A infection"},{"title3":"Rho GTPases and the control of cell behaviour"},{"title3":"Requirement of CDC42 for Salmonella-induced cytoskeletal and nuclear responses"},{"title3":"The novel Rho-family GTPase rif regulates coordinated actin-based membrane rearrangements"},{"title3":"Differential effects of simvastatin on mesangial cells"},{"title3":"Simvastatin inhibits TGFbeta1-induced fibronectin in human airway fibroblasts"},{"title3":"Endocytosis, actin cytoskeleton and signaling"},{"title3":"The mannose 6-phosphate receptor and the biogenesis of lysosomes"},{"title3":"Membrane domains in the secretory and endocytic pathways"},{"title3":"Pepstatin A alters host cell autophagic machinery and leads to a decrease in influenza A virus production"},{"title3":"Dissecting virus entry via endocytosis"},{"title3":"Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses"},{"title3":"Molecular characterization of light chain 3. A microtubule binding subunit of MAP1A and MAP1B"},{"title3":"S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3"},{"title3":"Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway"},{"title3":"The late stages of autophagy: how does the end begin?"},{"title3":"Evaluation of antiviral effect of atorvastatin on H1N1 infection in MDCK cells"},{"title3":"50% endpoint calculation"},{"title3":"Microculture virus titration - a simple colourimetric assay for influenza virus titration"},{"title3":"The agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus"},{"title3":"Attenuation of influenza virus infectivity with herbal-marine compound (HESA-A): an in vitro study in MDCK cells"},{"title3":"Quantitation of rabbit cytokine mRNA by real-time RT-PCR"},{"title3":"Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009"},{"title3":"Clinical features, complications and mortality in critically ill patients with 2009 influenza A (H1N1) in Sfax, Tunisia"},{"title3":"Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A (H1N1) disease"},{"title3":"Influenza morbidity and mortality in elderly patients receiving statins: a cohort study"},{"title3":"Statins for sepsis: a critical and updated review"},{"title3":"Statins for infection and sepsis: a systematic review of the clinical evidence"},{"title3":"Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study"},{"title3":"Statins reduce the expression of proinflammatory cytokines in influenza A virus infected CrFK cells"},{"title3":"Rho GTPases and the actin cytoskeleton"},{"title3":"Rho and Rac take center stage"},{"title3":"Rif proteins take to the RhoD: Rho GTPases at the crossroads of actin dynamics and membrane trafficking"},{"title3":"Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell"},{"title3":"Immune responses to influenza virus infection"},{"title3":"Regulation of intracellular actin polymerization by prenylated cellular proteins"},{"title3":"Statins inhibit HIV-1 infection by down-regulating Rho activity"},{"title3":"Kinetics of interaction of Rab5 and Rab7 with nucleotides and magnesium ions"},{"title3":"Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication"},{"title3":"Fluvastatin modulates renal water reabsorption in vivo through increased AQP2 availability at the apical plasma membrane of collecting duct cells"},{"title3":"Autophagy, apoptosis and the influenza virus M2 protein"},{"title3":"Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy"},{"title3":"Transport of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 and Cdc42 proteins"},{"title3":"Innate and adaptive immunity through autophagy"},{"title3":"A drug screening method based on the autophagy pathway and studies of the mechanism of evodiamine against influenza A virus"},{"title3":"Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c"},{"title3":"Autophagy as a regulated pathway of cellular degradation"}]},{"title2":"Influenza morbidity and mortality in elderly patients receiving statins: a cohort study","References":[{"title3":"Final report of the XVI Meeting on Vaccine Preventable-Diseases of the Pan American Health Organization."},{"title3":"Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis."},{"title3":"(2009) Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO."},{"title3":"Confronting an influenza pandemic with inexpensive generic agents: can it be done?"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia."},{"title3":"Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus."},{"title3":"Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection."},{"title3":"Avian influenza virus (H5N1): a threat to human health."},{"title3":"Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates."},{"title3":"In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells."},{"title3":"Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure."},{"title3":"Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients."},{"title3":"Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide."},{"title3":"Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels."},{"title3":"Inhibition of proinflammatory cytokine production by pravastatin."},{"title3":"LPS-induced cytokine production and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors."},{"title3":"Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes."},{"title3":"Prior statin therapy is associated with a decreased rate of severe sepsis."},{"title3":"The effect of statins on mortality in patients with bacteremia."},{"title3":"Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis."},{"title3":"The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia."},{"title3":"Statin treatment and reduced risk of pneumonia in patients with diabetes."},{"title3":"Statins and the risk of pneumonia: a population-based, nested case-control study."},{"title3":"Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia."},{"title3":"Prior statin use is associated with improved outcomes in community-acquired pneumonia."},{"title3":"Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients."},{"title3":"Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study."},{"title3":"Statin use and risk of community acquired pneumonia in older people: population based case-control study."},{"title3":"Evidence of bias in estimates of influenza vaccine effectiveness in seniors."},{"title3":"Coding accuracy of administrative drug claims in the Ontario Drug Benefit database."},{"title3":"Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction."},{"title3":"Cardiovascular health and services in Ontario: an ICES atlas."},{"title3":"Supply of physicians' services in Ontario."},{"title3":"Living and dying in Ontario: an opportunity for improved health information."},{"title3":"Using OHIP physician billing claims to ascertain individual influenza vaccination status."},{"title3":"Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm."},{"title3":"Determinants of home care utilization: who uses home care in Ontario?"},{"title3":"Canadian Immunization Guide."},{"title3":"Ambulatory care groups: a categorization of diagnoses for research and management."},{"title3":"Reducing Bias in Observational Studies Using Subclassification on the Propensity Score."},{"title3":"Statin adherence and risk of accidents: a cautionary tale."},{"title3":"Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox."},{"title3":"Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods."}]},{"title2":"Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study","References":[]},{"title2":"Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of mRNA levels for interleukin-1, interleukin-6, cyclooxygenase- 2 and p22phox by regulation of peroxisome proliferator-activated receptor (PPAR) in primary endothelial cells","References":[]},{"title2":"Statins reduce the expression of proinflammatory cytokines in influenza A virus infected CrFK cells","References":[]},{"title2":"Simvastatin suppresses RANTES-mediated neutrophilia in polyinosinic-polycytidylic acid-induced pneumonia","References":[]},{"title2":"Statins may decrease the fatality rate of Middle East Respiratory Syndrome infection","References":[{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"Middle East respiratory syndrome"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Drugs to cure avian influenza infection:multiple ways to prevent cell death"},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"Inhibition of NF-kappaB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival"},{"title3":"Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4/MYD88 pathway"},{"title3":"Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide"},{"title3":"Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway"}]},{"title2":"Virani SS. Is there a role for statin therapy in acute viral infections? Cardiology Magazine. Washington, DC:  American College of Cardiology; 2020. https://www.acc.org/latest-in-cardiology/articles/2020/03/18/15/09/is-there-a-role-for-statin-therapy-in-acute-viral-infections-covid-19","References":[]},{"title2":"Statins and the COVID-19 main protease: in silico evidence on direct interaction","References":[{"title3":"Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV"},{"title3":"Going global - Travel and the 2019 novel coronavirus"},{"title3":"Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic"},{"title3":"Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2"},{"title3":"Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review"},{"title3":"Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019"},{"title3":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)"},{"title3":"Understanding the potential role of statins in pneumonia and sepsis"},{"title3":"Severe sepsis and septic shock"},{"title3":"Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms"},{"title3":"Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial"},{"title3":"Statin therapy reduces plasma endothelin-1 concentrations: a meta-analysis of 15 randomized controlled trials"},{"title3":"Association between statin use and plasma D-dimer levels: a systematic review and meta-analysis of randomised controlled trials"},{"title3":"New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect?"},{"title3":"Rationale of statin therapy in septic patients"},{"title3":"Statins suppress Ebola virus infectivity by interfering with glycoprotein processing"},{"title3":"Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study"},{"title3":"The crytal structure of 2019-NCoV main protease in complex with an inhibitor N3"},{"title3":"Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation"},{"title3":"Structure of Mpro from COVID-19 virus and discovery of its inhibitors"},{"title3":"Familial hypercholesterolemia and COVID-19: triggering of increased sustained cardiovascular risk"},{"title3":"Management of patients with familial hypercholesterolaemia"},{"title3":"Effect of statin therapy on arterial wall inflammation based on 18F-FDG PET/CT: a systematic review and meta-analysis of interventional studies"},{"title3":"Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies"},{"title3":"COVID-19 treatment by repurposing drugs until the vaccine is in sight"},{"title3":"A practical treatment for patients with Ebola virus disease"}]},{"title2":"Moeller R, et al. Effect of statins on SARS-CoV-2 infection. medRxiv. 2020;20152272.","References":[]},{"title2":"The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections","References":[{"title3":"Expression of animal virus genomes"},{"title3":"Virus taxonomy: the database of the international committee on taxonomy of viruses (ICTV)"},{"title3":"Virus taxonomy"},{"title3":"Clinical development of reovirus for cancer therapy: an oncolytic virus with immune-mediated antitumor activity"},{"title3":"Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow"},{"title3":"Perturbation of gut microbiome leads to fluctuations in phage population density"},{"title3":"Baculoviruses: sophisticated pathogens of insects"},{"title3":"Bacterial symbionts in lepidoptera: their diversity, transmission, and impact on the host"},{"title3":"Taking a bite out of nutrition and arbovirus infection"},{"title3":"The global distribution and burden of dengue"},{"title3":"Zika virus and microcephaly: why is this situation a PHEIC?"},{"title3":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication"},{"title3":"Zika virus outbreak on yap Island, federated states of micronesia"},{"title3":"A distinct lineage of influenza A virus from bats"},{"title3":"Types of influenza viruses"},{"title3":"The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection"},{"title3":"Acute myocardial infarction after laboratory-confirmed influenza infection REPLY"},{"title3":"Progress and remaining gaps in estimating the global disease burden of influenza"},{"title3":"Towards a universal influenza vaccine: different approaches for one goal"},{"title3":"Estimated number of people dying from HIV-related causes"},{"title3":"HIV developing an HIV vaccine What are the paths and obstacles to a practical vaccine?"},{"title3":"Combination antiretroviral therapy (cART) restores HIV-1 infection-mediated impairment of JAK-STAT signaling pathway"},{"title3":"Cellular stress responses: cell survival and cell death"},{"title3":"Loss of stress response as a consequence of viral infection: implications for disease and therapy"},{"title3":"Herpes simplex virus-1 disarms the unfolded protein response in the early stages of infection"},{"title3":"Virus-induced ER stress and the unfolded protein response"},{"title3":"The role of oxidative stress in influenza virus infection"},{"title3":"XBP-1, a cellular target for the development of novel anti-viral strategies"},{"title3":"Stress-induced unfolded protein response contributes to Zika virus-associated microcephaly"},{"title3":"Induction of cellular stress overcomes the requirement of herpes simplex virus type 1 for immediate-early protein ICP0 and reactivates expression from quiescent viral genomes"},{"title3":"The role of secretory autophagy in zika virus transfer through the placental barrier"},{"title3":"Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics"},{"title3":"New frontiers in the treatment of colorectal cancer: autophagy and the unfolded protein response as promising targets"},{"title3":"Autoimmunity and apoptosis-therapeutic implications"},{"title3":"Death receptor signal transducers: nodes of coordination in immune signaling networks"},{"title3":"Apoptosis and cancer: mutations within caspase genes"},{"title3":"The Bcl2 family: regulators of the cellular life-or-death switch"},{"title3":"Viewing BCL2 and cell death control from an evolutionary perspective"},{"title3":"Mitochondrial apoptosis and BH3 mimetics"},{"title3":"Directly targeting the mitochondrial pathway of apoptosis for cancer therapy using BH3 mimetics - recent successes, current challenges and future promise"},{"title3":"Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy"},{"title3":"Apoptosis in development"},{"title3":"Interrogating the relevance of mitochondrial apoptosis for vertebrate development and postnatal tissue homeostasis"},{"title3":"Toward an understanding of the molecular mechanisms of physiological cell death"},{"title3":"Programmed cell death and the immune system"},{"title3":"Apoptosis: its origin, history, maintenance and the medical implications for cancer and aging"},{"title3":"Apoptosis in human disease: a new skin for the old ceremony?"},{"title3":"Death to flies: drosophila as a model system to study programmed cell death"},{"title3":"Identification of caspases and apoptosis in the simple metazoan Hydra"},{"title3":"The molecular mechanism of programmed cell death in C elegans"},{"title3":"The involvement of cysteine proteases and protease inhibitor genes in the regulation of programmed cell death in plants"},{"title3":"Plant life needs cell death, but does plant cell death need Cys proteases?"},{"title3":"The life and death of a plant cell"},{"title3":"Oxygen stress: a regulator of apoptosis in yeast"},{"title3":"Autophagy modulates transforming growth factor beta 1 induced epithelial to mesenchymal transition in non-small cell lung cancer cells"},{"title3":"Glioblastoma and chemoresistance to alkylating agents: involvement of apoptosis, autophagy, and unfolded protein response"},{"title3":"Autophagy is constitutively active in normal mouse sino-atrial nodal cells"},{"title3":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)"},{"title3":"Guidelines for the use and interpretation of assays for monitoring autophagy"},{"title3":"Immunologic manifestations of autophagy"},{"title3":"Autophagy and human diseases"},{"title3":"Autophagy in cellular metabolism and cancer"},{"title3":"Autophagy and the immune system"},{"title3":"The role of autophagy in neurodegenerative disease"},{"title3":"Simultaneous detection of autophagy and epithelial to mesenchymal transition in the non-small cell lung cancer cells"},{"title3":"Electron microscopy of lysosomerich fractions from rat liver"},{"title3":"Autophagy at the crossroads of catabolism and anabolism"},{"title3":"Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts"},{"title3":"Autophagy: renovation of cells and tissues"},{"title3":"Microautophagy: lesser-known self-eating"},{"title3":"Chaperone-mediated autophagy: roles in disease and aging"},{"title3":"Autophagy and apoptosis dysfunction in neurodegenerative disorders"},{"title3":"SnapShot: selective autophagy"},{"title3":"Hepatitis B and C virus-induced hepatitis: apoptosis, autophagy, and unfolded protein response"},{"title3":"Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development"},{"title3":"Common traits spark the mitophagy/xenophagy interplay"},{"title3":"Digesting the expanding mechanisms of autophagy"},{"title3":"Advances in autophagy regulatory mechanisms"},{"title3":"Dynamics and diversity in autophagy mechanisms: lessons from yeast"},{"title3":"An overview of the molecular mechanism of autophagy"},{"title3":"A unified nomenclature for yeast autophagy-related genes"},{"title3":"Architecture of the Atg17 complex as a scaffold for autophagosome biogenesis"},{"title3":"ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomes"},{"title3":"The origin of the autophagosomal membrane"},{"title3":"Deacetylation of nuclear LC3 drives autophagy initiation under starvation"},{"title3":"Genes involved in the regulation of different types of autophagy and their participation in cancer pathogenesis"},{"title3":"Autophagy, Metabolism, and Cancer"},{"title3":"Convergence of multiple autophagy and cytoplasm to vacuole targeting components to a perivacuolar membrane compartment prior to de novo vesicle formation"},{"title3":"The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation"},{"title3":"Autophagosomes form at ER-mitochondria contact sites"},{"title3":"The autophagosome: origins unknown, biogenesis complex"},{"title3":"Organelle-specific initiation of autophagy"},{"title3":"Selective autophagy: talking with the UPS"},{"title3":"Organellophagy: eliminating cellular building blocks via selective autophagy"},{"title3":"Self and nonself: how autophagy targets mitochondria and bacteria"},{"title3":"Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy"},{"title3":"The LC3 interactome at a glance"},{"title3":"UBQLN2 mediates autophagy-independent protein aggregate clearance by the proteasome"},{"title3":"Mechanisms of mitophagy"},{"title3":"Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells"},{"title3":"Nix is a selective autophagy receptor for mitochondrial clearance"},{"title3":"Essential role for Nix in autophagic maturation of erythroid cells"},{"title3":"Phosphorylation of Serine 114 on Atg32 mediates mitophagy"},{"title3":"Defining and measuring autophagosome flux:concept and reality"},{"title3":"Mitochondria and the autophagy-inflammation-cell death axis in organismal aging"},{"title3":"Autophagy fights disease through cellular self-digestion"},{"title3":"Autophagy activation in asthma airways remodeling"},{"title3":"Autophagy and the integrated stress response"},{"title3":"Autophagy is required to maintain muscle mass"},{"title3":"Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival"},{"title3":"Targeting autophagy in cancer"},{"title3":"Chaperone-mediated autophagy at a glance"},{"title3":"Autophagy in the control and pathogenesis of viral infection"},{"title3":"Autophagy in infection, inflammation and immunity"},{"title3":"Checking the garbage bin for problems in the house, or how autophagy assists in antigen presentation to the immune system"},{"title3":"Autophagy during viral infection : a double-edged sword"},{"title3":"Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity"},{"title3":"TRIM32-TAX1BP1-dependent selective autophagic degradation of TRIF negatively regulates TLR3/4-mediated innate immune responses"},{"title3":"Autophagy protects against Sindbis virus infection of the central nervous system"},{"title3":"Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes"},{"title3":"Influenza A virus proteins NS1 and hemagglutinin along with M2 are involved in stimulation of autophagy in infected cells"},{"title3":"Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages"},{"title3":"Dengue virus capsid protein usurps lipid droplets for viral particle formation"},{"title3":"Dengue virus-induced autophagy regulates lipid metabolism"},{"title3":"Dengue Virus inhibition of autophagic flux and dependency of viral replication on proteasomal degradation of the autophagy receptor p62"},{"title3":"Stressed to death - mechanisms of ER stress-induced cell death"},{"title3":"Apoptosis, autophagy and unfolded protein response pathways in Arbovirus replication and pathogenesis"},{"title3":"Endoplasmic reticulum stress signalling - from basic mechanisms to clinical applications"},{"title3":"Targeting the unfolded protein response in disease"},{"title3":"The unfolded protein response in breast cancer"},{"title3":"Novel roles of the unfolded protein response in the control of tumor development and aggressiveness"},{"title3":"Dual IRE1 RNase functions dictate glioblastoma development"},{"title3":"Stressed to death - mechanisms of ER stress-induced cell death"},{"title3":"Autophagy and the unfolded protein response promote profibrotic effects of TGF-beta1 in human lung fibroblasts"},{"title3":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond"},{"title3":"IRE1 signaling affects cell fate during the unfolded protein response"},{"title3":"A close connection between the PERK and IRE arms of the UPR and the transcriptional regulation of autophagy"},{"title3":"XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor"},{"title3":"Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha"},{"title3":"Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival"},{"title3":"PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress"},{"title3":"Autophagic machinery activated by dengue virus enhances virus replication"},{"title3":"Avian reovirus triggers autophagy in primary chicken fibroblast cells and Vero cells to promote virus production"},{"title3":"Chikungunya triggers an autophagic process which promotes viral replication"},{"title3":"Epizootic hemorrhagic disease virus induces and benefits from cell stress, autophagy, and apoptosis"},{"title3":"The p17 nonstructural protein of avian reovirus triggers autophagy enhancing virus replication via activation of phosphatase and tensin deleted on chromosome 10 (PTEN) and AMP-activated protein kinase (AMPK), as well as dsRNA-dependent protein kinase (PKR)/eIF2alpha signaling pathways"},{"title3":"Organelle-like membrane compartmentalization of positive-strand RNA virus replication factories"},{"title3":"Co-localization of constituents of the dengue virus translation and replication machinery with amphisomes"},{"title3":"Japanese encephalitis virus replication is negatively regulated by autophagy and occurs on LC3-I- and EDEM1-containing membranes"},{"title3":"Dengue virus and autophagy"},{"title3":"Stress responses in flavivirus-infected cells: activation of unfolded protein response and autophagy"},{"title3":"Induced autophagy reduces virus output in dengue infected monocytic cells"},{"title3":"West Nile Virus (WNV) replication is independent of autophagy in mammalian cells"},{"title3":"West Nile Virus growth is independent of autophagy activation"},{"title3":"Autophagy inhibits viral genome replication and gene expression stages in West Nile virus infection"},{"title3":"Amino acid substitutions in the non-structural proteins 4A or 4B modulate the induction of autophagy in West Nile virus infected cells independently of the activation of the unfolded protein response"},{"title3":"Japanese encephalitis virus activates autophagy through XBP1 and ATF6 ER stress sensors in neuronal cells"},{"title3":"Dengue virus infection induces autophagy: an in vivo study"},{"title3":"Subversion of cellular autophagosomal machinery by RNA viruses"},{"title3":"Linking dengue virus entry and translation/replication through amphisomes"},{"title3":"Japanese Encephalitis Virus Activates Autophagy as a Viral Immune Evasion Strategy"},{"title3":"The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner"},{"title3":"Flavivirus NS4A-induced autophagy protects cells against death and enhances virus replication"},{"title3":"Chikungunya virus-induced autophagy delays caspase-dependent cell death"},{"title3":"Analysis of the miRNA profile in C6/36 cells persistently infected with dengue virus type 2"},{"title3":"MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response"},{"title3":"The Atg5-atg12 conjugate associates with innate antiviral immune responses"},{"title3":"Biology of Zika Virus infection in human skin cells"},{"title3":"The Brazilian Zika virus strain causes birth defects in experimental models"},{"title3":"Implications of autophagy on arbovirus infection of mosquitoes"},{"title3":"Inflammation-induced, STING-dependent autophagy restricts zika virus infection in the drosophila brain"},{"title3":"Tick-borne flaviviruses alter membrane structure and replicate in dendrites of primary mouse neuronal cultures"},{"title3":"Electron tomography analysis of Tick-Borne Encephalitis Virus infection in human neurons"},{"title3":"Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence"},{"title3":"Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis"},{"title3":"Japanese encephalitis virus NS1' protein depends on pseudoknot secondary structure and is cleaved by caspase during virus infection and cell apoptosis"},{"title3":"Double-stranded RNA in hamster, chick, and mosquito cells infected with Sindbis virus"},{"title3":"Immunofluorescent demonstration of double-stranded RNA in the cytoplasm of Sindbis virus-infected cells"},{"title3":"Diversity in viral anti-PKR mechanisms: a remarkable case of evolutionary convergence"},{"title3":"Mcl-1 is a potential therapeutic target in multiple types of cancer"},{"title3":"Sindbis viral vector induced apoptosis requires translational inhibition and signaling through Mcl-1 and Bak"},{"title3":"Chikungunya virus mobilizes the apoptotic machinery to invade host cell defenses"},{"title3":"Crimean-Congo hemorrhagic fever virus-infected hepatocytes induce ER-stress and apoptosis crosstalk"},{"title3":"Cell type-specific mechanisms of interleukin-8 induction by dengue virus and differential response to drug treatment"},{"title3":"IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis"},{"title3":"Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection"},{"title3":"West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence"},{"title3":"Induction of apoptosis by Sindbis virus occurs at cell entry and does not require virus replication"},{"title3":"Nucleophosmin (NPM1)/B23 in the proteome of human astrocytic cells restricts chikungunya virus replication"},{"title3":"Neurovirulence comparison of Chikungunya virus isolates of the Asian and East/Central/South African genotypes from Malaysia"},{"title3":"The West Nile virus capsid protein blocks apoptosis through a phosphatidylinositol 3-kinase-dependent mechanism"},{"title3":"West Nile virus-induced bax-dependent apoptosis"},{"title3":"CLIPR-59 regulates TNF-alpha-induced apoptosis by controlling ubiquitination of RIP1"},{"title3":"The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose"},{"title3":"West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus"},{"title3":"West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis"},{"title3":"Induction of the cellular microRNA, Hs_154, by West Nile virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors"},{"title3":"Japanese encephalitis virus down-regulates thioredoxin and induces ROS-mediated ASK1-ERK/p38 MAPK activation in human promonocyte cells"},{"title3":"Replication-incompetent virions of Japanese encephalitis virus trigger neuronal cell death by oxidative stress in a culture system"},{"title3":"NS1' of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness"},{"title3":"Antiapoptotic but not antiviral function of Human bcl-2 assists establishment of Japanese encephalitis virus persistence in cultured cells"},{"title3":"Japanese encephalitis virus disrupts blood-brain barrier and modulates apoptosis proteins in THBMEC cells"},{"title3":"Neuropathogenesis of Japanese Encephalitis in a primate model"},{"title3":"Dengue virus type 3 isolated from a fatal case with visceral complications induces enhanced proinflammatory responses and apoptosis of human dendritic cells"},{"title3":"Differential effects of dengue virus on infected and bystander dendritic cells"},{"title3":"Gene expression profiling by microarray analysis reveals an important role for caspase-1 in dengue virus-induced p53-mediated apoptosis"},{"title3":"p53 activation following rift valley fever virus infection contributes to cell death and viral production"},{"title3":"NSm protein of rift valley fever virus suppresses virus-induced apoptosis"},{"title3":"Rift valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation"},{"title3":"Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death"},{"title3":"Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cells"},{"title3":"African horse sickness virus induces apoptosis in cultured mammalian cells"},{"title3":"Impact of dengue virus (serotype DENV-2) infection on liver of BALB/c mice: A histopathological analysis"},{"title3":"Suppression of the arboviruses Dengue and Chikungunya using a dual-acting group-I intron coupled with conditional expression of the Bax C-terminal domain"},{"title3":"Synthetic miRNAs induce dual arboviral-resistance phenotypes in the vector mosquito Aedes aegypti"},{"title3":"The south pacific epidemic strain of Zika virus replicates efficiently in human epithelial A549 cells leading to IFN-beta production and apoptosis induction"},{"title3":"Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3"},{"title3":"The structural proteins of epidemic and historical strains of Zika virus differ in their ability to initiate viral infection in human host cells"},{"title3":"Neuronal degeneration in mice induced by an epidemic strain of Saint Louis encephalitis virus isolated in Argentina"},{"title3":"Effects of manipulating apoptosis on Sindbis Virus infection of Aedes aegypti mosquitoes"},{"title3":"Rapid selection against arbovirus-induced apoptosis during infection of a mosquito vector"},{"title3":"Identification of AaCASPS7, an effector caspase in Aedes albopictus"},{"title3":"Arboviruses and apoptosis: the role of cell death in determining vector competence"},{"title3":"A novel mosquito ubiquitin targets viral envelope protein for degradation and reduces virion production during dengue virus infection"},{"title3":"West Nile virus differentially modulates the unfolded protein response to facilitate replication and immune evasion"},{"title3":"ATF6 signaling is required for efficient West Nile virus replication by promoting cell survival and inhibition of innate immune responses"},{"title3":"Differential unfolded protein response during Chikungunya and Sindbis virus infection: CHIKV nsP4 suppresses eIF2alpha phosphorylation"},{"title3":"Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress"},{"title3":"Iminosugars inhibit dengue virus production via inhibition of ER alpha-glucosidases-Not glycolipid processing enzymes"},{"title3":"Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo"},{"title3":"Dengue virus serotype infection specifies the activation of the unfolded protein response"},{"title3":"The stress granule component TIA-1 binds tick-borne encephalitis virus RNA and is recruited to perinuclear sites of viral replication to inhibit viral translation"},{"title3":"Tick-borne encephalitis virus triggers inositol-requiring enzyme 1 (IRE1) and transcription factor 6 (ATF6) pathways of unfolded protein response"},{"title3":"Venezuelan Equine Encephalitis Virus induces apoptosis through the unfolded protein response activation of EGR1"},{"title3":"Autophagy is involved in influenza A virus replication"},{"title3":"Suppression of influenza a virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1"},{"title3":"Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction"},{"title3":"Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy"},{"title3":"Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c"},{"title3":"Autophagy and signaling: their role in cell survival and cell death"},{"title3":"Cholesterol depletion induces autophagy"},{"title3":"Autophagy, apoptosis, and the influenza virus M2 protein"},{"title3":"Inhibitory effect of bafilomycin A1, a specific inhibitor of vacuolar-type proton pump, on the growth of influenza A and B viruses in MDCK cells"},{"title3":"Simvastatin modulates cellular components in influenza A virus-infected cells"},{"title3":"Functional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation"},{"title3":"Baicalin inhibits autophagy induced by influenza A virus H3N2"},{"title3":"Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling"},{"title3":"Proton channel activity of influenza A virus matrix protein 2 contributes to autophagy arrest"},{"title3":"The WD40 domain of ATG16L1 is required for its non-canonical role in lipidation of LC3 at single membranes"},{"title3":"Ubiquitination of the cytoplasmic domain of influenza A virus M2 protein is crucial for production of infectious virus particles"},{"title3":"The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR"},{"title3":"Autophagy is involved in regulating influenza A virus RNA and protein synthesis associated with both modulation of Hsp90 induction and mTOR/p70S6K signaling pathway"},{"title3":"Autophagy as a regulated pathway of cellular degradation"},{"title3":"Avian influenza A virus H5N1 causes autophagy-mediated cell death through suppression of mTOR signaling"},{"title3":"Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection"},{"title3":"Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence"},{"title3":"mTOR/p70S6K signaling distinguishes routine, maintenance-level autophagy from autophagic cell death during influenza A infection"},{"title3":"Autophagy is a critical regulator of memory CD8(+) T cell formation"},{"title3":"Homeostatic control of innate lung inflammation by Vici Syndrome Gene Epg5 and additional autophagy genes promotes influenza pathogenesis"},{"title3":"Mice deficient in EPG5 exhibit selective neuronal vulnerability to degeneration"},{"title3":"Autophagy diminishes the early interferon-beta response to influenza A virus resulting in differential expression of interferon-stimulated genes"},{"title3":"Influenza A virus-induced autophagy contributes to enhancement of virus infectivity by SOD1 downregulation in alveolar epithelial cells"},{"title3":"Autophagy proteins regulate innate immune response by inhibiting NALP3 inflammasome-mediated mitochondrial DNA release"},{"title3":"Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection"},{"title3":"Autophagy induction regulates influenza virus replication in a time-dependent manner"},{"title3":"TRIM23 mediates virus-induced autophagy via activation of TBK1"},{"title3":"Inhibition of highly pathogenic avian influenza (HPAI) virus by a peptide derived from vFLIP through its direct destabilization of viruses"},{"title3":"Detection of individual fluorescently labeled reovirions in living cells"},{"title3":"Uncovering the Rab5-independent autophagic trafficking of influenza A virus by quantum-dot-based single-virus tracking"},{"title3":"In vivo induction of apoptosis by influenza virus"},{"title3":"The 2009 pandemic A/Wenshan/01/2009 H1N1 induces apoptotic cell death in human airway epithelial cells"},{"title3":"Influenza virus induces apoptosis via BAD-mediated mitochondrial dysregulation"},{"title3":"Autophagy activation is required for influenza A virus-induced apoptosis and replication"},{"title3":"Lack of Bax prevents influenza A virus-induced apoptosis and causes diminished viral replication"},{"title3":"Apoptosis: a mechanism of cell killing by influenza A and B viruses"},{"title3":"bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation"},{"title3":"Induction of the cellular microRNA-29c by influenza virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors BCL2L2"},{"title3":"The influenza A virus NS1 protein inhibits activation of Jun N-Terminal Kinase and AP-1 transcription factors"},{"title3":"The PI3K/Akt pathway inhibits influenza A virus-induced Bax-mediated apoptosis by negatively regulating the JNK pathway via ASK1"},{"title3":"Construction of a transcriptome-driven network at the early stage of infection with influenza A H1N1 in human lung alveolar epithelial cells"},{"title3":"Neutrophil apoptosis during viral infections"},{"title3":"Avian influenza virus directly infects human natural killer cells and inhibits cell activity"},{"title3":"Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18"},{"title3":"Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle"},{"title3":"Influenza virus A/Beijing/501/2009(H1N1) NS1 interacts with beta-tubulin and induces disruption of the microtubule network and apoptosis on A549 cells"},{"title3":"Characterization of the 2009 pandemic A/Beijing/501/2009 H1N1 influenza strain in human airway epithelial cells and ferrets"},{"title3":"Highly pathogenic avian influenza A virus H5N1 NS1 protein induces caspase-dependent apoptosis in human alveolar basal epithelial cells"},{"title3":"Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression"},{"title3":"Requirement for Siva-1 for replication of influenza A virus through apoptosis induction"},{"title3":"Influenza A virus nucleoprotein induces apoptosis in human airway epithelial cells: implications of a novel interaction between nucleoprotein and host protein Clusterin"},{"title3":"Influenza A virus-induced caspase-3 cleaves the histone deacetylase 6 in infected epithelial cells"},{"title3":"Fucosyltransferase induction during influenza virus infection is required for the generation of functional memory CD4+T Cells"},{"title3":"Prion protein protects mice from lethal infection with influenza A viruses"},{"title3":"Avian influenza virus A/chicken/Hubei/489/2004 (H5N1) induces caspase-dependent apoptosis in a cell-specific manner"},{"title3":"Apoptosis induced by avian H5N1 virus in human monocyte-derived macrophages involves TRAIL-inducing caspase-10 activation"},{"title3":"The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian influenza viruses"},{"title3":"The PA-interacting host protein nucleolin acts as an antiviral factor during highly pathogenic H5N1 avian influenza virus infection"},{"title3":"The interferon stimulated gene 54 promotes apoptosis"},{"title3":"Broad-spectrum antiviral functions of duck interferon-induced protein with tetratricopeptide repeats (AvIFIT)"},{"title3":"IL-36gamma protects against severe influenza infection by promoting lung alveolar macrophage survival and limiting viral replication"},{"title3":"Influenza A virus infection triggers pyroptosis and apoptosis of respiratory epithelial cells through type I IFN signaling pathway in a mutually exclusive manner"},{"title3":"Effect of influenza vaccine on tumor necrosis factor-like Weak inducer of apoptosis (TWEAK) in older population"},{"title3":"N-acetyl-l-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)"},{"title3":"Screening host proteins required for bacterial adherence after H9N2 virus infection"},{"title3":"Quantitative proteomic analyses of influenza virus-infected cultured human lung cells"},{"title3":"Avian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses"},{"title3":"Comprehending a killer: the Akt/mTOR signaling pathways are temporally high-jacked by the highly pathogenic 1918 influenza virus"},{"title3":"Response of primary human airway epithelial cells to influenza infection: a quantitative proteomic study"},{"title3":"Influenza A infection of primary human airway epithelial cells up-regulates proteins related to purine metabolism and ubiquitin-related signaling"},{"title3":"The nucleoprotein of influenza A virus induces p53 signaling and apoptosis via attenuation of host ubiquitin ligase RNF43"},{"title3":"Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways"},{"title3":"Influenza A viral replication is blocked by inhibition of the inositol-requiring enzyme 1 (IRE1) stress pathway"},{"title3":"Interferon-inducible antiviral protein MxA enhances cell death triggered by endoplasmic reticulum stress"},{"title3":"Influenza induces endoplasmic reticulum stress, caspase-12-dependent apoptosis, and c-Jun N-terminal kinase-mediated transforming growth factor-beta release in lung epithelial cells"},{"title3":"Control of PERK eIF2alpha kinase activity by the endoplasmic reticulum stress-induced molecular chaperone P58IPK"},{"title3":"The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism"},{"title3":"Innate sensing of influenza A virus hemagglutinin glycoproteins by the host endoplasmic reticulum (ER) stress pathway triggers a potent antiviral response via ER-associated protein degradation"},{"title3":"Role of autophagy in HIV infection and pathogenesis"},{"title3":"Viruses and the autophagy pathway"},{"title3":"Mechanisms of HIV-associated lymphocyte apoptosis"},{"title3":"Apoptosis of uninfected cells induced by HIV envelope glycoproteins"},{"title3":"Fas ligand-mediated apoptosis in degenerative disorders of the brain"},{"title3":"Mechanisms of apoptosis induction by the HIV-1 envelope"},{"title3":"Nef deletion in HIV-1 eliminates peripheral CD4 T-cell loss in a humanized BLT mouse model of HIV disease"},{"title3":"HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT"},{"title3":"Visualizing Vpr-induced G2 arrest and apoptosis"},{"title3":"HIV-1 tat induces unfolded protein response and endoplasmic reticulum stress in astrocytes and causes neurotoxicity through glial fibrillary acidic protein (GFAP) activation and aggregation"},{"title3":"HIV infection and antiretroviral therapy lead to unfolded protein response activation"},{"title3":"Effect of chloroquine on some clinical and biochemical parameters in non-response chronic hepatitis C virus infection patients: pilot clinical trial"},{"title3":"Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy"},{"title3":"Autophagy: the multi-purpose bridge in viral infections and host cells"},{"title3":"Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria"}]},{"title2":"Autophagy activation is required for influenza A virus-induced apoptosis and replication","References":[]},{"title2":"Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research","References":[{"title3":"Pleiotropic effects of statins"},{"title3":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation"},{"title3":"Small GTP-Binding Proteins"},{"title3":"Effects of statins beyond lipid lowering: potential for clinical benefits"},{"title3":"Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model"},{"title3":"A Novel Anti-Inflammatory Role of Simvastatin in a Murine Model of Allergic Asthma"},{"title3":"Simvastatin Inhibits Airway Hyperreactivity: Implications for the Mevalonate Pathway and Beyond"},{"title3":"Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients"},{"title3":"The Airway Epithelium is Central to the Pathogenesis of Asthma"},{"title3":"Statin use reduces decline in lung function: VA Normative Aging Study"},{"title3":"Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study"},{"title3":"Statin use is associated with reduced mortality in COPD"},{"title3":"Statins in COPD: A Systematic Review"},{"title3":"Statin Exposure Reduces the Risk of Asthma-Related Hospitalizations and Emergency Room Visits in Asthmatic Patients on Inhaled Corticosteroids"},{"title3":"Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma"},{"title3":"Simvastatin in the treatment of asthma: lack of steroid-sparing effect"},{"title3":"Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 23-dioxygenase"},{"title3":"Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma"},{"title3":"Association of Childhood Obesity With Atopic and Nonatopic Asthma: Results From the National Health and Nutrition Examination Survey 1999-2006"},{"title3":"Central obesity is associated with nonatopic but not atopic asthma in a representative population sample"},{"title3":"Obesity: insight into the origins of asthma"},{"title3":"Obesity, waist size, and prevalence of current asthma in the California Teachers Study cohort"},{"title3":"Emerging Interface Between Metabolic Syndrome And Asthma"},{"title3":"Cluster Analysis and Clinical Asthma Phenotypes"},{"title3":"Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program"},{"title3":"Prediabetes and prehypertension in disease free obese adults correlate with an exacerbated systemic proinflammatory milieu"},{"title3":"Relation of C-Reactive Protein to Abdominal Adiposity"},{"title3":"Cardiovascular Disease Risk of Abdominal Obesity vs. Metabolic Abnormalities"},{"title3":"The Effects of Fenofibric Acid Alone and With Statins on the Prevalence of Metabolic Syndrome and its Diagnostic Components in Patients With Mixed Dyslipidemia"},{"title3":"Management of Hypertriglyceridemia in the Diabetic Patient"},{"title3":"Novel relationship of serum cholesterol with asthma and wheeze in the United States"},{"title3":"Vitamin D Levels, Lung Function, and Steroid Response in Adult Asthma"},{"title3":"Harboring of particulate allergens within secretory compartments by mast cells following IgE/FcepsilonRI-lipid raft-mediated phagocytosis"},{"title3":"Metabolic Abnormalities in Children with Asthma"},{"title3":"Apolipoprotein E Negatively Regulates House Dust Mite-induced Asthma via a LDL Receptor-mediated Pathway"},{"title3":"Enhancing effect of dietary cholesterol and inhibitory effect of pravastatin on allergic pulmonary inflammation"},{"title3":"ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lung"},{"title3":"Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors"},{"title3":"Lymphocyte Function-Associated Antigen-1 Blockade by Statins: Molecular Basis and Biological Relevance"},{"title3":"Statins Increase p21 through Inhibition of Histone Deacetylase Activity and Release of Promoter-Associated HDAC1/2"},{"title3":"Acute Antiinflammatory Properties of Statins Involve Peroxisome Proliferator-Activated Receptor-alpha via Inhibition of the Protein Kinase C Signaling Pathway"},{"title3":"Are statins analogues of vitamin D?"},{"title3":"Effects of Atorvastatin on Vitamin D Levels in Patients With Acute Ischemic Heart Disease"},{"title3":"Regulation of HMG-CoA reductase in MCF-7 cells by genistein, EPA, and DHA, alone and in combination with mevastatin"},{"title3":"Fluvastatin inhibits raft dependent Fcgamma receptor signalling in human monocytes"},{"title3":"Macrophage ABCA1 reduces MyD88 dependent toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol"},{"title3":"House dust mite allergen induces asthma via TLR4 triggering of airway structural cells"},{"title3":"The Different Hues of Lipid Rafts"},{"title3":"Neutral Sphingomyelinase 2: A Novel Target in Cigarette Smoke-Induced Apoptosis and Lung Injury"},{"title3":"Lung Injury and Cancer: Mechanistic Insights into Ceramide and EGFR Signaling under Cigarette Smoke"},{"title3":"Systemic administration of sphingosine-1-phosphate increases bronchial hyperresponsiveness in the mouse"},{"title3":"phingolipids in inflammation: pathological implications and potential therapeutic targets"},{"title3":"Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet"}]},{"title2":"The effects of statin therapy on the human airway","References":[]},{"title2":"Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53","References":[{"title3":"Apoptosis and cancer: mutations within caspase genes."},{"title3":"Development by self-digestion: molecular mechanisms and biological functions of autophagy."},{"title3":"Regulation and role of autophagy in mammalian cells."},{"title3":"Autophagy as a regulated pathway of cellular degradation."},{"title3":"Autophagy: a regulated bulk degradation process inside cells."},{"title3":"DRAM links autophagy to p53 and programmed cell death."},{"title3":"S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3."},{"title3":"Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma."},{"title3":"p53: new roles in metabolism."},{"title3":"p53 and metabolism: Inside the TIGAR."},{"title3":"p53 in health and disease."},{"title3":"A dual role of p53 in the control of autophagy."},{"title3":"Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c."},{"title3":"The coordinate regulation of the p53 and mTOR pathways in cells."},{"title3":"Regulation of autophagy by cytoplasmic p53."},{"title3":"Isoprenoids as mediators of the biological effects of statins."},{"title3":"All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells."},{"title3":"Activation of Rac1 increases c-Jun NH(2)-terminal kinase activity and DNA fragmentation in a calcium-dependent manner in rat myoblast cell line H9c2."},{"title3":"Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells."},{"title3":"Intracellular alkalinization suppresses lovastatin-induced apoptosis in HL-60 cells through the inactivation of a pH-dependent endonuclease."},{"title3":"Hydrophobic statins induce autophagy in cultured human rhabdomyosarcoma cells."},{"title3":"Role of caveolin-1 in p42/p44 MAP kinase activation and proliferation of human airway smooth muscle."},{"title3":"Bronchoalveolar lavage fluid from asthmatic subjects is mitogenic for human airway smooth muscle."},{"title3":"Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway."},{"title3":"Monitoring of programmed cell death in vivo and in vitro, -new and old methods of cancer therapy assessment."},{"title3":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry."},{"title3":"Autophagy, cytoplasm-to-vacuole targeting pathway, and pexophagy in yeast and mammalian cells."},{"title3":"Lysosomes and autophagy in cell death control."},{"title3":"In search of an &quot;autophagomometer&quot;."},{"title3":"Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells."},{"title3":"The mouse APG10 homologue, an E2-like enzyme for Apg12p conjugation, facilitates MAP-LC3 modification."},{"title3":"Induction of autophagy and inhibition of tumorigenesis by beclin 1."},{"title3":"Class III phosphoinositide 3-kinase:Beclin1 complex mediates the amino acid-dependent regulation of autophagy in C2C12 myotubes."},{"title3":"BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites."},{"title3":"Autophagy and signaling: their role in cell survival and cell death."},{"title3":"Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy."},{"title3":"Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells."},{"title3":"Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells."},{"title3":"Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3."},{"title3":"Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene."},{"title3":"Autophagy delays apoptotic death in breast cancer cells following DNA damage."},{"title3":"Autophagy delays sulindac sulfide-induced apoptosis in the human intestinal colon cancer cell line HT-29."},{"title3":"Self-eating and self-killing: crosstalk between autophagy and apoptosis."},{"title3":"Does autophagy contribute to cell death?"},{"title3":"Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3."},{"title3":"Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells."},{"title3":"The role of autophagy in tumour development and cancer therapy."},{"title3":"Another way to die: autophagic programmed cell death."},{"title3":"3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation."},{"title3":"3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture."},{"title3":"3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis."},{"title3":"Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells."},{"title3":"p53-Dependent and p53-independent activation of autophagy by ARF."},{"title3":"The mitochondrial permeability transition initiates autophagy in rat hepatocytes."},{"title3":"The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy."},{"title3":"Statin-induced heme oxygenase-1 increases NF-kappaB activation and oxygen radical production in cultured neuronal cells exposed to lipopolysaccharide."},{"title3":"Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress."}]},{"title2":"Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins","References":[]},{"title2":"Effect of atorvastatin on ACE2 expression in pressure overload induced cardiac hypertrophy in rats","References":[]},{"title2":"Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats","References":[{"title3":"Mechanisms of smooth muscle cell p oliferation and endothelial regeneration after vascular injury and stenting"},{"title3":"ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease"},{"title3":"Rosuvastatin reduces neointima formation in a rat model of balloon injury"},{"title3":"Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress"},{"title3":"Vascular smooth muscle cell proliferation in restenosis"},{"title3":"Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system"},{"title3":"Angiotensin-converting enzymes and drug discovery in cardiovascular diseases"},{"title3":"Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration"},{"title3":"The inhibitory effect of dexamethasone on platelet-derived growth factor-induced vascular smooth muscle cell migration through up-regulating PGC-1alpha expression"},{"title3":"Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling"},{"title3":"Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1/2 pathway"},{"title3":"Statin therapy prevents expansive remodeling in venous bypass grafts"}]},{"title2":"Influence of atorvastatin on angiotensin I metabolism in resting and TNF-alpha -activated rat vascular smooth muscle cells","References":[]},{"title2":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications","References":[]},{"title2":"Angiotensin converting enzyme-2 (ACE2) and its possible roles in hypertension, diabetes and cardiac function","References":[{"title3":"Rice, G.I., Thomas, D.A., Grant, P.J., Turner, A.J. and Hooper, N.M., Biochem. J. (2004) in press."}]},{"title2":"Aguilar C, F Ventura, L Rodriguez-Delfin. [Atorvastatin induced increase in homologous angiotensin I converting enzyme (ACE2) mRNA is associated to decreased fibrosis and decreased left ventricular hypertrophy in a rat model of diabetic cardiomyopathy]. Rev Peru Med Exp Salud Publica. 2011;28(2):264-72.","References":[]},{"title2":"The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts","References":[]},{"title2":"Effects of pravastatin on type 1 diabetic rat heart with or without blood glycemic control","References":[{"title3":"Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review"},{"title3":"Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis"},{"title3":"Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society"},{"title3":"Access to Healthcare during COVID-19"},{"title3":"Perceptions of diabetes technology use in cystic fibrosis-related diabetes management"},{"title3":"Barriers to continuous glucose monitoring in people with type 1 diabetes: Clinician perspectives"},{"title3":"Blood glucose estimation from voice: first review of successes and challenges"},{"title3":"Vocal characteristics in patients with type 2 diabetes mellitus"},{"title3":"Instrumental acoustic voice characteristics in adults with type 2 diabetes"},{"title3":"(2021) 11: A novel method to detect CF-related diabetes using changes in voice characteristics"},{"title3":"Detection of cystic fibrosis related diabetes through analysis of voice characteristics in telemedicine clinics"},{"title3":"Laryngoscopic and voice characteristics of aged persons"},{"title3":"Saloni, R., Sharma, K., &amp; Gupta, A. K. Classification of high blood pressure persons vs normal blood pressure persons using voice analysis. IJ Image Graph. Signal Process. 47-52 (2014)."},{"title3":"Voice disorders and associated risk markers among young adults in the United States"},{"title3":"Preoperative voice characteristics in thyroid patients"},{"title3":"Computerized analysis of speech and voice for Parkinson's disease: A systematic review"},{"title3":"Vascular risk factors and diabetic neuropathy"},{"title3":"Hypertension as a risk factor for diabetic neuropathy: A prospective study"},{"title3":"Acoustic analysis of voice in Parkinson's disease: a systematic review of voice disability and meta-analysis of studies"},{"title3":"Gender differences affecting vocal health of women in vocally demanding careers"},{"title3":"Biomechanics of fundamental frequency regulation: Constitutive modeling of the vocal fold lamina propria"},{"title3":"Impact of laryngeal findings on acoustic parameters of patients with laryngopharyngeal reflux"},{"title3":"Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis"},{"title3":"Disease related changes in vocal parameters of patients with type 2 diabetes mellitus"},{"title3":"The effect of type 1 diabetes mellitus on voice in pediatric patients"},{"title3":"Jeon, J., Palanica, A., Sarabadani, S., Lieberman, M. &amp; Fossat, Y. Biomarker potential of real-world voice signals to predict abnormal blood glucose levels. bioRxiv (2020)."},{"title3":"378-P: Human voice is modulated by hypoglycemia and hyperglycemia in type 1 diabetes"},{"title3":"OR13-6 deep learning-based voice screening technique for cystic fibrosis related diabetes"}]},{"title2":"Simvastatin inhibits TGFbeta1-induced fibronectin in human airway fibroblasts","References":[{"title3":"Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma"},{"title3":"Remodeling in asthma and chronic obstructive lung disease"},{"title3":"Remodeling in asthma and chronic obstructive pulmonary disease"},{"title3":"Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma"},{"title3":"Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities"},{"title3":"Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge"},{"title3":"Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma"},{"title3":"Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial"},{"title3":"Statin use reduces decline in lung function: VA Normative Aging Study"},{"title3":"The use of statins and lung function in current and former smokers"},{"title3":"Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs"},{"title3":"Effects of simvastatin on cigarette smoking-induced structural and functional changes in rat lungs"},{"title3":"Pleiotropic effects of statins"},{"title3":"The Mevalonate Cascade as a Target to Suppress Extracellular Matrix Synthesis by Human Airway Smooth Muscle"},{"title3":"3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture"},{"title3":"Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model"},{"title3":"Isoprenoids as mediators of the biological effects of statins"},{"title3":"Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin"},{"title3":"Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors"},{"title3":"Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies"},{"title3":"Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer"},{"title3":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986"},{"title3":"Morphologic and functional properties of bronchial cells isolated from normal and asthmatic subjects"},{"title3":"Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level"},{"title3":"Inhibition of geranylgeranylation blocks agonist-induced actin reorganization in human airway smooth muscle cells"},{"title3":"Role for protein geranylgeranylation in adult T-cell leukemia cell survival"},{"title3":"Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c"},{"title3":"Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins"},{"title3":"Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease"},{"title3":"Statin use is associated with reduced mortality in COPD"},{"title3":"Statin use is associated with improved function and survival of lung allografts"},{"title3":"A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma"},{"title3":"Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond"},{"title3":"Lovastatin inhibits bronchial hyperresponsiveness by reducing RhoA signaling in rat allergic asthma"},{"title3":"Inhibition of antigen-induced bronchial smooth muscle hyperresponsiveness by lovastatin in mice"},{"title3":"Statins inhibit protein lipidation and induce the unfolded protein response in the non-sterol producing nematode Caenorhabditis elegans"},{"title3":"Signaling events required for transforming growth factor-beta stimulation of connective tissue growth factor expression by cultured human lung fibroblasts"},{"title3":"Requirement for geranylgeranyl transferase I and acyl transferase in the TGF-beta-stimulated pathway leading to elastin mRNA stabilization"},{"title3":"TGF-beta1 stimulation of fibronectin transcription in cultured human lung fibroblasts requires active geranylgeranyl transferase I, phosphatidylcholine-specific phospholipase C, protein kinase C-delta, and p38, but not erk1/erk2"},{"title3":"Anti-cancer therapy: targeting the mevalonate pathway"},{"title3":"Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy"},{"title3":"Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction"},{"title3":"Protective effects of statin on cardiac fibrosis and apoptosis in adrenomedullin-knockout mice treated with angiotensin II and high salt loading"},{"title3":"Atorvastatin prevents left ventricular remodeling in spontaneously hypertensive rats"},{"title3":"Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts"},{"title3":"Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice"},{"title3":"Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects"},{"title3":"Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma"},{"title3":"Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma"},{"title3":"Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase"},{"title3":"Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c"}]},{"title2":"The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle","References":[]},{"title2":"Statin therapy and outcomes in trials of nintedanib in idiopathic pulmonary fibrosis","References":[]},{"title2":"Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis","References":[{"title3":"Idiopathic pulmonary fibrosis"},{"title3":"An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management"},{"title3":"An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis"},{"title3":"Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry"},{"title3":"Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials"},{"title3":"Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium"},{"title3":"Classification and natural history of the idiopathic interstitial pneumonias"},{"title3":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis"},{"title3":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials"},{"title3":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis"},{"title3":"Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis"},{"title3":"Global burden of CVD: focus on secondary prevention of cardiovascular disease"},{"title3":"Updated evidence on early statin therapy for acute coronary syndromes: meta-analysis of 18 randomized trials involving over 14,000 patients"},{"title3":"Statin use reduces decline in lung function: VA Normative Aging Study"},{"title3":"Simvastatin for the prevention of exacerbations in moderate-to-severe COPD"},{"title3":"Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports"},{"title3":"Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation"},{"title3":"Statins and the risk of interstitial lung disease: a cohort study"},{"title3":"Effects of simvastatin on pulmonary fibrosis, pulmonary hypertension and exercise capacity in bleomycin-treated rats"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis"},{"title3":"Statin use is associated with reduced mortality in patients with interstitial lung disease"},{"title3":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond"},{"title3":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis"},{"title3":"Clinical course and prediction of survival in idiopathic pulmonary fibrosis"},{"title3":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations"},{"title3":"Mechanisms of alveolar epithelial injury, repair, and fibrosis"},{"title3":"Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis"},{"title3":"Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins)"},{"title3":"Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells"},{"title3":"Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts"},{"title3":"TGF-beta signaling and the fibrotic response"},{"title3":"Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs"},{"title3":"Statin use is associated with improved function and survival of lung allografts"},{"title3":"A promoter SNP rs4073T&gt;A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode"},{"title3":"Lysophosphatidylcholine stimulation of alveolar epithelial cell interleukin-8 production and neutrophil chemotaxis is inhibited by statin treatment [abstract]"},{"title3":"Inhibitory effects of pitavastatin on fibrogenic mediator production by human lung fibroblasts"},{"title3":"Statin-induced proinflammatory response in mitogen-activated peripheral blood mononuclear cells through the activation of caspase-1 and IL-18 secretion in monocytes"},{"title3":"Role of proinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice"}]},{"title2":"Statin use is associated with reduced mortality in patients with interstitial lung disease","References":[{"title3":"Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society"},{"title3":"Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis"},{"title3":"The evolving pharmacotherapy of pulmonary fibrosis"},{"title3":"Regulation of the mevalonate pathway"},{"title3":"Rho GTPases and signaling networks"},{"title3":"Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorders"},{"title3":"RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis"},{"title3":"Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study"},{"title3":"The inflammation hypothesis and its potential relevance to statin therapy"},{"title3":"Statins and the risk of interstitial lung disease: a cohort study"},{"title3":"Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation"},{"title3":"Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports"},{"title3":"The Danish Civil Registration System. A cohort of eight million persons"},{"title3":"The Danish National Hospital Register. A valuable source of data for modern health sciences"},{"title3":"Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study"},{"title3":"Statin use and reduced cancer-related mortality"},{"title3":"The Danish Register of Causes of Death"},{"title3":"Review: a gentle introduction to imputation of missing values"},{"title3":"This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis"},{"title3":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein"},{"title3":"Statin-induced Kruppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses"},{"title3":"Basic science review: Statin therapy:Part I: The pleiotropic effects of statins in cardiovascular disease"},{"title3":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation"},{"title3":"Pleiotropic effects of statin therapy: molecular mechanisms and clinical results"},{"title3":"Potential therapeutic role for statins in respiratory disease"},{"title3":"Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy"},{"title3":"Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs"},{"title3":"Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits"},{"title3":"HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages"},{"title3":"Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes"},{"title3":"Diagnosis of interstitial lung diseases"},{"title3":"Simvastatin treatment of pulmonary hypertension: an observational case series"},{"title3":"Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT"},{"title3":"Statin adherence and risk of accidents: a cautionary tale"}]}]},{"title1":"Association of Statin Use With the In-Hospital Outcomes of 2019-Coronavirus Disease Patients: A Retrospective Study","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"First case of 2019 novel coronavirus in the United States","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Statins for community-acquired pneumonia: current state of the science","References":[]},{"title2":"Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study","References":[]},{"title2":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","References":[]},{"title2":"Emerging roles for cholesterol and lipoproteins in lung disease","References":[{"title3":"Inflammation, metabolic syndrome, and diet responsiveness"},{"title3":"Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006"},{"title3":"Potential therapeutic role for statins in respiratory disease"},{"title3":"Plasma lipoproteins: genetic influences and clinical implications"},{"title3":"Atherosclerosis"},{"title3":"New insights into the regulation of HDL metabolism and reverse cholesterol transport"},{"title3":"Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention"},{"title3":"ATP-binding cassette transporter AI and its role in HDL formation"},{"title3":"SR-BI inhibits ABCG1-stimulated net cholesterol efflux from cells to plasma HDL"},{"title3":"Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo"},{"title3":"Loss of ABCG1 results in chronic pulmonary inflammation"},{"title3":"Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis"},{"title3":"Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions"},{"title3":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals"},{"title3":"The inflammasomes: guardians of the body"},{"title3":"NLRP3 inflammasome activation: The convergence of multiple signaling pathways on ROS production?"},{"title3":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation"},{"title3":"Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis"},{"title3":"Uptake of low density lipoproteins by the hamster lung. Interactions with capillary endothelium"},{"title3":"Regulation of lung surfactant cholesterol metabolism by serum lipopoteins"},{"title3":"HDL is the major source of vitamin E for type II pneumocytes"},{"title3":"Lipoprotein-stimulated surfactant secretion in alveolar type II cells: mediation by heterotrimeric G proteins"},{"title3":"Lipoproteins are major and primary mitogens and growth promoters for human arterial smooth muscle cells and lung fibroblasts in vitro"},{"title3":"Role of cholesterol in the biophysical dysfunction of surfactant in ventilator-induced lung injury"},{"title3":"The effect of elevated dietary cholesterol on pulmonary surfactant function in adolescent mice"},{"title3":"Altered surfactant synthesis and function in rats with diet-induced hyperlipidemia"},{"title3":"Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II"},{"title3":"Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant"},{"title3":"Uptake, metabolism, and cytotoxicity of isomeric cholesterol-5,6-epoxides in rabbit aortic endothelial cells"},{"title3":"Comparative study of the cytotoxicity and apoptosis-inducing potential of commonly occurring oxysterols"},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury"},{"title3":"Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung"},{"title3":"Apoetm1Unc mice have impaired alveologenesis, low lung function, and rapid loss of lung function"},{"title3":"Pulmonary abnormalities due to ABCA1 deficiency in mice"},{"title3":"A critical role for ABCG1 in macrophage inflammation and lung homeostasis"},{"title3":"ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis"},{"title3":"ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lung"},{"title3":"ATP Binding Cassette Transporter G1 Deletion Induces IL-17-Dependent Dysregulation of Pulmonary Adaptive Immunity"},{"title3":"Apolipoprotein E negatively regulates house dust mite-induced asthma via a low-density lipoprotein receptor-mediated pathway"},{"title3":"Activation of the liver X receptor prevents lipopolysaccharide-induced lung injury"},{"title3":"Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses"},{"title3":"Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation"},{"title3":"Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense"},{"title3":"Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice"},{"title3":"Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin"},{"title3":"Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypes"},{"title3":"Hypercholesterolemia impairs immunity to tuberculosis"},{"title3":"Dietary cholesterol enhances pulmonary eosinophilic inflammation in a murine model of asthma"},{"title3":"Novel relationship of serum cholesterol with asthma and wheeze in the United States"},{"title3":"A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma"},{"title3":"Enhancing effect of dietary cholesterol and inhibitory effect of pravastatin on allergic pulmonary inflammation"},{"title3":"Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs"},{"title3":"A role for hydroxyl-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense"},{"title3":"Simvastatin has beneficial effect on pulmonary artery hypertension by inhibiting NF-kappaB expression"},{"title3":"Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis"},{"title3":"Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study"},{"title3":"Statin treatment and reduced risk of pneumonia in patients with diabetes"},{"title3":"Prior statin use is associated with improved outcomes in community-acquired pneumonia"},{"title3":"Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia"},{"title3":"The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia"},{"title3":"Statins and the risk of pneumonia: a population-based, nested case-control study"},{"title3":"Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients"},{"title3":"Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study"},{"title3":"Simvastatin in the treatment of asthma: lack of steroid-sparing effect"},{"title3":"Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase"},{"title3":"Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma"},{"title3":"Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research"},{"title3":"Statin use is associated with reduced mortality in COPD"},{"title3":"Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study"},{"title3":"Simvastatin treatment of pulmonary hypertension: an observational case series"},{"title3":"Statin use is associated with improved function and survival of lung allografts"},{"title3":"Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury"},{"title3":"A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study)"},{"title3":"Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial"},{"title3":"Anacetrapib, a novel CETP inhibitor: pursuing a new approach to cardiovascular risk reduction"},{"title3":"Effects of short-term treatment with atorvastatin in smokers with asthma--a randomized controlled trial"},{"title3":"Effects of torcetrapib in patients at high risk for coronary events"},{"title3":"Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells"},{"title3":"Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis"},{"title3":"5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthma"},{"title3":"D-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma"},{"title3":"Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide"},{"title3":"Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond"},{"title3":"Simvastatin inhibits TGFbeta1-induced fibronectin in human airway fibroblasts"},{"title3":"Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury"},{"title3":"D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes"},{"title3":"Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid"},{"title3":"Beneficial effects of ApoA-I on LPS-induced acute lung injury and endotoxemia in mice"},{"title3":"Reversal of elastase-induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice"},{"title3":"Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts"},{"title3":"Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis"},{"title3":"Statin use reduces decline in lung function: VA Normative Aging Study"},{"title3":"The use of statins and lung function in current and former smokers"},{"title3":"Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins"},{"title3":"Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a population-based analysis in Japan"},{"title3":"Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease"},{"title3":"Statin use in patients with asthma: a nationwide population-based study"},{"title3":"Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma"},{"title3":"The effect of statin therapy on allergic patients with asthma"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis"},{"title3":"Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension"}]},{"title2":"Statins in community acquired pneumonia: evidence from experimental and clinical studies","References":[]},{"title2":"The effect of statins on mortality in patients with bacteremia","References":[]},{"title2":"Statin treatment and mortality in bacterial infections-a systematic review and meta-analysis","References":[{"title3":"Statins for sepsis: a critical and updated review."},{"title3":"Statins and cancer: A systematic review and meta-analysis."},{"title3":"The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis."},{"title3":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms."},{"title3":"Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study."},{"title3":"Graft-versus-host disease: suppression by statins."},{"title3":"Effect of pravastatin on outcomes after cardiac transplantation."},{"title3":"HMG CoA reductase inhibitors (statins) for kidney transplant recipients."},{"title3":"Statins for the prevention and treatment of infections: a systematic review and meta-analysis."},{"title3":"Meta-Regression Method for Detecting and Estimating Empirical Effects in the Presence of Publication Selection."},{"title3":"Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics."},{"title3":"Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins."},{"title3":"The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases."},{"title3":"Preoperative statins and infectious complications following cardiac surgery."},{"title3":"Statin use and the risk of surgical site infections in elderly patients undergoing elective surgery."},{"title3":"Reduction in mortality associated with statin therapy in patients with severe sepsis."},{"title3":"Statin use and risk of community acquired pneumonia in older people: population based case-control study."},{"title3":"Statin therapy prior to ICU admission: protection against infection or a severity marker?"},{"title3":"An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998-1999 to 2005-2006"},{"title3":"Statin use and sepsis events [corrected] in patients with chronic kidney disease."},{"title3":"Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis."},{"title3":"Influence of statins on postoperative wound complications after inguinal or ventral herniorrhaphy."},{"title3":"Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a population-based analysis in Japan."},{"title3":"Influenza morbidity and mortality in elderly patients receiving statins: a cohort study."},{"title3":"Preoperative statin use and infection after cardiac surgery: a cohort study."},{"title3":"Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial."},{"title3":"Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study."},{"title3":"Preinjury statin use is associated with a higher risk of multiple organ failure after injury: a propensity score adjusted analysis."},{"title3":"Statins and the risk of pneumonia: a population-based, nested case-control study."},{"title3":"Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials."},{"title3":"Preoperative statin intake and morbid events after isolated coronary artery bypass grafting."},{"title3":"Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage."},{"title3":"Statin treatment and reduced risk of pneumonia in patients with diabetes."},{"title3":"Prior statin therapy is associated with a decreased rate of severe sepsis."},{"title3":"Prior statin use is associated with improved outcomes in community-acquired pneumonia."},{"title3":"Statin use does not affect the outcome of acute infection: a prospective cohort study."},{"title3":"Statin therapy is associated with decreased mortality in patients with infection."},{"title3":"Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients."},{"title3":"Statin therapy is associated with fewer deaths in patients with bacteraemia."},{"title3":"The effect of statins on mortality in patients with bacteremia."},{"title3":"Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study."},{"title3":"Effectiveness of statins in reducing the rate of severe sepsis: a retrospective evaluation."},{"title3":"Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia."},{"title3":"The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia."},{"title3":"Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis."},{"title3":"The impact of statins, ace inhibitors and gastric acid suppressants on pneumonia mortality in a UK general practice population cohort."},{"title3":"Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome."},{"title3":"Statin use and mortality within 180 days after bacteremia: a population-based cohort study."},{"title3":"Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients."},{"title3":"Statins do not improve short-term survival in an oriental population with sepsis."},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine."},{"title3":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review."},{"title3":"Statin adherence and risk of accidents: a cautionary tale."},{"title3":"Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin."},{"title3":"Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes."},{"title3":"Chromatography-tandem mass spectrometry method for the simultaneous quantitation of metoprolol succinate and simvastatin in human plasma."},{"title3":"Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins."},{"title3":"Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia."}]},{"title2":"The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis","References":[]},{"title2":"Statins for the prevention and treatment of infections: a systematic review and meta-analysis","References":[]},{"title2":"A practical treatment for patients with Ebola virus disease","References":[]},{"title2":"Statin therapy prior to ICU admission: protection against infection or a severity marker?","References":[{"title3":"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19"},{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"},{"title3":"Platelets contribute to disease severity in COVID-19"},{"title3":"Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series"},{"title3":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19"},{"title3":"Thromboinflammation and the hypercoagulability of COVID-19"},{"title3":"D-dimer-to-platelet ratio as a novel marker of in- hospital adverse outcomes among patients with acute pulmonary embolism: a single-center retrospective study"},{"title3":"D-dimer level in COVID-19 infection: a systematic review"},{"title3":"The clinical utility of D-dimer/platelet count ratio in pregnant women"},{"title3":"Prognostic factors for adverse outcomes in COVID-19 infection"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis"},{"title3":"Immune-inflammatory parameters in COVID-19 cases: a systematic review and meta-analysis"},{"title3":"COVID-19 pneumonia: CD8(+) T and NK cells are decreased in number but compensatory increased in cytotoxic potential"},{"title3":"Changes of hematological and immunological parameters in COVID-19 patients"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19"},{"title3":"Mild versus severe COVID-19: laboratory markers"},{"title3":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19"},{"title3":"Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"An inflammatory cytokine signature predicts COVID-19 severity and survival"},{"title3":"Relationships of the neutrophil-lymphocyte and CRP-albumin ratios with the duration of hospitalization and fatality in geriatric patients with COVID-19"},{"title3":"COVID-19 Pandemi Raporu (20 Mart-20 Kasim 2020) (Article in Turkish)"}]},{"title2":"World medical association declaration of helsinki: ethical principles for medical research involving human subjects","References":[]},{"title2":"Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis","References":[]},{"title2":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia","References":[]},{"title2":"Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia","References":[]},{"title2":"Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study","References":[]},{"title2":"Acute coronary syndromes: the way forward from mechanisms to precision treatment","References":[{"title3":"The molecular bases of the acute coronary syndromes"},{"title3":"Current concepts of the pathogenesis of the acute coronary syndromes"},{"title3":"Mechanisms of acute coronary syndromes and their implications for therapy"},{"title3":"Requiem for the 'vulnerable plaque'"},{"title3":"Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease"},{"title3":"Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic Death"},{"title3":"Coronary plaque disruption"},{"title3":"Concept of vulnerable/unstable plaque"},{"title3":"Plaque Characterization by Coronary Computed Tomography Angiography and the Likelihood of Acute Coronary Events in Mid-Term Follow-Up"},{"title3":"Mechanisms of progression in native coronary artery disease role of healed plaque disruption"},{"title3":"A prospective natural-history study of coronary atherosclerosis"},{"title3":"The Dynamic Nature of Coronary Artery Lesion Morphology Assessed by Serial Virtual Histology Intravascular Ultrasound Tissue Characterization"},{"title3":"Inflammation and atherosclerosis"},{"title3":"High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study"},{"title3":"Not all plaque ruptures are born equal: an optical coherence tomography study"},{"title3":"Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction"},{"title3":"Mechanisms of plaque formation and rupture"},{"title3":"Morphological-biohumoral correlations in acute coronary syndromes: pathogenetic implications"},{"title3":"In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography"},{"title3":"Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade"},{"title3":"The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina"},{"title3":"Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?"},{"title3":"Perturbation of the T-cell repertoire in patients with unstable angina"},{"title3":"Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes"},{"title3":"Emerging role of IL-17 in atherosclerosis"},{"title3":"Transforming growth factor-beta signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway"},{"title3":"Human regulatory T cells: role in autoimmune disease and therapeutic opportunities"},{"title3":"Identification of unique adaptive immune system signature in acute coronary syndromes"},{"title3":"Altered CD31 expression and activity in helper T cells of acute coronary syndrome patients"},{"title3":"Increased PTPN22 expression and defective CREB activation impair regulatory T-cell differentiation in non-ST-segment elevation acute coronary syndromes"},{"title3":"Low-dose colchicine for secondary prevention of cardiovascular disease"},{"title3":"Rationale and design of the cardiovascular inflammation reduction trial: A test of the inflammatory hypothesis of atherothrombosis"},{"title3":"The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study"},{"title3":"Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)"},{"title3":"A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation"},{"title3":"Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells"},{"title3":"Expansion of human regulatory T-cells from patients with type 1 diabetes"},{"title3":"Vaccine for atherosclerosis"},{"title3":"Thin-capped atheromata with reduced collagen content in pigs develop in coronary arterial regions exposed to persistently low endothelial shear stress"},{"title3":"Augmented expression and activity of extracellular matrix-degrading enzymes in regions of low endothelial shear stress co-localize with coronary atheromata with thin fibrous caps in pigs"},{"title3":"Vasospasm of atherosclerotic coronary arteries precipitates acute ischemic myocardial damage in myocardial infarction-prone strain of the Watanabe heritable hyperlipidemic rabbits"},{"title3":"Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease"},{"title3":"Plaque rupture and sudden death related to exertion in men with coronary artery disease"},{"title3":"Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque"},{"title3":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals"},{"title3":"Relationship between cholesterol crystals and culprit lesion characteristics in patients with stable coronary artery disease: an optical coherence tomography study"},{"title3":"Imaging the subcellular structure of human coronary atherosclerosis using micro-optical coherence tomography"},{"title3":"Mechanical properties of model atherosclerotic lesion lipid pools"},{"title3":"The impact of calcification on the biomechanical stability of atherosclerotic plaques"},{"title3":"Recent highlights of ATVB: calcification"},{"title3":"Zooming in on the genesis of atherosclerotic plaque microcalcifications"},{"title3":"Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque"},{"title3":"How does lipid lowering prevent coronary events? New insights from human imaging trials"},{"title3":"Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization"},{"title3":"Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography"},{"title3":"Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming"},{"title3":"Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective"},{"title3":"ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial"},{"title3":"Substrates of acute coronary syndromes: new insights into plaque rupture and erosion"},{"title3":"High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study"},{"title3":"Pathology of Human Coronary and Carotid Artery Atherosclerosis and Vascular Calcification in Diabetes Mellitus"},{"title3":"Inflammation and plaque vulnerability"},{"title3":"TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion"},{"title3":"Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in Mice - Implications for Superficial Erosion"},{"title3":"The accumulation of specific types of proteoglycans in eroded plaques: a role in coronary thrombosis in the absence of rupture"},{"title3":"The structure and regulation of hyaluronan-binding proteins"},{"title3":"A role for the endothelial glycosaminoglycan hyaluronan in neutrophil recruitment by endothelial cells cultured for prolonged periods"},{"title3":"Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis"},{"title3":"Triglycerides on the rise: should we swap seats on the seesaw?"},{"title3":"Coronary Neutrophil Extracellular Trap Burden and Deoxyribonuclease Activity in ST-Elevation Acute Coronary Syndrome Are Predictors of ST-Segment Resolution and Infarct Size"},{"title3":"Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells"},{"title3":"Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study)"},{"title3":"Superficial erosion and the precision management of acute coronary syndromes: not one-size-fits-all"},{"title3":"The Who, What, Why, When, How and Where of Vasospastic Angina"},{"title3":"3-year follow-up of patients with coronary artery spasm as cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study follow-up"},{"title3":"Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study over 20 years"},{"title3":"Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography"},{"title3":"Major Racial Differences in Coronary Constrictor Response Between Japanese and Caucasians With Recent Myocardial Infarction"},{"title3":"Coronary microvascular dysfunction"},{"title3":"Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo Syndrome"},{"title3":"Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy"},{"title3":"Coronary microvascular spasm triggers transient ischemic left ventricular diastolic abnormalities in patients with chest pain and angiographically normal coronary arteries"},{"title3":"Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus"},{"title3":"Autonomic changes associated with spontaneous coronary spasm in patients with variant angina"},{"title3":"Coronary artery spasm induced in atherosclerotic miniature swine"},{"title3":"Role of protein kinase C-mediated pathway in the pathogenesis of coronary artery spasm in a swine model"},{"title3":"Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm"},{"title3":"2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities-from bench to bedside"},{"title3":"Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure"},{"title3":"Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina"},{"title3":"Mechanisms of coronary artery spasm"},{"title3":"Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation"},{"title3":"Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina"},{"title3":"Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research"}]},{"title2":"Potential therapeutic role for statins in respiratory disease","References":[]},{"title2":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","References":[{"title3":"Clinical and immunological characteristics of human infections with H5N6 avian influenza virus"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure"},{"title3":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology"},{"title3":"Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease"},{"title3":"The serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Effects of calcium channel blockers comparing to angiotensinconverting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumoniarelated outcomes"},{"title3":"An expanded definition of the adult respiratory distress syndrome"},{"title3":"A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice"},{"title3":"Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure"},{"title3":"Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases Wuhan, China 2019-2020"},{"title3":"Angiotensin blockade in late autosomal dominant polycystic kidney disease"},{"title3":"Hypoalbuminemia in acute illness: is there a rationale for intervention?"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse"},{"title3":"Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: Clinical and virological findings"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections"}]},{"title2":"Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist","References":[{"title3":"Epidemiology of hypertension"},{"title3":"2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines"},{"title3":"The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease"},{"title3":"Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition"},{"title3":"Physiology of local renin-angiotensin systems"},{"title3":"AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions"},{"title3":"Pre-treatment with the angiotensin receptor 1 blocker losartan protects renal blood flow and oxygen delivery after propofol-induced hypotension in pigs"},{"title3":"Losartan increases renal blood flow during isoflurane anesthesia in sheep"},{"title3":"Effects of losartan, prazosin and a vasopressin V1-receptor antagonist on renal and femoral blood flow in conscious sheep"},{"title3":"The role of endogenous angiotensin II in the regulation of renal haemodynamics and proximal fluid reabsorption in the rat"},{"title3":"Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats"},{"title3":"Renal responses to AT1 blockade in angiotensin II-induced hypertensive rats"},{"title3":"Modulation of tubuloglomerular feedback by angiotensin II type 1 receptors during the development of Goldblatt hypertension"},{"title3":"Sex hormones and hypertension"},{"title3":"The protective effects of estrogen on the cardiovascular system"},{"title3":"The &quot;his and hers&quot; of the renin-angiotensin system"},{"title3":"Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats"},{"title3":"The arterial depressor response to chronic low-dose angiotensin II infusion in female rats is estrogen dependent"},{"title3":"Estrogen modulates AT1 receptor gene expression in vitro and in vivo"},{"title3":"Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS"},{"title3":"Renin angiotensin system and gender differences in the cardiovascular system"},{"title3":"Incidence and prognosis of resistant hypertension in hypertensive patients"},{"title3":"Regulation of intrarenal angiotensin II in hypertension"},{"title3":"Sequential activation of the intrarenal renin-angiotensin system in the progression of hypertensive nephropathy in Goldblatt rats"},{"title3":"Sex differences in the renal vascular responses of AT1 and Mas receptors in two-kidney-one-clip hypertension"},{"title3":"Differential effect of angiotensin II on blood circulation in the renal medulla and cortex of anaesthetised rats"},{"title3":"High-dose estradiol-replacement therapy enhances the renal vascular response to angiotensin II via an AT2-receptor dependent mechanism"},{"title3":"Renal vascular response to angiotensin II administration in two kidneys-one clip hypertensive rats treated with high dose of estradiol: the role of Mas receptor"},{"title3":"Role of Mas receptor antagonist A799 in renal blood flow response to Ang 1-7 after bradykinin administration in ovariectomized estradiol-treated rats"},{"title3":"The hypertensive potential of estrogen: an untold story"},{"title3":" Oral Contraceptives and High Blood Pressure: Changes in Plasma Renin, Renin Substrate and Aldosterone Excretion"},{"title3":"Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR"},{"title3":"Segmental differences in angiotensin receptor subtypes in interlobular artery of hydronephrotic rat kidneys"},{"title3":"Renal hemodynamics in rats with myocardial infarction: selective antagonism of angiotensin receptor subtypes"},{"title3":"Disparate roles of AT2 receptors in the renal cortical and medullary circulations of anesthetized rabbits"},{"title3":"AT2 receptors mediate tonic renal medullary vasoconstriction in renovascular hypertension"},{"title3":"Sex-related differences in the intratubular renin-angiotensin system in two-kidney, one-clip hypertensive rats"},{"title3":"Differential regulation of renal angiotensin subtype AT1A and AT2 receptor protein in rats with angiotensin-dependent hypertension"},{"title3":"Intrarenal AT1 receptor and ACE binding in ANG II-induced hypertensive rats"},{"title3":"Renal angiotensin II receptor regulation in two-kidney, one clip hypertensive rats: effect of ACE inhibition"},{"title3":"Autocrine and paracrine function of angiotensin 1-7 in tissue repair during hypertension"},{"title3":"Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats"},{"title3":"Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats"},{"title3":"Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17beta-oestradiol regulation of renal pathology in renal wrap hypertension in rats"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors"},{"title3":"Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes"}]},{"title2":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications","References":[]},{"title2":"Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)","References":[{"title3":"Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)"},{"title3":"Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cyto-Chrome P450 inhibitors"},{"title3":"Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients"},{"title3":"Rhabdomyolysis caused by comedication with simvastatin and clarithromycin"},{"title3":"Simvastatin-amiodarone interaction resulting in thabdornyolysis, azotemia, and possible hepatotoxicity"}]},{"title2":"Are statins safe in patients with COVID-19?","References":[{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Low serum cholesterol level among patients with COVID-19 infection in Wenzhou, China"},{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway"},{"title3":"Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study"},{"title3":"Influenza morbidity and mortality in elderly patients receiving statins: A cohort study"},{"title3":"Hypolipidemia is associated with the severity of COVID-19"},{"title3":"Treating the host response to Ebola virus disease with generic statins and angiotensin receptor blockers"},{"title3":"Cardiovascular disease, drug therapy, and mortality in COVID-19"},{"title3":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL Study: a randomized trial"}]},{"title2":"Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection","References":[]},{"title2":"The characteristics of 50 hospitalized COVID-19 patients with and without ARDS","References":[]},{"title2":"Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series","References":[{"title3":"COVID-19"},{"title3":"Critical supply shortages - The need for ventilators and personal protective equipment during the covid-19 pandemic"},{"title3":"International comparisons of intensive care: informing outcomes and improving standards"},{"title3":"Fair allocation of scarce medical resources in the time of covid-19"},{"title3":"Characteristics and outcomes of 21 critically ill patients with covid-19 in Washington State"},{"title3":"Clinical characteristics of covid-19 in New York City"},{"title3":"Covid-19 in critically ill patients in the Seattle region - case series"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York City area"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region"},{"title3":"Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. medRxiv. 2020."},{"title3":"The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients"},{"title3":"NYS Department of Health. NYS Health Profiles - New York Presbyterian - Columbia Presbyterian Center 2020."},{"title3":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support"},{"title3":"Algorithm AS 217: Computation of the dip statistic to test for unimodality"},{"title3":"Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality"},{"title3":"Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain"},{"title3":"Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness"},{"title3":"Associations between prolonged intubation and developing post-extubation dysphagia and aspiration pneumonia in non-neurologic critically ill patients"},{"title3":"Neurologic features in severe SARS-CoV-2 Infection"},{"title3":"Virtually perfect? Telemedicine for covid-19"}]},{"title2":"The effects of ARBs, ACEis, and statins on clinical outcomes of COVID-19 infection among nursing home residents","References":[{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Imbalance between pulmonary angiotensin-converting enzyme and angiotensin-converting enzyme 2 activity in acute respiratory distress syndrome"},{"title3":"Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist"},{"title3":"Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury"},{"title3":"Treating the host response to emerging virus diseases: Lessons learned from sepsis, pneumonia, influenza and Ebola"},{"title3":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease"},{"title3":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2"},{"title3":"A revised systematic review and meta-analysis on the effect of statins on D-dimer levels"},{"title3":"Evaluation of protein C and protein S levels in patients with diabetes mellitus receiving therapy with statins and ACE inhibitors or angiotensin II receptor blockers"},{"title3":"COVID-19: the vasculature unleashed"},{"title3":"Hiding in plain sight: An approach to treating patients with severe COVID-19 infection"},{"title3":"Statins and the COVID-19 main protease: In silico evidence on direct interaction"},{"title3":"Prior use of both a statin and ARB is associated with lower mortality for patients hospitalized with pneumonia"},{"title3":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes"},{"title3":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension"},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"COVID-19 - Epidemiologisch bulletin van 29 april 2020"},{"title3":"7,000 of US coronavirus deaths happened in association with nursing homes. That's almost 20% of all US deaths"},{"title3":"Clinical presentation of COVID-19: A systematic review focusing on upper airway symptoms"},{"title3":"Firth logistic regression for rare variant association tests"},{"title3":"Bias reduction of maximum-likelihood-estimates"},{"title3":"Epidemiology of Covid-19 in a long-term care facility in King County, Washington"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy"},{"title3":"Covid-19: Deaths in care home deaths in England and Wales rise sharply"},{"title3":"Angiotensin converting enzyme inhibitors and angiotensin receptor blockers and outcome of COVID-19: A systematic review and meta-analysis"},{"title3":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19"},{"title3":"Anticoagulants may aid COVID-19 patients, NYC data suggest"},{"title3":"Compassionate use of remdesivir for patients with severe Covid-19"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19"},{"title3":"The convalescent sera option for containing COVID-19"}]}]},{"title1":"Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study","References":[{"title2":"WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. WHO Dir. Gen. speeches. 2020;:4","References":[]},{"title2":"In-Hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19","References":[{"title3":"Critical care management of adults with community-acquired severe respiratory viral infection"},{"title3":"Statin therapy in COVID-19 infection: much more than a single pathway"},{"title3":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial"},{"title3":"Statin therapy in COVID-19 infection"},{"title3":"A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study)"},{"title3":"Considerations for statin therapy in patients with COVID-19"},{"title3":"The effects of ARBs, ACEIs and statins on clinical outcomes of COVID-19 infection among nursing home residents"},{"title3":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals"},{"title3":"Position statement of the ESC council on hypertension on ACE-inhibitors and angiotensin receptor blockers"},{"title3":"Acute respiratory distress syndrome: advances in diagnosis and treatment"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Treating influenza with statins and other immunomodulatory agents"},{"title3":"Treating the host response to Ebola virus disease with generic statins and angiotensin receptor blockers"},{"title3":"Hiding in plain sight: an approach to treating patients with severe COVID-19 infection"},{"title3":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis"},{"title3":"Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide"},{"title3":"Survivor treatment selection bias in observational studies: examples from the AIDS literature"},{"title3":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies"},{"title3":"Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Chinese expert consensus on the use of statins in elderly with dyslipidemia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A statement from the International Society of Hypertension on COVID-19"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis"},{"title3":"Longitudinal association between markers of liver injury and mortality in COVID-19 in China"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study"},{"title3":"Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind"},{"title3":"Web site and R Package for computing E-values"},{"title3":"Simvastatin in the acute respiratory distress syndrome"},{"title3":"Neutrophils and immunity: challenges and opportunities"},{"title3":"The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial"},{"title3":"Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial"},{"title3":"Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - a systematic review and meta-analysis"},{"title3":"The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011"},{"title3":"The treatment of unrelated disorders in patients with chronic medical diseases"},{"title3":"Statins and the COVID-19 main protease: in silico evidence on direct interaction"},{"title3":"Pulmonary infections in the elderly lead to impaired neutrophil targeting, which is improved by simvastatin"},{"title3":"Simvastatin improves neutrophil function and clinical outcomes in pneumonia. A pilot randomized controlled clinical trial"},{"title3":"NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin"},{"title3":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation"},{"title3":"The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts"},{"title3":"Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study"},{"title3":"COVID-19, ACE2, and the cardiovascular consequences"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications"},{"title3":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome"},{"title3":"Sensitivity analysis in observational research: introducing the E-value"},{"title3":"C-reactive protein as a biomarker of severe H1N1 influenza"},{"title3":"Comparison of imputation methods for missing laboratory data in medicine"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases interim guidance"},{"title3":"Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation"},{"title3":"2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America"},{"title3":"Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4/MYD88 pathway"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"}]},{"title2":"Identification of atovaquone, ouabain and mebendazole as FDA approved drugs Tar-geting SARS-CoV-2 (version 4)","References":[]},{"title2":"The effects of Arbs, ACEis, and statins on clinical outcomes of COVID-19 infection among nursing home residents","References":[{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Imbalance between pulmonary angiotensin-converting enzyme and angiotensin-converting enzyme 2 activity in acute respiratory distress syndrome"},{"title3":"Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist"},{"title3":"Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury"},{"title3":"Treating the host response to emerging virus diseases: Lessons learned from sepsis, pneumonia, influenza and Ebola"},{"title3":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease"},{"title3":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2"},{"title3":"A revised systematic review and meta-analysis on the effect of statins on D-dimer levels"},{"title3":"Evaluation of protein C and protein S levels in patients with diabetes mellitus receiving therapy with statins and ACE inhibitors or angiotensin II receptor blockers"},{"title3":"COVID-19: the vasculature unleashed"},{"title3":"Hiding in plain sight: An approach to treating patients with severe COVID-19 infection"},{"title3":"Statins and the COVID-19 main protease: In silico evidence on direct interaction"},{"title3":"Prior use of both a statin and ARB is associated with lower mortality for patients hospitalized with pneumonia"},{"title3":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes"},{"title3":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension"},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"COVID-19 - Epidemiologisch bulletin van 29 april 2020"},{"title3":"7,000 of US coronavirus deaths happened in association with nursing homes. That's almost 20% of all US deaths"},{"title3":"Clinical presentation of COVID-19: A systematic review focusing on upper airway symptoms"},{"title3":"Firth logistic regression for rare variant association tests"},{"title3":"Bias reduction of maximum-likelihood-estimates"},{"title3":"Epidemiology of Covid-19 in a long-term care facility in King County, Washington"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy"},{"title3":"Covid-19: Deaths in care home deaths in England and Wales rise sharply"},{"title3":"Angiotensin converting enzyme inhibitors and angiotensin receptor blockers and outcome of COVID-19: A systematic review and meta-analysis"},{"title3":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19"},{"title3":"Anticoagulants may aid COVID-19 patients, NYC data suggest"},{"title3":"Compassionate use of remdesivir for patients with severe Covid-19"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19"},{"title3":"The convalescent sera option for containing COVID-19"}]},{"title2":"Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection","References":[]},{"title2":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy","References":[]},{"title2":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","References":[]},{"title2":"Predictors of early and late stroke following cardiac surgery","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","References":[]},{"title2":"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Fourth universal definition of myocardial infarction (2018"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Kidney disease is associated with in-hospital death of patients with COVID-19"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"COVID-19, SARS and MERS: are they closely related?"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Association between acute infections and risk of acute coronary syndrome: a meta-analysis"},{"title3":"Cardiac troponin I levels and alveolar-arterial oxygen gradient in patients with community-acquired pneumonia"},{"title3":"Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes"},{"title3":"Acute myocardial infarction in hospitalized patients with community-acquired pneumonia"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study"},{"title3":"Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes"},{"title3":"Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"COVID-19 and the cardiovascular system","References":[{"title3":"Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome"},{"title3":"The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target"},{"title3":"Mechanisms of COVID-19-induced heart failure: a short review"},{"title3":"The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science"},{"title3":"Mechanisms of COVID-19 pathogenesis in diabetes"},{"title3":"Cardiac iron overload promotes cardiac injury in patients with severe COVID-19"},{"title3":"Sexual dimorphism in COVID-19: potential clinical and public health implications"},{"title3":"Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities"},{"title3":"The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects"},{"title3":"Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?"},{"title3":"Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference"},{"title3":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress"},{"title3":"Hamidi A and Olsson A K: Platelets, NETs and cancer"},{"title3":"Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"COVID-19 and Cardiovascular Disease: From Bench to Bedside"},{"title3":"A global meta-analysis of depression, anxiety, and stress before and during COVID-19"},{"title3":"COVID-19 With Stress Cardiomyopathy Mortality and Outcomes Among Patients Hospitalized in the United States: A Propensity Matched Analysis Using the National Inpatient Sample Database"},{"title3":"Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic"},{"title3":"COVID-19 and metabolic syndrome"},{"title3":"Association between social isolation and reduced mental well-being in Swedish older adults during the first wave of the COVID-19 pandemic: the role of cardiometabolic diseases"},{"title3":"Metabolic Syndrome: Updates on Pathophysiology and Management in 2021"},{"title3":"COVID-19, Myocarditis and Pericarditis"},{"title3":"Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets"},{"title3":"Cardiometabolic syndrome:an emergent feature of Long COVID?"},{"title3":"Risk factors for severe and critically ill COVID-19 patients: A review"},{"title3":"The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19"},{"title3":"Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19"},{"title3":"Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses"},{"title3":"Impact of sex and gender on COVID-19 outcomes in Europe"},{"title3":"Depression and Anxiety in Old Age during the COVID-19 Pandemic: A Comparative Study of Individuals at Cardiovascular Risk and the General Population"},{"title3":"Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2"},{"title3":"Effects of Life Events and Social Isolation on Stroke and Coronary Heart Disease"},{"title3":"Association of social relationships with incident cardiovascular events and all-cause mortality"},{"title3":"Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation"},{"title3":"Domestic violence against women and the COVID-19 pandemic: What is the role of psychiatry?"},{"title3":"Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases"},{"title3":"Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: A nationwide analysis"},{"title3":"Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review"},{"title3":"SARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node Pacemaker Cells"},{"title3":"Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews"},{"title3":"Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor"},{"title3":"COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors"},{"title3":"COVID-19 infection and its impact on case fatality in patients with pulmonary embolism"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Loneliness and social isolation as risk factors for mortality: a meta-analytic review"},{"title3":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases"},{"title3":"COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis"},{"title3":"Nationwide Analysis of the Outcomes and Mortality of Hospitalized COVID-19 Patients"},{"title3":"N6-Acetyl-L-Lysine and p-Cresol as Key Metabolites in the Pathogenesis of COVID-19 in Obese Patients"},{"title3":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease"},{"title3":"Cardiovascular manifestations and treatment considerations in COVID-19"},{"title3":"TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation"},{"title3":"Incidence and risk factors of myocarditis in hospitalized patients with COVID-19"},{"title3":"Vascular Endothelial Cell Biology: An Update"},{"title3":"ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease"},{"title3":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)"},{"title3":"Implications of the COVID-19 Pandemic for Cardiovascular Disease and Risk-Factor Management"},{"title3":"Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review"},{"title3":"SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2"},{"title3":"Incidence and long-term specific mortality trends of metabolic syndrome in the United States"},{"title3":"Mental health outcomes of coronavirus infection survivors: A rapid meta-analysis"},{"title3":"COVID-19 and cardiovascular diseases"},{"title3":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders"},{"title3":"Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease"},{"title3":"Gender-based disparities in COVID-19 patient outcomes"},{"title3":"Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19"},{"title3":"Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients"},{"title3":"Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus"},{"title3":"TMPRSS2 activity may mediate sex differences in COVID-19 severity"},{"title3":"COVID-19 and its cardiovascular effects: a systematic review of prevalence studies"},{"title3":"Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19"},{"title3":"Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin"},{"title3":"SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity"},{"title3":"Metabolic Syndrome and Its Components in Patients with COVID-19: Severe Acute Respiratory Syndrome (SARS) and Mortality. A Systematic Review and Meta-Analysis"},{"title3":"Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury"},{"title3":"The Global Epidemic of the Metabolic Syndrome"},{"title3":"COVID-19 and cellular senescence"},{"title3":"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China"},{"title3":"Endothelial Cell-Activating Antibodies in COVID-19"},{"title3":"COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19"},{"title3":"SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1"},{"title3":"Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19"},{"title3":"Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis"},{"title3":"Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician"},{"title3":"Identifying age- and sex-specific COVID-19 mortality trends over time in six countries"},{"title3":"SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3"},{"title3":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection"},{"title3":"Sex- and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility"},{"title3":"Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones"},{"title3":"The bi-directional association between loneliness and depression among older adults from before to during the COVID-19 pandemic"},{"title3":"Inflammation: Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis"},{"title3":"Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling"},{"title3":"Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality"},{"title3":"Acute Cardiac Events During COVID-19-Associated Hospitalizations"},{"title3":"SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes"},{"title3":"Excess risk for acute myocardial infarction mortality during the COVID-19 pandemic"},{"title3":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition"},{"title3":"APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19"},{"title3":"Neutrophil extracellular traps in COVID-19. JCI"}]},{"title2":"Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis","References":[]},{"title2":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Pleiotropic effects of statins on the cardiovascular system","References":[]},{"title2":"Immune modulatory effects of statins","References":[]},{"title2":"Statins: a viable candidate for host-directed therapy against infectious diseases","References":[]},{"title2":"[Pleiotropic effects of statins]","References":[]},{"title2":"Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins","References":[]},{"title2":"Effect of statin treatment on short term mortality after pneumonia episode: cohort study","References":[{"title3":"Office for National Statistics. Guidance for doctors completing medical certificates of cause of death in England and Wales: from the Office for National Statistics' Death Certification Advisory Group. ONS, 2008."}]},{"title2":"Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study","References":[]},{"title2":"Influenza morbidity and mortality in elderly patients receiving statins: a cohort study","References":[{"title3":"Final report of the XVI Meeting on Vaccine Preventable-Diseases of the Pan American Health Organization."},{"title3":"Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis."},{"title3":"(2009) Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO."},{"title3":"Confronting an influenza pandemic with inexpensive generic agents: can it be done?"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia."},{"title3":"Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus."},{"title3":"Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection."},{"title3":"Avian influenza virus (H5N1): a threat to human health."},{"title3":"Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates."},{"title3":"In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells."},{"title3":"Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure."},{"title3":"Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients."},{"title3":"Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide."},{"title3":"Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels."},{"title3":"Inhibition of proinflammatory cytokine production by pravastatin."},{"title3":"LPS-induced cytokine production and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors."},{"title3":"Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes."},{"title3":"Prior statin therapy is associated with a decreased rate of severe sepsis."},{"title3":"The effect of statins on mortality in patients with bacteremia."},{"title3":"Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis."},{"title3":"The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia."},{"title3":"Statin treatment and reduced risk of pneumonia in patients with diabetes."},{"title3":"Statins and the risk of pneumonia: a population-based, nested case-control study."},{"title3":"Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia."},{"title3":"Prior statin use is associated with improved outcomes in community-acquired pneumonia."},{"title3":"Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients."},{"title3":"Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study."},{"title3":"Statin use and risk of community acquired pneumonia in older people: population based case-control study."},{"title3":"Evidence of bias in estimates of influenza vaccine effectiveness in seniors."},{"title3":"Coding accuracy of administrative drug claims in the Ontario Drug Benefit database."},{"title3":"Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction."},{"title3":"Cardiovascular health and services in Ontario: an ICES atlas."},{"title3":"Supply of physicians' services in Ontario."},{"title3":"Living and dying in Ontario: an opportunity for improved health information."},{"title3":"Using OHIP physician billing claims to ascertain individual influenza vaccination status."},{"title3":"Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm."},{"title3":"Determinants of home care utilization: who uses home care in Ontario?"},{"title3":"Canadian Immunization Guide."},{"title3":"Ambulatory care groups: a categorization of diagnoses for research and management."},{"title3":"Reducing Bias in Observational Studies Using Subclassification on the Propensity Score."},{"title3":"Statin adherence and risk of accidents: a cautionary tale."},{"title3":"Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox."},{"title3":"Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods."}]},{"title2":"An assessment of the effect of statin use on the incidence of acute respiratory infections in England during Winters 1998-1999 to 2005-2006","References":[]},{"title2":"Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: open-label, randomized study","References":[]},{"title2":"Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial","References":[]},{"title2":"Statins may decrease the fatality rate of middle East respiratory syndrome infection","References":[{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"Middle East respiratory syndrome"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Drugs to cure avian influenza infection:multiple ways to prevent cell death"},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"Inhibition of NF-kappaB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival"},{"title3":"Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4/MYD88 pathway"},{"title3":"Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide"},{"title3":"Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway"}]},{"title2":"Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease","References":[{"title3":"Human infection with new influenza A (H1N1) virus: clinical observations in hospitalized patients, Americas, July 2009- update."},{"title3":"Risk factors for hospitalization and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)."},{"title3":"Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza."},{"title3":"Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California."},{"title3":"Prior statin therapy is associated with a decreased rate of severe sepsis."},{"title3":"The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases."},{"title3":"Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis."},{"title3":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness."},{"title3":"Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from inter-pandemic community acquired pneumonia in adults."},{"title3":"Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009."},{"title3":"Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand."},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada."},{"title3":"Statins and sepsis: multiple modifications at multiple levels."},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia."},{"title3":"Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection."},{"title3":"Pandemic influenza: a potential role for statins in treatment and prophylaxis."},{"title3":"Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work."},{"title3":"The impact of statins, ace inhibitors and gastric acid suppressants on pneumonia mortality in a UK general practice population cohort."},{"title3":"Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study."},{"title3":"The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial."},{"title3":"Statin use and sepsis events in patients with chronic kidney disease."},{"title3":"Statins for the prevention and treatment of infections: a systematic review and meta-analysis."},{"title3":"The effect of statins on mortality from severe infections and sepsis: A systematic review and meta-analysis."},{"title3":"Statin use and risk of community acquired pneumonia in older people: population based case-control study."},{"title3":"Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study."},{"title3":"An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998-1999 to 2005-2006."}]},{"title2":"Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis","References":[]},{"title2":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications","References":[]},{"title2":"Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats","References":[{"title3":"Mechanisms of smooth muscle cell p oliferation and endothelial regeneration after vascular injury and stenting"},{"title3":"ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease"},{"title3":"Rosuvastatin reduces neointima formation in a rat model of balloon injury"},{"title3":"Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress"},{"title3":"Vascular smooth muscle cell proliferation in restenosis"},{"title3":"Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system"},{"title3":"Angiotensin-converting enzymes and drug discovery in cardiovascular diseases"},{"title3":"Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration"},{"title3":"The inhibitory effect of dexamethasone on platelet-derived growth factor-induced vascular smooth muscle cell migration through up-regulating PGC-1alpha expression"},{"title3":"Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling"},{"title3":"Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1/2 pathway"},{"title3":"Statin therapy prevents expansive remodeling in venous bypass grafts"}]},{"title2":"The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts","References":[]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Angiotensin-Converting enzyme 2 is a functional receptor for the SARS coronavirus","References":[]},{"title2":"Physiology of local renin-angiotensin systems","References":[]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","References":[]},{"title2":"The Danish national patient register","References":[{"title3":"Positive predictive value of cardiovascular diagnoses in the Danish national patient registry: a validation study"},{"title3":"Validation study in four health-care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug-related upper gastrointestinal bleeding risk"},{"title3":"Assessment of ICD-10-CM code assignment validity for case finding of outpatient anticoagulant-related bleeding among medicare beneficiaries"},{"title3":"Primer: administrative health databases in observational studies of drug effects:advantages and disadvantages"},{"title3":"The Danish national patient registry: a review of content, data quality, and research potential"},{"title3":"The Danish national patient register"},{"title3":"The validity of intracerebral hemorrhage diagnoses in the Danish patient registry and the Danish stroke registry"},{"title3":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium"},{"title3":"Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs"},{"title3":"Clinical utility of new bleeding criteria: a prospective study of evaluation for the bleeding academic research consortium definition of bleeding in patients undergoing percutaneous coronary intervention"},{"title3":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH"},{"title3":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients"},{"title3":"Comparison of events across bleeding scales in the ENGAGE AF-TIMI 48 Trial"},{"title3":"Bleeding in cardiac patients prescribed antithrombotic drugs: electronic health record phenotyping algorithms, incidence, trends and prognosis"},{"title3":"Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-event registry"},{"title3":"Anticoagulants' safety and effectiveness in general practice: a nationwide prospective cohort study"},{"title3":"Usefulness of health registers for detection of bleeding events in outcome studies"},{"title3":"Anticoagulation risk assessment for patients with non-valvular atrial fibrillation and venous thromboembolism: a clinical review"},{"title3":"Review: health care utilization and costs of elderly persons with multiple chronic conditions"},{"title3":"Comparison of the five Danish regions regarding demographic characteristics, healthcare utilization, and medication use:a descriptive cross-sectional study. Dalal K, ed"},{"title3":"Befolkningstal [Population figures]"},{"title3":"Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving"},{"title3":"Medicin uden skade i Danmark [Medication without harm in Denmark]"},{"title3":"Medication without harm - global patient safety challenge on medication safety"},{"title3":"The Danish health care system and epidemiological research: from health care contacts to database records"},{"title3":"Probable inference, the law of succession, and statistical inference"},{"title3":"Validation of ICD-10-CM diagnosis codes for identification of patients with acute hemorrhagic stroke in a national health insurance claims database"},{"title3":"Subdural hematoma cases identified through a Danish patient register: diagnosis validity, clinical characteristics, and preadmission antithrombotic drug use"},{"title3":"Intracerebral hemorrhage: positive predictive value of diagnosis codes in two nationwide Danish registries"},{"title3":"Predictive value of stroke discharge diagnoses in the Danish national patient register"},{"title3":"The positive predictive value of spontaneous subarachnoid hemorrhage diagnoses in the Danish national patient register"},{"title3":"The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish national registry of patients"},{"title3":"Positive predictive value of peptic ulcer diagnosis codes in the Danish national patient registry"},{"title3":"Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control"}]},{"title2":"The Danish national prescription registry","References":[]},{"title2":"The Danish civil registration system","References":[]},{"title2":"Danish education registers","References":[]},{"title2":"Danish registers on personal income and transfer payments","References":[]},{"title2":"Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people","References":[]},{"title2":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","References":[{"title3":"Liu L, Forman S, Barton B. Fitting Cox model using PROC PHREG and beyond in SAS. 2009. http://support.sas.com/resources/papers/proceedings09/236-2009.pdf."}]},{"title2":"Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction","References":[]},{"title2":"Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction","References":[]},{"title2":"On the estimation of average treatment effects with right-censored time to event outcome and competing risks","References":[]},{"title2":"R core team 2014 R: a language and environment for statistical computing. R foundation for statistical computing","References":[]},{"title2":"Study of ruxolitinib plus simvastatin in the prevention and treatment of respiratory failure of COVID-19","References":[]},{"title2":"Coronavirus Response - Active Support for Hospitalised Covid-19 Patients","References":[]},{"title2":"Preventing cardiac complication of COVID-19 disease with early acute coronary syndrome therapy: a randomised controlled trial","References":[]},{"title2":"Atorvastatin in COVID-19 (STATCO19)","References":[]},{"title2":"Liver injury during highly pathogenic human coronavirus infections","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Researchers scramble to understand camel connection to MERS"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Hematological and biochemical factors predicting SARS fatality in Taiwan"},{"title3":"Dynamic changes of liver function and myocardial enzyme in 259 patients with severe acute respiratory syndrome"},{"title3":"Clinical characteristics and mechanism of liver function injury in 250 patients with severe acute respiratory syndrome"},{"title3":"Prevention and treatment of liver injury in SARS patients-222 cases analysis"},{"title3":"Effect of SARS associated coronavirus on peripheral blood picture and liver function"},{"title3":"The clinic characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome"},{"title3":"Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome"},{"title3":"Study of the relationship SARS and hepatitis virus B"},{"title3":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients"},{"title3":"Clinical feature of liver injury in patients with severe acute respiratory syndrome"},{"title3":"Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome"},{"title3":"The dynamic change of liver injury in patients with severe acute respiratory syndrome"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"},{"title3":"Ultrastructure pathology of all organs in severe acute respiratory syndrome"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway"},{"title3":"Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Characteristics and outcomes of Middle East respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia"},{"title3":"Clinical and laboratory findings of Middle East respiratory syndrome coronavirus infection"},{"title3":"Critically Ill patients with the Middle East respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"The multifunctional or moonlighting protein CD26/DPPIV"},{"title3":"Multi-organ damage in human dipeptidyl peptidase 4 transgenic mice infected with Middle East respiratory syndrome-coronavirus"},{"title3":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile"},{"title3":"Coronavirus disease"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"COVID-19 in a Designated Infectious Diseases HospitalOutside Hubei Province, China"},{"title3":"Clinical features of COVID-19-related liver damage"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, Hubei"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of 82 death cases with COVID-19"},{"title3":"Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China"},{"title3":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-1 coronavirus receptor2 ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection"},{"title3":"Cholangiocyte pathobiology"},{"title3":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Diagnosis and Treatment of Coronavirus disease 2019 (Trial Version 7)"},{"title3":"Guidelines for the management of drug-induced liver injury"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Isolation and characterization of 2019-nCoV-like coronavirus from Malayan pangolins"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical features of COVID-19-Related liver functional abnormality","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2[J]"},{"title3":"WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Chinese Center for Disease Control and Prevention"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Diagnosis and treatment scheme of new coronavirus infected pneumonia. 2020"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Presumed asymptomatic carrier transmission of COVID-19"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Pathogenetic mechanisms of severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"A case of late presentation of darunavir-related cholestatic hepatitis"},{"title3":"Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity"},{"title3":"Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir"},{"title3":"Efficacies of lopinavir/ritonavir and arbidol in the treatment of novel coronavirus pneumonia"}]},{"title2":"Statins and its hepatic effects: newer data, implications, and changing recommendations","References":[{"title3":"Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: A meta-analysis of &gt;40 000 patients"},{"title3":"Expanding statin use to help more at-risk patients is causing financial heartburn"},{"title3":"The use of evidence-based therapy in acute myocardial infarction patients admitted to hospital during the Gulf registry of acute coronary events (Gulf Race)"},{"title3":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines"},{"title3":"The safety of statins in clinical practice"},{"title3":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)"},{"title3":"Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia"},{"title3":"Statin-related adverse events: A meta-analysis"},{"title3":"Diagnosis, prevention, and management of statin adverse effects and intolerance: Proceedings of a Canadian Working Group Consensus Conference"},{"title3":"Misperception among physicians and patients regarding the risks and benefits of statin treatment: The potential role of direct-to-consumer advertising"},{"title3":"Drug-induced liver injury: An overview over the most critical compounds"},{"title3":"Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians"},{"title3":"Lipid-lowering agents and hepatotoxicity"},{"title3":"Lipid-lowering agents that cause drug-induced hepatotoxicity"},{"title3":"Atorvastatin associated liver disease"},{"title3":"Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: A therapeutic dilemma"},{"title3":"Side effects of statins: Hepatitis versus &quot;transaminitis&quot;-myositis versus CPKitis"},{"title3":"The liver and lovastatin"},{"title3":"Defining patient risks from expanded preventive therapies"},{"title3":"Statins and liver toxicity: A meta-analysis"},{"title3":"Statins in liver disease: A molehill, an iceberg, or neither?"},{"title3":"Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force"},{"title3":"National Lipid Association Statin Safety Task Force Liver Expert Panel. An assessment of statin safety by hepatologists"},{"title3":"ACC/AHA/NHLBI clinical advisory on the use and safety of statins"},{"title3":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein"},{"title3":"Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia"},{"title3":"Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing"},{"title3":"An overview of the clinical safety profile of atorvastatin (lipitor), a new HMG-CoA reductase inhibitor"},{"title3":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis"},{"title3":"Pravachol (Package Insert). Bristol-Myers Squibb"},{"title3":"Risks associated with statin therapy: A systematic overview of randomized clinical trials"},{"title3":"Long-term safety and efficacy profile of simvastatin"},{"title3":"Hepatotoxicity of commonly used drugs: Nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs"},{"title3":"Considerations for safe use of statins: Liver enzyme abnormalities and muscle toxicity"},{"title3":"Review article: Drug hepatotoxicity"},{"title3":"Autoimmune hepatitis triggered by statins"},{"title3":"Hepatotoxicity associated with statin use: Analysis of the cases included in the Spanish Hepatotoxicity Registry"},{"title3":"Statin associated hepatic adverse effects: A retrospective review from a regional hospital in sultanate of Oman"},{"title3":"Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network"},{"title3":"Safety of statins"},{"title3":"Statin use is not associated with liver related mortality"},{"title3":"Food and Drug Administration. FDA Drug Safety Communication: Important Safety Label Changes to Cholesterol. Lowering Statin Drugs"},{"title3":"Safety of HMG-CoA reductase inhibitors: Focus on atorvastatin"},{"title3":"Statins in older adults"},{"title3":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report"},{"title3":"Adverse events associated with individual statin treatments for cardiovascular disease: An indirect comparison meta-analysis"},{"title3":"Safety of statins: Focus on clinical pharmacokinetics and drug interactions"},{"title3":"Treating statin-intolerant patients"},{"title3":"The myth of statin-induced hepatotoxicity"},{"title3":"Jaundice due to suspected statin hepatotoxicity: A case series"},{"title3":"Statin hepatotoxicity: Is it a real concern?"},{"title3":"Management of the patient with statin intolerance"},{"title3":"Management of statin intolerance"},{"title3":"Statin adverse effects: Patients' experiences and laboratory monitoring of muscle and liver injuries"},{"title3":"Statin safety evidence from the published literature"},{"title3":"Screening for statin-related toxicity: The yield of transaminase and creatine kinase measurements in a primary care setting"},{"title3":"New statin labeling requirements: An overview"},{"title3":"Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients"},{"title3":"Statins in primary biliary cirrhosis: Are they safe?"},{"title3":"Safety of statin therapy in patients with preexisting liver disease"},{"title3":"Liver tests are irrelevant when prescribing statins"},{"title3":"Prescribing statins to patients with nonalcoholic fatty liver disease: Real cardiovascular benefits outweigh theoretical hepatotoxic risk"},{"title3":"Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes"},{"title3":"Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity"},{"title3":"Pravastatin in patients with nonalcoholic steatohepatitis: Results of a pilot study"},{"title3":"Atorvastatin for the treatment of NASH"},{"title3":"Statin use and non-alcoholic steatohepatitis in at risk individuals"},{"title3":"Statins and hepatic steatosis: Perspectives from the Dallas Heart Study"},{"title3":"Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia"},{"title3":"Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis"},{"title3":"Incidence of statin hepatotoxicity in patients with hepatitis C"},{"title3":"Experience with statin use in patients with chronic hepatitis C infection"},{"title3":"Fluvastatin inhibits hepatitis C replication in humans"},{"title3":"Retrospective analysis of the effect of taking a statin along with peginterfereon and ribavirin (PI plus R) on SVR"},{"title3":"Sustained virologic response and other potential genotype-specific roles of statins among patients with hepatitis C-related chronic liver diseases"},{"title3":"Effectiveness and hepatotoxicity of statins in men seropositive for hepatitis C virus"},{"title3":"The association between Statins use and risk of hospitalization for acute hepatitis in patients with HBV infection"},{"title3":"Statin use in patients with cirrhosis: A retrospective cohort study"},{"title3":"Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients"},{"title3":"Statin use and the risk of liver cancer: A population-based case - Control study"}]},{"title2":"ESC guidance for the diagnosis and management of cv disease during the COVID-19 pandemic","References":[]},{"title2":"Large-Vessel stroke as a presenting feature of covid-19 in the young","References":[{"title3":"Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study."},{"title3":"Large artery ischaemic stroke in severe acute respiratory syndrome (SARS)."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."}]},{"title2":"SARS-CoV-2 and stroke in a new York healthcare system","References":[]},{"title2":"COVID-19 update: Covid-19-associated coagulopathy","References":[{"title3":"Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. On-line April10"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"},{"title3":"High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter propspective cohort study"},{"title3":"Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to D-dimer levels"},{"title3":"Large-vessel stroke as a presenting feature of Covid-19 in the young"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans"},{"title3":"Toward understanding the 2019 Coronavirus and its impact on the heart"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Novel pathogenic characteristics of highly pathogenic avian influenza virus H7N9: viraemia and extrapulmonary infection"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study"},{"title3":"Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19"},{"title3":"Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity"},{"title3":"Pericytes in the microvasculature"},{"title3":"Diversity within pericytes"},{"title3":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases"},{"title3":"Targeting potential drivers of COVID-19: neutrophil extracellular traps"},{"title3":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"},{"title3":"Sharma A, Garcia G, Arumugaswami V, Svendsen CN (2020) Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection. bioRxiv. 2020:2020.04.21.051912"},{"title3":"Tubuloreticular inclusions in renal allografts associate with viral infections and donor-specific antibodies"},{"title3":"Hemophagocytic lymphohistiocytosis in adults: associated diagnoses and outcomes, a ten-year experience at a single institution"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"McGonagle D, Sharif K, O'Regan A, Bridgewood C (2020) The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev 102537."},{"title3":"Coronin 1A, a novel player in integrin biology, controls neutrophil trafficking in innate immunity"},{"title3":"Translational implications of platelets as vascular first responders"},{"title3":"The interaction of bacterial pathogens with platelets"},{"title3":"Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A"},{"title3":"The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases"},{"title3":"Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays"},{"title3":"Neutrophil extracellular traps promote deep vein thrombosis in mice"},{"title3":"Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma"},{"title3":"Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo"},{"title3":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood"},{"title3":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells"},{"title3":"Extracellular RNA is a natural cofactor for the (auto-)activation of factor VII-activating protease (FSAP)"},{"title3":"Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation"},{"title3":"Polyphosphate and RNA differentially modulate the contact pathway of blood clotting"},{"title3":"Polyphosphate in thrombosis, hemostasis, and inflammation"},{"title3":"Neutrophil extracellular trap-microparticle complexes enhance thrombin generation via the intrinsic pathway of coagulation in mice"},{"title3":"Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbalpha"},{"title3":"Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation"},{"title3":"Neutrophil extracellular traps enhance procoagulant activity in patients with oral squamous cell carcinoma"},{"title3":"Neutrophil extracellular traps in COVID-19"},{"title3":"Platelets in neutrophil recruitment to sites of inflammation"},{"title3":"Platelet interleukin-1alpha drives cerebrovascular inflammation"},{"title3":"Transendothelial migration drives dissociation of plateletmonocyte complexes"},{"title3":"von Willebrand factor directly interacts with DNA from neutrophil extracellular traps"},{"title3":"The role of RNA uptake in platelet heterogeneity"},{"title3":"Platelets and platelet-like particles mediate intercellular RNA transfer"},{"title3":"The role of platelet microvesicles in intercellular communication"},{"title3":"Activation of the human contact system on neutrophil extracellular traps"},{"title3":"Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones"},{"title3":"Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs)"},{"title3":"Neutrophil-mediated proteolysis of thrombospondin-1 promotes platelet adhesion and string formation"},{"title3":"Human neutrophil elastase induces endothelial cell apoptosis by activating the PERK-CHOP branch of the unfolded protein response"},{"title3":"Neutrophils release brakes of coagulation"},{"title3":"The effect of leukocyte elastase on tissue factor pathway inhibitor"},{"title3":"Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets"},{"title3":"Neutrophil derived cathepsin G induces potentially thrombogenic changes in human endothelial cells: a scanning electron microscopy study in static and dynamic conditions"},{"title3":"Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms"},{"title3":"Functional responses and molecular mechanisms involved in histone-mediated platelet activation"},{"title3":"Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4"},{"title3":"Neutrophil extracellular traps in the second decade"},{"title3":"Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature"},{"title3":"VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice"},{"title3":"Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development"},{"title3":"Severe COVID-19 infection associated with endothelial activation"},{"title3":"Inflammatory mechanisms in the lung"},{"title3":"Innate immunity to respiratory viruses"},{"title3":"TGF-beta is a critical mediator of acute lung injury"},{"title3":"The inflammatory reflex"},{"title3":"The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors"},{"title3":"Pulmonary megakaryocytes: &quot;missing link&quot; between cardiovascular and respiratory disease?"},{"title3":"Platelets in lung biology"},{"title3":"Innate and adaptive immunity in the pathogenesis of atherosclerosis"},{"title3":"Covid-19 treatment update: follow the scientific evidence"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area"},{"title3":"The significance of disseminated intravascular coagulation on multiple organ dysfunction during the early stage of acute respiratory distress syndrome"},{"title3":"Fibrin and D-dimer bind to monomeric GPVI"},{"title3":"Effects of plasmin on von Willebrand factor and platelets: a narrative review"},{"title3":"Platelet collagen receptor glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation"},{"title3":"Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis"},{"title3":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19"},{"title3":"ESC/EACTS Guidelines on the management of valvular heart disease"},{"title3":"Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis"},{"title3":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up"},{"title3":"Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines"},{"title3":"Impact of the COVID-19 pandemic on therapeutic choices in thrombosis-hemostasis"}]}]},{"title1":"Statin Use and In?Hospital Mortality in Patients With Diabetes Mellitus and COVID?19","References":[{"title2":"Covid-19:navigating the uncharted","References":[{"title3":"Center for Infectious Disease Research and Policy. Global COVID rise continues; 50 nations report B117 variant. Available from URL: https://www.cidrap.umn.edu/news-perspective/2021/01/global-covid-rise-continues-50-nations-report-b117-variant (accessed February 2021)."},{"title3":"COVID-19 vaccines: breaking record times to first-in-human trials"},{"title3":"The Harvard Gazette. Fauci says herd immunity possible by fall, 'normality' by end of 2021. Available from URL: https://news.harvard.edu/gazette/story/2020/12/anthony-fauci-offers-a-timeline-for-ending-covid-19-pandemic (accessed February 2021)."},{"title3":"Anesthesia Patient Safety Foundation. Protecting our Patients: APSF Recommends that Anesthesia Professionals be Included in the First Phase of Vaccinations. Available from URL: https://www.apsf.org/news-updates/protecting-our-patients-apsf-recommends-that-anesthesia-professionals-be-included-in-the-first-phase-of-vaccinations (accessed February 2021)."},{"title3":"When, where, and how do immunizations fail?"}]},{"title2":"COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU","References":[]},{"title2":"Mild versus severe COVID-19: laboratory markers","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan"},{"title3":"Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible?"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis"},{"title3":"Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia"},{"title3":"Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID-19"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan"},{"title3":"2019 novel coronavirus patients' clinical characteristics, discharge rate and fatality rate of meta-analysis"},{"title3":"Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with 2019 novel coronavirus pneumonia"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia"},{"title3":"Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19"},{"title3":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial","References":[]},{"title2":"Hiding in plain sight: an approach to treating patients with severe COVID-19 infection","References":[{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19):China, 2020"},{"title3":"A practical treatment for patients with Ebola virus disease"},{"title3":"Simvastatin decreases lipopoly-saccharide-induced pulmonary inflammation in healthy volunteers"},{"title3":"Role of claudin-5 in the attenuation of murine acute lung injury by simvastatin"},{"title3":"Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases"},{"title3":"Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-kappaB pathways"},{"title3":"Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola"},{"title3":"Treating the host response to Ebola virus disease with generic statins and angiotensin receptor blockers"},{"title3":"Treating Ebola patients: a 'bottom up' approach using generic statins and angiotensin receptor blockers"},{"title3":"A randomized, controlled trial of Ebola virus disease therapeutics"},{"title3":"Treating Ebola in eastern DRC"},{"title3":"Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist"},{"title3":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications"},{"title3":"Imbalance between pulmonary angiotensin-converting enzyme and angiotensin-converting enzyme 2 activity in acute respiratory distress syndrome"},{"title3":"Do viral infections mimic bacterial sepsis? The role of microvascular permeability: a review of mechanisms and methods"},{"title3":"The Damage-Response Framework as a tool for the physician-scientist to understand the pathogenesis of infectious diseases"},{"title3":"Clinician-initiated research on treating the host response to pandemic influenza"}]},{"title2":"Pleiotropic effects of statins on the cardiovascular system","References":[]},{"title2":"Early statin treatment following acute myocardial infarction and 1-year survival","References":[]},{"title2":"Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells","References":[]},{"title2":"Endothelial cell infection and endotheliitis in COVID-19","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Offline: COVID-19:bewilderment and candour"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2"},{"title3":"The assessment of endothelial function: from research into clinical practice"},{"title3":"Endothelial dysfunction - a marker of atherosclerotic risk"},{"title3":"The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion"},{"title3":"Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients"},{"title3":"Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis"},{"title3":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis"},{"title3":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed"}]},{"title2":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications","References":[]},{"title2":"COVID-19, ACE2, and the cardiovascular consequences","References":[]},{"title2":"A note on competing risks in survival data analysis","References":[{"title3":"Survival analysis part II: Multivariate data analysis - an introduction to concepts and methods"},{"title3":"Survival analysis part III: Multivariate data analysis - choosing a model and assessing its adequacy and fit"},{"title3":"Survival analysis part I: Basic concepts and first analyses"},{"title3":"Survival analysis part IV: Further concepts and methods in survival analysis"},{"title3":"Regression models and life tables (with discussion)"},{"title3":"A proportional hazards model for the sub-distribution of a competing risk"},{"title3":"A review and critique of some models used in competing risk analysis"},{"title3":"A class of k-sample tests for comparing the cumulative incidence of a competing risk"},{"title3":"Nonparametric estimation from incomplete observations"},{"title3":"A 20-year perspective on the International Fanconi anemia Registry (IFAR)"},{"title3":"Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data"},{"title3":"The analysis of failure times in the presence of competing risks"},{"title3":"Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations"},{"title3":"Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches"}]},{"title2":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","References":[]},{"title2":"Propensity-score matching with competing risks in survival analysis","References":[{"title3":"The central role of the propensity score in observational studies for causal effects"},{"title3":"An introduction to propensity-score methods for reducing the effects of confounding in observational studies"},{"title3":"Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement"},{"title3":"A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003"},{"title3":"A report card on propensity-score matching in the cardiology literature from 2004 to 2006: a systematic review and suggestions for improvement"},{"title3":"A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals"},{"title3":"The performance of different propensity score methods for estimating marginal hazard ratios"},{"title3":"Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study"},{"title3":"The performance of different propensity score methods for estimating absolute effects of treatments on survival outcomes: a simulation study"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments"},{"title3":"Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo study"},{"title3":"Introduction to the analysis of survival data in the presence of competing risks"},{"title3":"Tutorial in biostatistics: competing risks and multi-state models"},{"title3":"Competing risk regression models for epidemiologic data"},{"title3":"The number needed to treat: a clinically useful measure of treatment effect"},{"title3":"An assessment of clinically useful measures of the consequences of treatment"},{"title3":"Basic statistics for clinicians: 3. Assessing the effects of treatment: measures of association"},{"title3":"Odds ratio, relative risk, absolute risk reduction, and the number needed to treat-which of these should we use?"},{"title3":"Clinically useful measures of effect in binary analyses of randomized trials"},{"title3":"A tutorial on methods to estimating clinically and policy-meaningful measures of treatment effects in prospective observational studies: a review"},{"title3":"Philosophy of inference from retrospective studies"},{"title3":"Article types and preparation"},{"title3":"Calculating the number needed to treat for trials where the outcome is time to an event"},{"title3":"Number needed to treat for time-to-event data with competing risks"},{"title3":"A proportional hazards model for the subdistribution of a competing risk"},{"title3":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data"},{"title3":"A class of K-sample tests for comparing the cumulative incidence of a competing risk"},{"title3":"Average causal effects from nonrandomized studies: a practical guide and simulated example"},{"title3":"Competing risks regression for clustered data"},{"title3":"Competing risks regression for stratified data"},{"title3":"Type I error rates, coverage of confidence intervals, and variance estimation in propensity-score matched analyses"},{"title3":"Comparing paired vs non-paired statistical methods of analyses when making inferences about absolute risk reductions in propensity-score matched samples"},{"title3":"A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions"},{"title3":"Plasmode simulation for the evaluation of pharmacoepidemiologic methods in complex healthcare databases"},{"title3":"The number of primary events per variable affects estimation of the subdistribution hazard competing risks model"},{"title3":"Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial"},{"title3":"The cardiovascular health in ambulatory care research team (CANHEART): using big data to measure and improve cardiovascular health and healthcare services"},{"title3":"A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry"},{"title3":"Estimating causal effects of treatments in randomized and nonrandomized studies"},{"title3":"A comparison of 12 algorithms for matching on the propensity score"},{"title3":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies"},{"title3":"Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates"},{"title3":"R: a language and environment for statistical computing"},{"title3":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples"},{"title3":"Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding"},{"title3":"The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies"},{"title3":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men"},{"title3":"Ipw: an R package for inverse probability weighting"},{"title3":"Nonparametric estimation of average treatment effects under exogeneity: a review"},{"title3":"A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study"},{"title3":"Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations"},{"title3":"The performance of different propensity-score methods for estimating relative risks"},{"title3":"The performance of different propensity score methods for estimating marginal odds ratios"},{"title3":"Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score"},{"title3":"The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies"},{"title3":"The use of bootstrapping when using propensity-score matching without replacement: a simulation study"},{"title3":"Double propensity-score adjustment: a solution to design bias or bias due to incomplete matching"},{"title3":"The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes"},{"title3":"Estimating the effect of treatment on binary outcomes using full matching on the propensity score"},{"title3":"Comparing the performance of propensity score methods in healthcare database studies with rare outcomes"}]},{"title2":"Variable selection for propensity score models","References":[{"title3":"The central role of the propensity score in observational studies for causal effects"},{"title3":"Tutorial in biostatistics: propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group"},{"title3":"Variable selection for propensity score models"},{"title3":"A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study"},{"title3":"Estimating causal effects from large data sets using propensity scores"},{"title3":"On a class of bias-amplifying covariates that endanger effect estimates"},{"title3":"Confounding control in healthcare database research: challenges and potential approaches"},{"title3":"Effects of adjusting for instrumental variables on bias and precision of effect estimates"},{"title3":"Invited Commentary: Understanding Bias Amplification"},{"title3":"A Comparison of Covariate Selection Approaches for Propensity Score (PS) Derivation"},{"title3":"Confounding and collapsibility in causal inference"},{"title3":"Improving automated database studies"},{"title3":"A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods"},{"title3":"The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies"},{"title3":"Reducing bias in a propensity score matched-pair sample using greedy matching techniques. (Paper 214-26)"},{"title3":"Marginal structural models and causal inference in epidemiology"},{"title3":"Marginal structural models to estimate the causal effect of zidovudine on the Survival of HIV-Positive Men"},{"title3":"Constructing inverse probability weights for marginal structural models"},{"title3":"Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models"},{"title3":"The effectiveness of adjustment by subclassification in removing bias in observational studies"},{"title3":"Data, Design, and Background Knowledge in Etiologic Inference"}]},{"title2":"Methods for constructing and assessing propensity scores","References":[]},{"title2":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19","References":[{"title3":"Critical care management of adults with community-acquired severe respiratory viral infection"},{"title3":"Statin therapy in COVID-19 infection: much more than a single pathway"},{"title3":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial"},{"title3":"Statin therapy in COVID-19 infection"},{"title3":"A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study)"},{"title3":"Considerations for statin therapy in patients with COVID-19"},{"title3":"The effects of ARBs, ACEIs and statins on clinical outcomes of COVID-19 infection among nursing home residents"},{"title3":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals"},{"title3":"Position statement of the ESC council on hypertension on ACE-inhibitors and angiotensin receptor blockers"},{"title3":"Acute respiratory distress syndrome: advances in diagnosis and treatment"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Treating influenza with statins and other immunomodulatory agents"},{"title3":"Treating the host response to Ebola virus disease with generic statins and angiotensin receptor blockers"},{"title3":"Hiding in plain sight: an approach to treating patients with severe COVID-19 infection"},{"title3":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis"},{"title3":"Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide"},{"title3":"Survivor treatment selection bias in observational studies: examples from the AIDS literature"},{"title3":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies"},{"title3":"Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Chinese expert consensus on the use of statins in elderly with dyslipidemia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A statement from the International Society of Hypertension on COVID-19"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis"},{"title3":"Longitudinal association between markers of liver injury and mortality in COVID-19 in China"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study"},{"title3":"Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind"},{"title3":"Web site and R Package for computing E-values"},{"title3":"Simvastatin in the acute respiratory distress syndrome"},{"title3":"Neutrophils and immunity: challenges and opportunities"},{"title3":"The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial"},{"title3":"Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial"},{"title3":"Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - a systematic review and meta-analysis"},{"title3":"The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011"},{"title3":"The treatment of unrelated disorders in patients with chronic medical diseases"},{"title3":"Statins and the COVID-19 main protease: in silico evidence on direct interaction"},{"title3":"Pulmonary infections in the elderly lead to impaired neutrophil targeting, which is improved by simvastatin"},{"title3":"Simvastatin improves neutrophil function and clinical outcomes in pneumonia. A pilot randomized controlled clinical trial"},{"title3":"NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin"},{"title3":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation"},{"title3":"The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts"},{"title3":"Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study"},{"title3":"COVID-19, ACE2, and the cardiovascular consequences"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications"},{"title3":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome"},{"title3":"Sensitivity analysis in observational research: introducing the E-value"},{"title3":"C-reactive protein as a biomarker of severe H1N1 influenza"},{"title3":"Comparison of imputation methods for missing laboratory data in medicine"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases interim guidance"},{"title3":"Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation"},{"title3":"2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America"},{"title3":"Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4/MYD88 pathway"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"}]},{"title2":"The role of inflammation in diabetes: current concepts and future perspectives","References":[{"title3":"Diagnosis of diabetes"},{"title3":"Changes in diabetes-related complications in the United States, 1990-2010"},{"title3":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction."},{"title3":"Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study"},{"title3":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II"},{"title3":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030"},{"title3":"WHO. Global report on diabetes Geneva WHO"},{"title3":"General aspects of diabetes mellitus"},{"title3":"American Diabetes Association Classification and diagnosis of diabetes: standards of medical care in diabetes 2018"},{"title3":"Global estimates of the prevalence of diabetes for 2010 and 2030"},{"title3":"Diabetes in Asia: epidemiology, risk factors, and pathophysiology"},{"title3":"Inflammation and insulin resistance"},{"title3":"On the treatment of glycosuria and diabetes mellitus with sodium salicylate"},{"title3":"Aspirin and diabetes mellitus"},{"title3":"Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy."},{"title3":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance"},{"title3":"Fibrinolysis in obesity"},{"title3":"Reduction of blood fibrinolytic activity in diabetes mellitus by insulin"},{"title3":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis"},{"title3":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men"},{"title3":"Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study"},{"title3":"Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes."},{"title3":"Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K."},{"title3":"Therapeutic approaches to target inflammation in type 2 diabetes."},{"title3":"Type 1 diabetes"},{"title3":"How does type 1 diabetes develop?: the notion of homicide or beta-cell suicide revisited"},{"title3":"Analysis of islet inflammation in human type 1 diabetes"},{"title3":"Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies"},{"title3":"Type 1 diabetes: new perspectives on disease pathogenesis and treatment."},{"title3":"Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study"},{"title3":"The NOD mouse: a model of immune dysregulation"},{"title3":"Both CD4+ and CD8+ T cells are required for IFN-gamma gene expression in pancreatic islets and autoimmune diabetes development in biobreeding rats"},{"title3":"Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice."},{"title3":"Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populations"},{"title3":"Pancreatic pathology in type 1 diabetes mellitus"},{"title3":"In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice"},{"title3":"T helper cell subsets in insulin-dependent diabetes"},{"title3":"Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes"},{"title3":"Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages."},{"title3":"Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes"},{"title3":"Reduction of circulating neutrophils precedes and accompanies type 1 diabetes"},{"title3":"Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients"},{"title3":"Immune cell crosstalk in type 1 diabetes"},{"title3":"How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets"},{"title3":"Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production"},{"title3":"Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated beta-cell death"},{"title3":"PTPN2, a candidate gene for type 1 diabetes, modulates interferon-gamma-induced pancreatic beta-cell apoptosis"},{"title3":"Interferon-gamma potentiates endoplasmic reticulum stress-induced death by reducing pancreatic beta cell defence mechanisms"},{"title3":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function"},{"title3":"B-lymphocyte depletion with rituximab and beta-cell function: two-year results"},{"title3":"Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8+ T cells in type 1 diabetes"},{"title3":"Anti-CD3 clinical trials in type 1 diabetes mellitus"},{"title3":"Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study"},{"title3":"alpha1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1beta responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes."},{"title3":"Vitamin D, immune tolerance, and prevention of type 1 diabetes"},{"title3":"A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes"},{"title3":"Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual beta-cell function in new-onset type 1 diabetes mellitus"},{"title3":"Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials"},{"title3":"Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes"},{"title3":"Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study"},{"title3":"Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism"},{"title3":"Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study."},{"title3":"Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects Evidence for a hyperbolic function."},{"title3":"Pathogenesis of type 2 diabetes mellitus"},{"title3":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes"},{"title3":"Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake."},{"title3":"Type 2 diabetes as a disease of ectopic fat?"},{"title3":"Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause"},{"title3":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus"},{"title3":"C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study,1984-1998."},{"title3":"The molecular mechanisms of obesity paradox"},{"title3":"A central role for JNK in obesity and insulin resistance."},{"title3":"Inflammation and metabolic disorders"},{"title3":"Macrophages, inflammation, and insulin resistance."},{"title3":"Inflammatory links between obesity and metabolic disease"},{"title3":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization"},{"title3":"CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity"},{"title3":"Periadventitial adipose tissue plays a critical role in vascular remodeling"},{"title3":"Anatomical locations of human brown adipose tissue: functional relevance and implications in obesity and type 2 diabetes"},{"title3":"Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis"},{"title3":"A critical appraisal of the prevalence and metabolic significance of brown adipose tissue in adult humans."},{"title3":"Obesity, inflammation, and insulin resistance."},{"title3":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity"},{"title3":"Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue"},{"title3":"Adiponectin: from obesity to cardiovascular disease."},{"title3":"State of the union between metabolism and the immune system in type 2 diabetes"},{"title3":"Bariatric surgeries: beyond restriction and malabsorption."},{"title3":"Mechanisms of weight loss, diabetes control and changes in food choices after gastrointestinal surgery"},{"title3":"Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery?"},{"title3":"Insights into the role of the microbiome in obesity and type 2 diabetes."},{"title3":"An obesity-associated gut microbiome with increased capacity for energy harvest"},{"title3":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome"},{"title3":"Host-gut microbiota metabolic interactions"},{"title3":"Interactions between the microbiota and the immune system"},{"title3":"Immuno-microbiota cross and talk: the new paradigm of metabolic diseases"},{"title3":"Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity"},{"title3":"Metabolic endotoxemia initiates obesity and insulin resistance."},{"title3":"Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity."},{"title3":"Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity."},{"title3":"Metabolism meets immunity: The role of free fatty acid receptors in the immune system"},{"title3":"Causality of small and large intestinal microbiota in weight regulation and insulin resistance"},{"title3":"The effect of short-chain fatty acids on human monocyte-derived dendritic cells"},{"title3":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation"},{"title3":"Butyrate blocks interferon-gamma-inducible protein-10 release in human intestinal subepithelial myofibroblasts"},{"title3":"Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation"},{"title3":"Genetics of type 2 diabetes"},{"title3":"beta-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment."},{"title3":"Increased number of islet-associated macrophages in type 2 diabetes"},{"title3":"Islet amyloid with macrophage migration correlates with augmented beta-cell deficits in type 2 diabetic patients"},{"title3":"Saturated fatty acid and TLR signaling link beta cell dysfunction and islet inflammation"},{"title3":"Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes"},{"title3":"Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes"},{"title3":"The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia"},{"title3":"Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes."},{"title3":"Impact of islet autoimmunity on the progressive beta-cell functional decline in type 2 diabetes"},{"title3":"Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1beta production and beta-cell dysfunction"},{"title3":"Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes"},{"title3":"Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function"},{"title3":"Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I."},{"title3":"Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation."},{"title3":"Osteopontin protects the islets and beta-cells from interleukin-1 beta-mediated cytotoxicity through negative feedback regulation of nitric oxide"},{"title3":"Leucine metabolism in regulation of insulin secretion from pancreatic beta cells"},{"title3":"Reactive nitrogen species in the chemical biology of inflammation"},{"title3":"Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus"},{"title3":"Inflammatory mechanisms in the regulation of insulin resistance"},{"title3":"Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy"},{"title3":"Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance"},{"title3":"Adaptive immunity in obesity and insulin resistance"},{"title3":"Blockade of receptor activator of nuclear factor-kappaB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus"},{"title3":"Neuroinflammation in overnutrition-induced diseases"},{"title3":"Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action."},{"title3":"Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus"},{"title3":"The role of C-reactive protein genetic variability in the onset of carotid artery disease and renal function impairment in patients with diabetes mellitus type 2"},{"title3":"Twenty year fitness trends in young adults and incidence of prediabetes and diabetes: the CARDIA study"},{"title3":"Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study"},{"title3":"Inflammatory markers and bariatric surgery: a meta-analysis"},{"title3":"Improvement of plasma adiponectin, leptin and C-reactive protein concentrations by orlistat: a systematic review and meta-analysis"},{"title3":"Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release"},{"title3":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein"},{"title3":"Statin therapy and risk of developing type 2 diabetes: a meta-analysis"},{"title3":"Combined effects of atorvastatin and metformin on glucose-induced variations of inflammatory process in patients with diabetes mellitus"},{"title3":"Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?"},{"title3":"A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma"},{"title3":"Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial"},{"title3":"The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial"},{"title3":"Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin"},{"title3":"Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells"},{"title3":"Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction"},{"title3":"Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells"},{"title3":"Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis"},{"title3":"Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model."},{"title3":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes"},{"title3":"Canagliflozin: a new hope in the antidiabetic armamentarium"},{"title3":"Targeting inflammation in the treatment of type 2 diabetes: time to start"},{"title3":"Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis"},{"title3":"Anti-inflammatory agents: present and future"},{"title3":"Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S."},{"title3":"The effect of sodium salicylate and aspirin on NF-kappa B."},{"title3":"Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes"},{"title3":"Salsalate improves glycemia and inflammatory parameters in obese young adults"},{"title3":"Reduction of insulin resistance and plasma glucose level by salsalate treatment in persons with prediabetes"},{"title3":"Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes"},{"title3":"A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance"},{"title3":"Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial"},{"title3":"The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial"},{"title3":"Potential role of salicylates in type 2 diabetes"},{"title3":"Effect of methotrexate use and erythrocyte methotrexate polyglutamate on glycosylated hemoglobin in rheumatoid arthritis"},{"title3":"Low-dose methotrexate for the prevention of atherosclerotic events"},{"title3":"Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab"},{"title3":"Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis"},{"title3":"Relapse of diabetes after interruption of chronic administration of anti-tumor necrosis factor-alpha antibody infliximab: a case observation"},{"title3":"Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis"},{"title3":"Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases."},{"title3":"Effect of etanercept on insulin sensitivity in nine patients with psoriasis"},{"title3":"Infliximab in the treatment of Crohn disease and type 1 diabetes."},{"title3":"Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM"},{"title3":"No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients."},{"title3":"Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes"},{"title3":"Effects of etanercept in patients with the metabolic syndrome"},{"title3":"TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome."},{"title3":"Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes"},{"title3":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus"},{"title3":"Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study"},{"title3":"Impact of interleukin-1beta antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: results of secondary endpoints from a randomized, placebo-controlled trial"},{"title3":"Effect of anti-IL-1beta antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial"},{"title3":"Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1beta antibody, in patients with type 2 diabetes."},{"title3":"Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial"},{"title3":"Anti-inflammatory therapy with canakinumab for the prevention and management of diabetes"},{"title3":"Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes."},{"title3":"The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset type 1 diabetes (IMDIAB XI)."},{"title3":"Preliminary studies related to anti-interleukin-1beta therapy in children with newly diagnosed type 1 diabetes"},{"title3":"Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset"},{"title3":"One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitus"},{"title3":"The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance"},{"title3":"The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study"},{"title3":"Effect of diacerein on insulin secretion and metabolic control in drug-naive patients with type 2 diabetes: a randomized clinical trial."}]},{"title2":"Cells of innate and adaptive immunity in type 2 diabetes and obesity","References":[]},{"title2":"COVID-19 pandemic, coronaviruses, and diabetes mellitus","References":[]},{"title2":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia:a systematic review, meta-analysis, and meta-regression","References":[{"title3":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes Atlas, 9th edition"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Diabetes is a risk factor for the progression and prognosis of COVID-19"},{"title3":"COVID-19 and diabetes"},{"title3":"World Health Organization. Report of the WHO-China joint mission on coronavirus disease 2019 COVID-19 report. vol. vol. 2019. n.d."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical features and treatment of COVID-19 patients in Northeast Chongqing"},{"title3":"Platelet-to-lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease-19"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China"},{"title3":"Clinical characteristics of patients with severe pneumonia caused by the 2019 novel coronavirus in Wuhan, China"},{"title3":"Early prediction of disease progression in 2019 novel coronavirus pneumonia patients outside Wuhan with CT and clinical characteristics"},{"title3":"Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing,China"},{"title3":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients"},{"title3":"COVID-19 in a designated infectious diseases Hospital Outside Hubei Province,China"},{"title3":"Neutrophil-to-Lymphocyte ratio Predicts severe illness patients with 2019 novel coronavirus in the early stage"},{"title3":"Non-severe vs severe symptomatic COVID-19: 104 cases from the outbreak on the cruise ship &quot;Diamond Princess&quot; in Japan"},{"title3":"Clinical characteristics and risk factors for fatal outcome in patients with 2019-coronavirus infected disease (COVID-19) in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical features of patients infected with the 2019 novel coronavirus (COVID-19) in Shanghai, China"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Radiographic findings and other predictors in adults with Covid-19"},{"title3":"Analysis of death risk factors among 200 COVID-19 patients in Wuhan, China: a hospital-based case-cohort study"},{"title3":"Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan , China"},{"title3":"Clinical characteristics of SARS-CoV-2 infections involving 325 hospitalized patients outside Wuhan"},{"title3":"Epidemiological Characteristics of 417 patients infected with COVID-19 and 368 discharged cases among them in Shenzhen City , China CURRENT STATUS : under review"},{"title3":"Wang D, Li R, Wang J, Jiang Q, Gao C, Yang J, et al. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study. Res Sq n.d.:1-17. doi:10.21203/rs.3.rs-19680/v1."},{"title3":"COVID-19, diabetes mellitus and ACE2: the conundrum"},{"title3":"The effect of Short-term hyperglycemia on the innate immune system"},{"title3":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long Structural studies of SARS coronavirus"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is Blocked by a clinically proven protease inhibitor"},{"title3":"Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats"},{"title3":"Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infection with reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"The dilemma of coronavirus disease 2019, aging, and cardiovascular disease: Insights from cardiovascular aging science"},{"title3":"Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics"},{"title3":"Immune dysfunction in patients with diabetes mellitus (DM)"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Diabetes is a risk factor for the progression and prognosis of COVID-19","References":[{"title3":"Diabetes is a risk factor for the progression and prognosis of COVID-19"},{"title3":" https://www.cdc.gov/diabetes/basics/diabetes.html. Accessed April 10, 2020."},{"title3":"The immune system's involvement in obesity-driven type 2 diabetes"},{"title3":" https://bit.ly/2xjKnOF. Accessed April 10, 2020."},{"title3":"Severe outcomes among patients with coronavirus disease 2019-United States, February 12-March 16, 2020"}]},{"title2":"Anti-inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes","References":[]},{"title2":"2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines","References":[]},{"title2":"Trends and disparities in statin use and low-density lipoprotein cholesterol levels among US patients with diabetes, 1999-2014","References":[]}]}]}